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A b s t r a c t
It is well established that certain anthracene-9,10-diones such as Mitoxantrone (24b) and 
Amentantrone (24a) are potent anticancer drugs but suffer from the disadvantage that they are 
also cardiotoxic. Few sulfur containing anthracene-9,10-diones have been researched for their 
biological activity, and the current studies were aimed to synthesise a series of anthracene-
9,10-dione derivatives containing both as substituted and as part of the ring system in an 
endeavour to conserve their anticancer activity but reduce their cardiotoxicity. A series of 
twenty four anthracene-9,10-diones were synthesized, seventeen of which have not been 
previously reported. Twelve of those derivatives contained sulfur and include the 1,4- 
bis(amino)-5,8-bis(sulfanyl)anthracene-9,10-diones, which were synthesised from the 
amination of 2,3-dihydro-9,10-dihydroxy-5,8-dichloroanthracene-l,4-dione with selected 
amines followed by the subsequent reaction with thiolates. A ring derivative was also 
synthesised, 7-(aminoalkyl)-14H-naptho[2,3-a]phenothiazine-8,13-dione from the reaction of 
l-(alkylamino)-4-hydroxyanthracene-9,10-dione and 2-aminothiophenol with boric acid. 
Semi-empirical molecular orbital methods were employed to model the anthracene-9,10-dione 
derivatives. To establish the most appropriate method for calculation a set of well known 
anthracene-9,10-diones were selected from the Cambridge crystallographic database and 
compared to computational data obtained using the AMI, PM3 and MNDO methods. All 
three methods give reasonable structures by comparison with the experimental data, when 
suitable constraints were applied to the optimisations. On balance the AMI method was 
selected to model the synthesized anthracene-9,10-dione derivatives in this work. AMI 
produced more accurate results for the nitrogen-carbon and oxygen carbon bond lengths. It 
also required no constraints when the simple sulfur derivatives were optimised. A series of 
reference calculations at the ab initio 6-31G** level were also carried out, to check veracity of 
the of the results obtained form the AMI method.
The computational data highlighted two factors that may be significant in the biological 
activity of anthracene-9,10-diones. It appears that molecules that are biologically active 
contain alkylamino groups at the 1-and 4- position and have ionization potentials in the range 
of 7.7-7.9 eV. The computational data of the derivatives synthesized in this work shows 
many of them meet this criteria and therefore may possess anti-cancer activity, though this 
aspect of the research was not addressed in the current studies.
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CHAPTER 
ONE
In t r o d u c t i o n
1
1.0General Background
Anthracene-9,10-dione (1) is the most important derivative of anthracene. It can be 
prepared by the condensation of phthalic anhydride and benzene or the direct oxidation of 
anthracene. It is a colourless crystalline solid, which melts at 285°C and has a molecular 
formula C14H8O2; it also forms an important class of dyes.
o
o
(1)
Renewed interest in the chemistry of anthracene-9,10-diones follows the discovery of the 
anthracyclines. These compounds are an important class of clinical antitumor agents1, 
with doxorubicin (2) being one of the most effective and widely prescribed anti-cancer 
agents in the field of chemotherapy. It is this class of anthracene-9,10-dione, which 
forms the basis of this thesis, and accordingly the use of anthracene-9,10-dione anti­
cancer agents is reviewed in depth, followed by a brief account of the other applications 
of anthracene-9,10-diones including their use as dyes and pigments.
2
O OH O
.OH
'OH
OMe O OH O
Me'
NH
OH
(2)
1.1 Anthracyclines
The anthracyclines were first discovered in the 1950’s with the isolation of a number of 
pigmented substances from the strains of Streptomyces pururascens species2 (3-6).
OH OH OHOH OH
OH OH OHOH OH OH
(3) (4)
OH OH OHOH
CH-
OH
OH OH OHOH OH OH
(5)
3
These compounds were characterised as glycosides of various substituted 
tetrahydronaphthacenequinones. Rhodomycin (7) was found to have antitumor properties 
but the compound was not suitable for human therapy due to the high toxicity in mice3.
HO
OH O OH O
HO
OH
This discovery sparked further investigation into the biological properties of other 
derivatives in this class of compounds. In 1963, two research groups Faramitalia4 and 
Rhone-Poulenic4 independently described the isolation and characterisation of 
daunomycin (rubidomycin) (8a), which, had antitumor properties and potential for 
treatment in humans. In 1969 the Faramitalia group isolated doxorubicin (Adriamycin) 
(8b) from Streptomyces peucetius var. caesius4. Extensive testing showed its superiority 
over daunomycin and this was confirmed in clinical tests against solid tumours. It is
4
interesting to note that a relatively small structural change, namely the introduction o f a 
hydroxyl group, results in a large improvement of biological activity (8 a-b).
OH
'OH
OMe OH
Me
(8)
(a)X=H Daunomycin
(b) X=OH Adriamycin
There has been in excess o f2000 anthracyclines synthesised to date however none have 
superseded die anti tumour activity of Daunomycin and Adriamycin.
1.1.1 Daunomycin
The first report on the anti tumour activity o f daunomycin indicated exceptional 
pharmacological properties. The drug was tested mainly on leukaemias, Hodgkin’s 
disease, lymphosarcoma and reticular cell sarcoma. However toxic side effects were 
noted in patients: they were stomatitis, alopecia, bone marrow suppression and 
gastrointestinal disturbances. The most serious limiting factor was recognized as the 
dose dependent cardiotoxicity.
5
1.1.2 Adriamycin
Adriamycin exhibited the same kind of inhibitory effect as daunomycin, but was 
generally more potent Clinical trials confirmed the early promise of this valuable agent, 
which proved to be effective as a single agent or when combined with other drugs. The 
results of extensive clinical trials proved that the drug had a wide-ranging spectrum of 
activity, though the only real limiting factor was again the cardiotoxicity.
Cardiotoxicity is attributed to the formation of a drug iron complex, which can lead to 
harmful free radicals, due to the complex’s ability to undergo reversible oxidation. These 
free radicals damage the cardiac muscles, which are deficient in protective antioxidants. 
In an attempt to counteract this cardiotoxicity the anthracyclines have been administered 
with drugs that combat this harmful side effect Such cardioprotective agents include 
dexrazoxane5(ICRF-187, Zinecard, 9), which works by competing for iron
This is affected when the molecule is hydrolysed to its ring opened form (10) in vivo, 
which has a high affinity for metal ions, in a similar manner to EDTA (11).
H
NH
6
HN
\ N
/
(9)
/
V
HOOC-
HOOC-
NH
\ N
/
2H20
HOOC-
H2NOC-
v y
(11) V
\
-COOH
-COOH
(10)
-COOH
-CONH2
1.13 Classification on basis of structure or mode of action
Anthracyclines are classified upon the similarity in structure and the unique groups, 
which they may possess. Anthracyclines can also be classified into those, which bind 
intercalatively to DNA, and those, which do not There are two classes of intercalative 
anthracyclines, class I which inhibit both DNA and RNA equally and class II which 
inhibits RNA synthesis 200 to 1300 times more effectively than DNA synthesis. Class 
I\& n, can be further divided on the ability of the molecules to bind to DNA. The 
anthracyclines can also be further classified on their ability to form a non-cleavable 
complex with topoisomerase II and DNA.
1.1.4 Mode of action
Despite their extensive clinical utilisation, the mode of action is subject to controversy6. 
It has been discovered that anthracyclines rapidly enter cells, gather in the nuclei and 
bind to DNA. Anthracyclines can bind to DNA in two ways, into the minor groove or 
intercalatively. Minor groove binding is a result of DNA being twisted into its double 
helical form. Because the DNA bases in the double helix are not twisted 180° to each
7
other, two grooves appear, the minor and the major grove (Figure 1 -1). The minor 
groove is where anthracyclines preferentially bind to DNA.
Major - 
groove
Major
groove
M inor-
groove
Figure 1-1. Minor groove binding of anthracyclines (yellow) with DNA (red & blue).
Anthracyclines can also bind to DNA intercalatively. As the chromophore is a planar 
polycyclic molecule it has the ability to slip in between the DNA base pairs7, this is 
known as intercalation (Figure 1-2).
8
Figure 1-2. Intercalation of anthracyclines (yellow) into DNA (red & blue)
Minor grove binding and intercalation can stop the DNA from unwinding (in the same 
way something getting stuck in a zipper would cause it to jam or a stick in a bicycle 
wheel). If the DNA cannot unwind the cell cannot replicate and will therefore die.
Minor grove binding and intercalation cannot account solely for the potency of these 
drugs, though the process is thought to act as some sort of “anchoring mechanism” 8 until 
a cell killing event occurs.
Once bound to the DNA they can further interfere with cell transcription and replication
in two ways.
I. Anthracyclines interfere with the normal mode of action of topoisomerase n, which is 
an important class of enzyme that is essential for cell replication. It is involved in the 
unwinding of a cells DNA from its double helical form into single strands. 
Anthracyclines form an un-cleavable complex with the enzyme. This complex is not
9
sufficient to insure cell death, however once the complex is formed the enzymes mode 
of action is modified. Instead of just unwinding and separating the DNA strands it now 
also causes breaks in the DNA strand. These strand breaks are then sensed by the cell 
via a series of stress associated pathways, the cell arrests and apoptosis (see p26 section 
1.2.9) occurs9.
n. Anthracyclines can also form damaging free radicals via enzymatic reduction. A one- 
electron reduction produces a semiquinone and two-electron reduction gives a 
hydroquinone. The semiquinone radical is capable of transferring its electron to 
molecular oxygen to form a superoxide radical, which is converted to hydrogen 
peroxide via a disproportionation process. Damage occurs when the hydrogen peroxide 
comes into contact with reduced metal ion such as copper or iron, which then leads to 
formation of the hydroxyl radical. This highly reactive hydroxyl radical is responsible 
for oxidation of fatty acids, degradation of proteins and DNA damage via Fenton type 
reactions. This process is why these compounds are so cardiotoxic, as the heart is 
susceptible to free radical damage because of a deficiency in protective enzymes. Free 
radicals can also form covalent bonds with DNA, which in effect stabilize the double 
helix preventing DNA from unwinding. For a cell to replicate the DNA it must be 
unwound into its single form. If a cell cannot do this it cannot perform the basic 
functions that keep it alive and it therefore dies.
1.1.5 Recent developments in the field of anthracyclines
Despite the widespread use of Adriamycin and Daunomycin for thirty years, there have 
been few improvements to the drugs, despite extensive research aimed at developing 
anthracyclines with greater activity and lower cardiotoxicity. This research has lead to
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the synthesis of over 2000 analogues. Some of the derivatives including Cariomycin (or 
Carubicin (20) 10 originally developed in the Soviet Union in the 1980’s, Aclacinomycin 
A (or Aclarubicin (21)11 that were both marketed in France and Japan for the treatment of 
leukaemia.
OH
OH
OH
OH OH
OHOH
Me'
Me'
NH
OH
(20)
Me'
HO (21)
Other marketed compounds include daunorubicin benzoylhydrazone (Zorubicin or 
Rubidazone®)12 and Idarubicin hydrochloride (Idamycin) (22b), which differs from the 
parent drug daunomycin (22a), by the absence of a methoxy group at position 4.
11
R O OH O
Me'
NH-
OH
(22)
(a)R>sOMe Daunomycin 
(b) R=H Idrarubicin
The absence of this group increases the drugs lipophilicity and its DNA binding ability. 
One approach to improve the effectiveness of doxorubicin has been to improve its 
delivery to tumours, using drug-carrier technology. This approach can be classified in 
two ways, depending on whether there is a specific recognition of a tumour by the carrier 
or simply preferential distribution. The advantages of this technology are less of the drug 
is required, resulting in less damage to non-tumour cells and fewer side effects.
For example, encapsulation of Adriamycin or daunomycin in liposomes has been used 
and there have been three commercial products marketed as Lipodox ®, Doxil ©and 
DaunoXome ®. More interesting, however, is the development of conjugates of 
doxorubicin with amino acids such as N-L-leucyldoxorubicin (23), which has superior 
efficiency over doxorubicin.
12
These drug conjugates work on the principle that many cancers exhibit elevated levels of 
peptide hormone receptors to which the amino acid has a high affinity for. More recent 
developments include the discovery that tumour cells require an intensive network of 
blood vessels to supply their ever-increasing size. This blood vessel network has 
identification markers attached to the blood vessel cell surfaces and are known as 
antigens. These antigens are proteins and are different for each type of cell they are 
attached to they act in the same way as a postcode. Tumour cells were found to express 
an antigen known as the, a i integrin, and peptides have been found that selectively bind 
to this antigen, such as Arg-Gly-Asp (RGD) or Asn-Gly-Arg. These peptides when 
attached to Adriamycin were found to greatly enhance the drug’s efficiency13.
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1.2 Simpler Anthracene-9,10-dione derivatives
Following extensive research into the anthracyclines it was proposed that the amino sugar 
component was responsible for the cardiotoxicity14. It was therefore suggested that a 
simpler planar molecule with properly selected amino or amino alkyl side chain could 
eliminate the cardiotoxicity15,16 It was found that the 1,4-bis[[2-[(2-
hydroxyethyl)amino]ethyl]amino]-anthracene-9,l O-dione (24a) (Amentantrone) had good 
activity against leukaemia, confirming this suggestion. Further investigation led to the 
discovery that substitution at the 5 and 8 positions of the anthracene-9,1 O-dione 
chromophore with hydroxyl group improved the antineoplastic activity. Thus 1,4- 
dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-anthracene-9,1 O-dione (24b) 
(Mitoxantrone) requires just one tenth of the dose17 of that required by l,4-bis[[2-[(2- 
hydroxyethyl)amino]ethyl]amino]-anthracene-9,l O-dione (24a) derivative for 
antineoplastic activity.
R O N
(24)
(a)R=H Ametantrone 
(b) R= OH Mitoxantrone
It was later discovered that the increased activity of Mitoxantrone was limited due to the 
ten fold increase in the cardiotoxicity and therefore the effectiveness of Mitoxantrone and
14
Amentantrone is similar at the optimal dose18. Although these compounds are 
cardiotoxic, they are less cardiotoxic than anthracyclines. Clinically they are used instead 
of the anthracyclines if the patient has a history of cardiac problems. The most common 
dose-limiting factor for Mitoxantrone is the myelosuppression, which is a decrease in the 
ability of the blood cell-producing tissues of bone marrow to produce all types of blood 
cells19 and in most cases it is not severe or life threatening. Acute toxicities include 
nausea, vomiting, stomatitis and alopecia but these are less severe when compared with 
doxorubicin. Other effects include flu like symptoms and the blue discoloration of the 
skin, fingernails and the urine20.
U .1  Synthesis
Preparation of the 1,4-bis[(amino alkyl)amino] anthracene-9,10-diones is achieved by the 
condensation of the appropriate leuco or reduced (leuco is the term used in the dye 
industry) form of the anthracene-9,1 O-dione (25), with an excess amount of amine at 50- 
55°C followed by subsequent air oxidation21
o,
OH
OH
NHROH
2 RNH2
OH
(26)
NHR
NHR
NHR
(27)
(25)
R=OH or H
Scheme 1-1. Synthesis of l,4-bis(aminoalkyl)anthracene-9,10-diones
The oxidation of (26) takes place with relative ease and it is difficult to isolate, even if the 
reaction has been carried out under a nitrogen atmosphere.
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1.2.2 Structure vs. Biological activity
After detailed structure activity results on the 1,4-bis [(amino alkyl)amino] anthracene-
9,10-diones the following observations were made.
I. Anthracene-9,1 O-dione its self has no activity.
II. Removal of the terminal hydroxyl group on the side chain of (24a) and (24b) leads 
to retained activity but at a lower level.
III. The distance between the two nitrogen’s on the side chain of (24a) and (24b) is an 
important factor, the optimum being two carbons apart.
IV. Insertion of additional ethyl amino units into the side chain drastically reduces 
activity, indicating that additional basic centres and lengthening of the side chain is 
undesirable.
V. The nitrogen in the centre of the side chain plays an important role in activity. No 
activity is noticed when this nitrogen is replaced by a methylene unit or another 
atom such as sulphur.
VI Hydroxyl substitution at the 5 and 8 positions of the anthracenedione greatly 
improves activity.
1.2.3 Mode of action
The mode of action for these compounds is very similar to that of the anthracyclines (see 
section 1.1.4, p7) and as with the anthracyclines the specific mechanism is unclear. It is 
probably a combination of the following factors (for more detail see section 1.1.4, p7)
I. They are flat and planar molecules and therefore can intercalate into DNA.
II. They can under go a reversible oxidation process resulting in formation of free 
radicals22,23.
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I l l  They can interfere with the normal mode of action of topoisomerase II24’25.
TV. The drug Mitoxantrone can undergo reaction with glutathione via an enzyme-mediated 
reaction (Scheme 1 -4). Glutathione is a tripeptide that is involved in protecting DNA 
and RNA by mopping up reactive species such as free radicals. Therefore the loss of 
glutathione can lead to cell death26.
OH OHOH
RS.Glutathione
Enzyme
RS
OH OHOH
OH
IHHN
SH
Glutathione
Scheme 1-2. Enzyme catalysed reaction of glutathione with Mitoxantrone
1.2.4 Unsymmetrically substituted 1,4-bis [(amino alkyl)amino] anthracene-9,10- 
diones
Several un-symmetrically substituted analogues that hold the “Mitoxantrone side-arm” at 
position 1 and a hydroxyl or amino substituents at position 4 also show high anti tumour 
activity (27a-b)
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Y O NH2CH2CH2NHCH2CH2OH
Y O X
(27)
(a) Y= OH or H 
(b)X=OHorNH2
The introduction of different amino alkyl groups at position 1 and 4 has lead to 
compounds with good in vitro activity, in particular analogues such as (28), although this 
compound was inactive in vivo19.
(28)
1.2.5 Metal chelating anthracene-9,10-diones27
With the uncertainty about the mode of action, attempts were made to synthesise 
anthracene-9,10-diones that would have improved efficiency to form free radicals to see 
if their formation was an important factor in the anticancer activity. Anthracene-9,10- 
diones were therefore synthesized that had side chains, which had, metal chelating
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properties such as the peptide Gly-L-His-L-Lys or Gly-Gly-L-His (29 a-b) which have a 
high affinity for copper and iron28.
H
(29)
(a) R=OH R i =Gly-L-His-L-Lys 
(b) R= OH Rj =Gly-Gly-L-His
Anthracene-9,10-diones of (29a) showed excellent in vitro activity but was inactive in
vivo, however (29b), had good in vitro activity and good in vivo activity against
leukaemia cells in mice. The activity of (29b) is slightly less active than Mitoxantrone
(24b) the parent drug but it is less toxic. The poor activity in vivo of (29a) has been
attributed to the poor cell penetration and degradation of the molecule. Anthracene-9,10-
diones were also synthesised with chelating ligands such as (30)29 but these had no in
vitro activity, because the large side chain has altered the DNA binding properties.
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1.2.6 Amidoanthracene-9,10-diones
In an attempt to assess the role of the primary nitrogen in the side chain of Mitoxantrone 
and Amentantrone, the amidoanthracene-9,10-diones (31a,b) were synthesised. 
Modification of the nitrogen atom attached directly to the anthracene-9,1 O-dione nucleus 
would be expected to exert significant influence on the electron density in the anthracene-
9,1 O-dione nucleus, and thus the 7i-electron interaction with DNA bases and also the 
electron-accepting ability of the quinone system. Therefore nitrogen atoms bonded to the 
anthracene-9,1 O-dione should have important consequences on the anti-tumour activity 
and cardiotoxicity of the compounds.
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NHCO(CH2)2NR1R2
NHCO(CH2)2NR1R2o
(31)
(a) R!=H R2= CH2CH2OH 
(bJR^RrCHa
Due to acylation, the nitrogen’s attached to the anthracene-9,1 O-dione ring will have lost 
their basic character causing a strong reduction of 7c-electron density in the quinone 
moiety30. The in vitro testing of the amidoanthracene-9,10-diones showed considerable 
activity, comparable to that of Amentantrone. Thus modification of the primary nitrogen 
in the side chain does not affect activity. As with Mitoxantrone, the optimal number of 
carbons between the nitrogen’s in the side chain is two, but unlike Mitoxantrone the 
ethanolic side chain in (31a) has lower activity compared to the methyl derivatives (31b). 
In vivo testing, however, revealed poor activity, and in higher doses both compounds 
were toxic.
Further research showed that the amidoanthracene-9,10-diones mode of action was 
different in vitro. The acylation of the ring nitrogen atoms causes conformational 
constraints and therefore the side chains are less flexible leading to differences in the 
interaction of the compounds with DNA especially with the base nitrogen and 
electrostatic oxygen atoms that are in the plane of the bases31.
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Research has show that the amidoanthracene-9,10-diones act on g-quadruplex of DNA32, 
which is a secondary structure adopted by DNA sequences that are rich in the base 
guanine. Four guanine bases can associate in a planar, hydrogen bonded assembly called 
a g-tetrad (or quartet) where each guanine simultaneously accepts and donates two 
hydrogen bonds33. Successive layers of g-tetrads allow single stranded DNA to adopt a 
folded back structure called the g-tetraplex (or g-quadruplex) (Figure 1-3).
Figure 1-3. (a)A single DNA strand folded into a g-quadruplex (b) the DNA g- 
quadruplex stabilized by an amidoanthracene-9,1 O-dione.
The g-quadruplex is a structure found in the telomere regions of DNA, telomeres are the 
ends of chromosomal DNA. Their function is to protect the important information stored 
in a DNA strand, just like pieces of plastic on the end of a shoelace protects it from 
fraying. Telomeres are around 50-200 bases long and are rich in guanine. Each time a 
cell divides the telomere becomes shortened. Once the telomeres reach a critical length
2 2
the cell enters a non-divide state called senescence, which leads to irreversible cell death. 
This shortening of the telomeres is one of the reason why a cell ages. However, 
shortening of telomeres doesn’t occur in cancerous cells, because of the presence of the 
enzyme telomerase, which repairs the telomeres and therefore prevents them from 
shortening, thus making the cell immortal. The enzyme telomerase has been found in 85- 
95% of all tumours and is used as a diagnostic marker for cancer; telomerase is therefore 
an obvious target for cancer drugs. The fact that amidoanthracene-9,10-diones bind to 
the g-quadruplex is not sufficient to account for its activity, but telomerase requires DNA 
to be in its single stranded form with no secondary structure, the g-quadruplex is an 
example of such a structure, amido anthracene-9,10-diones initiate the formation of the g- 
quadruplex’s and stabilize the structures once they have formed, therefore telomerase is 
inhibited by amidoanthracene-9,10-diones. If telomerase cannot maintain the length of 
the telomeres cancerous cells are no longer immortal and therefore die. Currently the 
amidoanthracene-9,10-diones are too toxic to normal cells and are therefore not yet 
viable drugs for the treatment of cancer.
1.2.7 l,4-Bis-(2,3-Epoxy pro py lam ino)-9,10-anthracene-9,10-diones
Teroxirone34 (32) is a 1,3,5 triazine molecule, which contains alkylating epoxide moieties 
in its amino side chains.
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Teroxirone is a diverse antineoplastic drugs that contain reactive groups capable of 
covalently modifying a variety of biological molecules and therefore have a different 
mode of action compared to the previously mentioned anthracene-9,1 O-dione drugs. 
Thus, a single molecule containing an anthracene-9,1 O-dione moiety with alkylating 
epoxide groups could prove beneficial.33. In order to achieve this l,4-bis-(2,3- 
epoxypropylamino)anthracene-9,l O-dione was synthesised (35).
HO
NH- NH-
NaOH
NH- NH-
(35)(34)
HO
Scheme 1-3. Synthesis of l,4-bis-(2,3“epoxypropylainino)anthracene-9,10-diones. 
Compound (35) contains both a planar intercalating moiety and an alkylating functional 
group, therefore it should be able to intercalate into the DNA backbone and react with
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important cellular molecules. Initial testing has shown that (35) show potential activity 
and selective cytotoxicity.
1.2.8 1,4-Bis-[me thoxyamin o]anthracene-9,10-diones
Methoxyamine analogues (36) have been prepared, which could act as bio reductive 
alkylators under cellular conditions36.
NHOCBjO
(36)
It has been suggested that intermediate (37) might be formed by enzymatic sequential 
two electron reduction to (36) followed by reductive elimination of the N-0 bonds, which 
might be expected to undergo attack by nucleophilic cellular components to form 
covalently bonded species. An event of this type could lead to cellular destruction of 
hypoxic tumours36.
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NH
NHOO
(36) (37)
Figure 1-4. Enzymatic reduction followed by reductive elimination of the N-O bond
Synthesis is achieved by reaction of l,4-difluroanthracene-9,lO-dione with 
methoxylamine in DMSO36.
1.2.9 l,3-Dihydroxy-anthracene-9,10-diones derivatives37
This class of anthracenediones (38,39) is thought to directly induce apoptosis of a cell. 
Apoptosis, or programmed cell death, is a normal component of the development and 
health of multicellular organisms. Cells die in response to a variety of stimuli, and during 
apoptosis this is done in a controlled and regulated fashion. This makes apoptosis 
distinct from other forms of cell death such as cell injuiy, which is due to mechanical 
damage or exposure to toxic chemicals. Cell injuiy has a characteristic series of changes, 
the cell and their organelles, swell because the ability of the plasma membrane to control 
the passage of ions and water is disrupted, the cell then bursts and the contents leak out, 
leading to inflammation of surrounding tissues38. Apoptosis, by contrast, is a process in 
which cells play an active role in their own death, which is why apoptosis is often 
referred to as cell suicide39. An example of apoptosis is the formation of the fingers and 
toes of the foetus, which requires the removal of the tissue between them or the loss of a
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tadpole’s tale, as it becomes a frog.
OH
R
OH
R‘
(38)
(a) n=2 R-R=H
(b) n=2 R -R=C2H5
(c) n=2 R'=R=CH3 
(e) n=3 R'=R=H 
(1) n=3 R’=R=C2H5 
(g) n=3 R’=R=CH3
(b) R'=R=C2H5
(c) R’=R=CH3
The simple 1,3-dihydroxy-anthracene-9,1 O-dione (40) is synthesised from the 
condensation of phthalic anhydride with 1,3-dimethoxybenzene.
o
OMe
.O + A1C1,
"OMe
(40)
Scheme 1-4. Synthesis of l,3-dihydroxy-anthracene-9,lO-dione. 
Compounds (38) in turn are synthesised from the reaction of co-dibromoalkane with (40) 
in the appropriate solvent to give (41), which is then aminated with the appropriate
amine.
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OHOH
NHRR'
(41) (38)
OH
OH
O
Compounds (39) in turn are synthesised from the reaction of (40) with sodium hydroxide 
in 2-propanol and epichlorohydrin to give (42) as the major product and (43) as the 
minor. The product (42) is then ring opened with the appropriate amine to give (39).
OHOHOH
Cl
OH
HO.(42) (43)(40) NHRR’
OH
OH
(39)
Initial testing on cancer cells indicates that compound (38g) causes fragmentation of 
DNA in the cells, which is generally used to characterise cell death by apoptosis40. The 
mechanism of action is unclear and requires further research.
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1.2.10 Anthracycline mimics
In attempt to combine the anthracyclines with the simpler structure of the Mitoxantrone 
compounds such as (43)41 were synthesised. They consist of 1,4-dihydroxyanthracene-
9,1 O-dione with a doxorubicin sugar mimic attached at position 3.
O  OH
OH
(43)
The preliminary evaluation in vitro showed activity against leukaemia cell lines, though 
the activity is approximately one order of magnitude less than Daunomycin, which is 
surprising for such a simple analogue.
1.2.11 Tetrahydrobenz[a]anthracene-9,l O-dione derivatives
This class of compound (44) mimics the type of functional groups and stereochemistry 
found in the anthracyclines.
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NHHO.
N
H
OMeNHHO,
N
H
(44)
Introduction of the D ring introduces a non-polar zone, which should influence 
intercalation into DNA42. Synthesis is achieved from the reaction of 3,6-dimethoxy 
phthalic anhydride (45) with 1,2,3,4,-tetrahydronapthalene (46), followed by 
demethylation of (47), subsequent reduction, and then amination.
OMe
OMe
(45)
O +
OMe
(46)
OMe
OMe OMe
(47)
NHR
NHR OMe
(44)
Testing showed that compound (44) demonstrated significant antileukemic activity42.
1.2.12 Bisanthracene-9,10-dione derivatives43
The concept of bis-intercalating agents evolved from the view that combining two 
intercalating agents into one molecule would produce a more efficient DNA intercalator 
with double the capacity. Bifunctional ligands such as (48), in which both anthracene-
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9,1 O-dione molecules could intercalate simultaneously, should have greater selectivity 
due to the increased size of the binding site and as a consequence be less toxic.
OH OH
(CH;
OH O O OH O
O
,NH2
(48)
In the designing such bisintercalators it was proposed that the simpler anthracycline 
analogue (49) would be appropriate.
(49> (50)
The mimic (49) had already shown activity similar to daunomycin (50) and it was 
reasoned that if two molecules were joined via a linker it might be possible to create a
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new class of DNA bisintercalators (48) with greater biological activity. However 
biological testing in vitro showed that the bisintercalator (48) were less active than the 
simple anthracenedione (49) on leukaemia cell lines43.
1.2.13 Anthracene-9,1 O-dione oligodeoxynucleotide conjugates
Oligodeoxynucleotides (ODN’s) are short length of manmade genetic material44 and are 
capable of binding to a DNA double helix which results in the formation of a triple 
helix45. ODN’s are designed to specifically target genes and interfere with protein 
production4* One problem with ODNs is their poor cellular uptake46 so they are 
combined with other intercalating molecules such as anthracene-9,1 O-dione. The 
combination of ODN’s with anthracene-9,1 O-dione leads to derivatives that can 
specifically target cancerous cells rather than all rapidly dividing cells (see figure 1 -5).
H. .O P-
ACGTCAGGTGGCACT
ODNLinker
Figure 1-5. l,4-dimethylanthracene-9,10-dione-oligodeoxynucleotide conjugate47
1.3 Hetero-substituted anthracene-9,1 O-dione analogues
The study of congeners with heteroatoms in the anthracene-9,1 O-dione nucleus is a 
relatively unexplored area. Heterocyclic analogues could potentially retain the same 
spatial and planar characteristics for DNA interaction but could also have extra bonding
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or basic or reactive sites, and potentially have improved activity, and reduced 
cardiotoxicity.
13.1 Anthrapyrazoles
The first reported synthesis of anthrapyrazoles (51) was in 1912 in conjunction with the 
dyestuff Pyrazoloanthrone yellow (52)48.
HN-•NHOH
.OH (52)
(51)
(a) X= H 
(b) X= OH
The quasi-iminoquinone considerably reduces ability to under go electrochemical 
reduction, in theory making the compound less cardiotoxic relative to Adriamycin49 
Compounds (51a-b) were shown to have a unique biochemistry and an excellent pre- 
clinical in vivo anticancer activity and were entered into clinical trials50. Clinical trials 
showed good activity against breast cancer but as with other anthracenediones they 
showed cardiotoxicity51. The compounds are synthesised by a two-stage condensation, 
starting with the requisite l,4-dichloro-anthracene-9,lO-dione precursors (53).
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nh2r
Cl n h r 2
(53) (55)(54)
X=H or OH
Further reported developments include the synthesis of the aza-anthrapyrazole. It is 
interesting to note that the position of the nitrogen in the ring system is of importance and 
only 9-aza-anthrapyrazole (56b) is active32.
(56)
(a)X 1=NX2=X3=X4=C
(b) X2=N X3=X4=X1 =C
(c) X3=N X4=X1=X2=C
(d) X4=N X1=X2=X3=C
Anthrapyrazoles represent an important development in the anthracenedione class of 
drugs as they show activity against cancer cells lines that are resistant to other drugs like 
Adriamycin, Daunomycin, Mitoxantrone Amentantrone, etc. The prolonged treatment of 
cancer patients with drugs has led to the development of tumours that are resistant to the 
drugs and is the major reason why chemotherapy fails. Multi-drug resistance (MDR), is 
the principal reason many cancers develop resistance to antineoplastic agents. Tumours 
usually consist of mixed populations of malignant cells, some of which are drug-sensitive
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while others are drug-resistant. Chemotherapy kills drug-sensitive cells, but leaves behind 
a higher proportion of drug-resistant cells. As the tumour begins to grow again, 
chemotherapy may fail because the remaining tumour cells are now resistant . MDR is 
due to the presence of at least two molecular "pumps” in tumour-cell membranes that 
actively expel chemotherapy drugs from the interior thus rendering them useless. These 
pumps include P-glycoprotein and the so-called multi drug resistance-associated protein 
(MRP). This has led to a search for drugs, which can combat MDR 
One benefit from the discovery of MDR is it can be used to protect chemotherapy- 
sensitive non-cancerous cells, such as bone marrow stem cells, which need to be 
protected from the effects of chemotherapeutic agents. Bone marrow destruction is the 
single most important dose-limiting toxicity factor in the treatment of cancer patients.
One reason is that recovery of bone marrow requires the removal of the patient from the 
chemotherapy regime, thus allowing cancer cells to grow again. If MDR can be 
conferred to such cells, patients could be given higher doses of anticancer agents than 
could be given normally.
13.2 Anthrapyridazones54
Following the success of the anthrapyrazoles it was postulated that the presence of a 
heterocyclic ring condensed with the anthracenedione chromophore could produce 
compounds with cytotoxic activity towards multi drug resistant cells. Anthrapyridazones 
(57,58) represent such a class of compounds.
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NHR
X O NHR
(57)
(a) X=H 
(b)X=OH
NHR
NHR O 
(58)
As previously found with other anthracenediones the presence of hydroxyl groups on the 
chromophore greatly increases the anti tumour activity (57b). Synthesis is achieved via 
the suitably protected l,4-dichloro-5,8-dihydroxyanthracene-9,lO-dione (59).
OBzl OBzi CN
CuCN
OBzl OBzl
(59) (60)
COOH
OBzl
(61)
OH
OH
(57b)
OBzl
OBzlOBzl
(62) (63)
Scheme 1-5. Synthesis of Anthrapyridazones
r n h n h 2
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The anthrapyridazones have been evaluated for cytotoxicity. The 2,6 disubstituted 
derivatives (57b) are more active than 6-mono substituted derivatives (58). Compound 
(64) in particular has shown increased activity over Mitoxantrone in MDR cell lines.
OH
OH HN
N
(64)
The anthrapyridazones constitute a novel class of anthracenedione analogues capable of 
overcoming multi drug resistance of tumour cells due to the presence of the heterocyclic 
ring system.
13.3 6,9~Bis [(amino alkyl)amino]benzo[g]isoquinoline-5,10-diones
In a search for anthracene-9,1 O-dione analogues with increased efficiency it was 
suggested that nitrogen atoms in the ring, such as structure (65), might have increased 
affinity for DNA and improve the ability of the chromophore to intercalate55.
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O N(CH2)nR
(65)
Synthesis is achieved via condensation of pyridine-3,4-dicarboxylic anhydride (66) with 
1,4-dimethoxybenzene (67), followed by the reduction of the product (68) and 
subsequent animation.
(66)
OMe OH
.0 + r i
OMe
(67)
O
(68)
OH
This group of compounds exhibits a wide range of in vitro activity, including drug 
resistant cell lines. Activity is also displayed in a N-oxide derivative (69)
0  N(CH2)2RR i
%
NfCH^ RR!
(69)
R=RI=CH3 orH
These heterocyclic bioisosteric models are representative of the first anthracene-9-10- 
diones, which display antileukemic activity comparable to Mitoxantrone.
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13.4 1,4-Bis [(amino alkyl)amino]benzo[g]-phthalazine-5,10diones
To further research on 6,9-bis[(aminoalkyl)amino]benzo[g]isoquinoline-5,10-diones the 
2,3-diaza group was introduced into the anthracene-9,10-dione nucleus (70).
O NHR
O
(70)
NHR
Synthesis was attempted via oxidation of the appropriately protected anthracene but 
yields were poor. The reaction however was achieved via a one step silyliation- 
amination of the appropriately reduced quinone (71).
OH O O NHR
‘NH
.NH
OH O
(71)
NHR
(70)
Scheme 1-6. Synthesis of l*4-bis[(amino alkyl)amino]benzo[g]-phthalazine-5,10<
diones
The introduction of the diaza group into the anthracene-9,10-dione nucleus reduces the 
affinity for DNA compared to Amentantrone but does produce compounds with a high 
level of activity in vitro but there is no in vivo activity56.
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13.5 Imidazoacridinone derivatives
This group of compounds (72) is highly reactive in vitro and in vivo against tumour cell 
lines. It enters cells rapidly and accumulates within the nucleus. They are currently 
under going phase I clinical trials .
NHCH2CH2N(CH2CH3)2
HO.
(72)
Synthesis is achieved from animation of l-chloro-7-hydroxy(methoxy)-4-nitro-9(10H)- 
acridone (73) to give (74). The nitro group of (75) is then reduced and reacted with the 
appropriate carboxylic acid.
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HO,
(73)
NHR
N H 2R
[H]
NHRNHR
HO,HO.
(76)
Scheme 1-7. Synthesis of imidazoacridinone derivatives.
Studies have show that molecules with the hydroxyl group in the same position of (72) 
are much more active though the aminoalkyl side chain is essential for high activity, 
especially the diethylaminoethylamino side chain. These derivatives inhibit catalytic 
activity of topoisomerase. They also induce the arrest of the cell cycle and cause 
apoptosis. The mechanism is not folly understood, though metabolic activation is 
considered as a preliminary step for their biochemical action. The metabolically 
activated drug is probably more reactive towards nucleophilic agents such as pyrimidine 
bases in DNA or sulfhydryl groups in proteins.
13.6 Benzothiopyranoindones
This class of compounds are related to the anthrapyrazoles, but a sulphur atom has 
replaced one of the carbonyl groups (77a,b).
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(77)
(a) X=OH
(b) X=H
HN
5
\
The substitution of the sulphur atom virtually eliminates the possibility of redox cycling 
and subsequent radical formation in vivo. Synthesis is achieved via reaction of 
thiosalicylic acid with 2,4-dichloronitrobenzene (Scheme 1 -8).
Friedel cratfs 
A1C13NaOEt
+
Cu
‘SH  Cl
NOj NOa n o 2
Scheme 1-8. Synthesis of benzothiopyranoindones
Some compounds showed good activity in vivo. Also synthesised were the 
corresponding oxides of sulphur (78).
■NR •NR■NR
lypd
x=Br, Cl
NH2n o 2
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RX N-------------- N
(o \
X HN
(78) \
R
n=l or 2
However, the higher oxidation state on the sulphur atom in the molecule had a deleterious 
effect, and reduced activity. This can be attributed to both electronic and steric effects, 
resulting in a lower electron density in the chromophore and loss of the planar nature of 
the chromophore, with the latter being the most detrimental as it prevents effective DNA 
intercalation.
13.7 5,8-Bis[(amino alkyI)amino]naptho[2,3-b]thiophene-4,9-diones
In a further attempt to introduce sulphur into the nucleus one of the benzyl rings of the 
anthracenedione molecule was replaced with a thiophene ring (79)58
NHR
NHRO
(79)
These thiophene analogues should maintain the planarity and spatial electronic 
characteristics of the carbocyclic quinone model that may be necessary for molecular
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recognition at a cellular level (e.g. intercalation). They are prepared from commercially 
available 2,3-dicyanohydroquinone as shown (Scheme 1-9).
OH
OH
,CN
1 Dimethyl sulfate 
2.Conc.H^SC)4
■CN
OHO C H j
(80)OH
Scheme 1-9. Synthesis of 5,8-bis[(amino alkyl)amiiio]naptho[2,3-b]thiopheiie-4,9-
diones
Intermediate (80) is then deprotected and reduced to form the leuco anthracenedione, 
which is then reacted with the appropriate amine. Biological activity of compounds 
(81a,b), is comparable to Mitoxantrone on leukemic cells.
NHR
NHR
(81)
(a) R =  (CH 2)2N H 2 
(b ) R =  (C H 2)2N H (C H 2)2O H
13.8 Thioxanthone
During the second world war German scientists developed a drug known as Miracil D or 
Thioxanthone (82), which is a orally administered drug for the treatment of 
Schistosomiasis, also known as bilharziasis, a parasitic disease that leads to chronic ill 
health.59
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NH(CH2)2N(C2H5)2
(82)
Miracil D is prepared from condensing diethylaminoethylamine with l-chloro-4- 
methylthiaxanthone, which is obtained from the reaction of thiosalicylic acid with p- 
chlorotoluene in sulphuric acid. Although this generates a mixture of 2 isomers, the 1- 
chloro derivative is sufficiently reactive to selectively condense with the amine60. It is 
interesting to note that derivatives with maximum activity have a separation of two 
carbons between the two nitrogen’s in the side chain, which is analogous to the activity 
shown by Mitoxantrone. Miracil D also shows some anti-tumour activity. In attempt to 
improve the activity further the side chain was replaced with the Mitoxantrone 
aminoalkyl side chain. This increased the activity but not to a level with any therapeutic 
potential61.
Recent research has show that Miracil D or Luctathone as it is also known can be used as 
radio sensitising agent in cancer radiotherapy. It specifically targets topoisomerase n, 
trapping the enzyme and DNA in a complex. This research has led to the synthesis of the 
analogue (83).
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N-------------NHCH2CH2N(CH2CH3)2
This compound is veiy closer related to the benzothiopyranoindones (Section 1.3.5.). It 
has shown good activity in vitro.
13.9 Acridones
• 63Acronycine (84) the acridone alkaloid isolated from Acronychia baueri (Rutaceae) was 
found to have in vivo activity against tumours.
OCH-
(84)
However due to it poor water solubility it was unsuitable for clinical use. Compounds 
(85-86) were synthesised in an attempt to combine some of the features of acronycine and 
thioxanthone, also synthesised were some oxygen analogous.
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(85)
(a) X=S R=NMe2
(b) X=0 R=NMe2
(c) X=S R=NEt2
(d) X=0 R=NEt2
(86)
(a) X=S R=NMe2
(b) X=0 R=NMe2
(c) X=S R=NEt2
(d) X=0 R=NEt2
In general all derivatives are more active than acridone but are still not as active as 
Mitoxantrone.
13.10 Steroid-Anthracene-9,10-dione Hybrids
The combination of different classes of bioactive compounds can produce novel and 
potentially bioactive compounds. Taking into account the effectiveness of anthracene-
9.10-dione based drugs in the field of chemotherapy the combination of the anthracene-
9.10-dione molecule with steroids, which are important vectors for biological activity, 
could lead to drugs with enhanced activity, such as (87).
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R*
R-
(87)
The steroid-anthracene-9,10-dione hybrids were synthesised using a Diels-Alder 
approach, (Scheme 1-10).
Toluene 100°C
Scheme 1-10. Synthesis of steroid-anthracene-9,10-dione hybrids
Initial testing has shown some derivatives to be as active as doxorubicin in vitro and 
further investigations are in progress to asses the full potential of these compounds.64
13.11 Cyclopent[a]anthracene-9,10-dione derivatives
MMC (88) (mitomycin C), is a bioreductive-alkylating agent that cross links DNA and 
inhibits cancerous cells. However it also destroys healthy cells, as it is not selective 
enough for clinical use. In an attempt to improve selectivity, anthracene-9,10-dione 
analogues of MMC were synthesised (89a-b).
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OM e
NH
O
NH
(89)
*qq\ <a> R=OCH2CH2N(CH2CH2Cl)2
W  (b) R=CH2OCONHMe
These analogues should have the ability to intercalate into DNA and bind covalently. 
Compound (89a) shows good in vitro activity against leukaemia cells, although it is less 
potent than (88). The main draw back of compound (89a) is the life span, as it 
decomposes after 3 months due to the presence of the mustard side chain. As a result 
2,3,-azindino-4-[[(methylaminocarbonyl]methyl]cyclopent[a]anthracene-6,11 ,dione 
(89b) was synthesised and was found to be just as effective against leukemic and solid 
tumour cells as (88) in vitro, and it appears to be less toxic. It is also able to intercalate 
into DNA and function as a topoisomerase II inhibitor. Further testing is required to fully 
evaluate the potential of this class of anthracene-9,10-diones65
1.4 Other uses of anthracene-9,10-diones
1.4.1 Anthracene-9,10-dione dyes
The main use of anthracene-9,10-dione has been in the manufacture of dyestufifs. Many 
derivatives have been synthesised and used as dyes for cotton, polyester, nylon, and 
wool. They can also be used as colorants for plastic, wood, and paints. Although 
anthracene-9,10-dione itself does not absorb in the visible region introduction of different
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groups into one of the 8 positions, produces compounds that do absorb in the visible 
region 66 Anthracene-9,10-dione derivatives that possess substituents that are good 
electron donors have deeper and stronger colour (90a-c)
O X,
o x2
(90) Colour
(a) X,=H X2=N02,C1 or Br Yellow
(b) X ^H  X2-NH2,0 , NHMe or NHPh Orange to red
(c)X ,= X2=NH2,NHMe or NHPh Blue
In 1901 Rene Bohn patented the first anthracene-9,10-dione vat dye Indanthrene blue RS 
or 6,15-dihydro-5,9,14,18-anthrazinetetrone 67(91).
o
O (91)
It is still in use today as a food colouring El 30. Anthracene-9,10-dione dyes such as 
alizarin (92) are vat dyes, as they can be reduced to form more soluble compounds, and 
can then be oxidised once on the fabric. Alizarin (92) occurs naturally as a glycoside in 
the roots of madder, which was used by the ancient Egyptians as a dyestuff.
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o
(92)
Alizarin dissolves in alkali giving purple or red solutions, which are precipitated, as lakes 
by heavy metal salts. It is now synthesised from anthracene-9,10-dione-2-sulphonic acid 
(93) with sodium hydroxide and KCIO368 (Scheme 1-11). Alizarin is an important 
starting material for other anthracene-9,10-dione dyes.
OH
.OH
O
Scheme 1-11. Alizarin synthesis
Aminoanthracene-9,10-diones include dyes such as Quinizarin Green (l,4-bis(p- 
toluidinio)anthracene-9,10-dione) (94),which is a disperse dye. Most anthracene-9,10- 
dione dyes are disperse or reactive dyes.
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Disperse dyes have low solubility in water, but they can interact with the polyester chains 
by forming dispersed particles. Their main use is the dyeing of polyesters, and they find 
minor use dyeing cellulose acetates and polyamides. The dye is generally applied under 
pressure, at temperatures of about 130°C. At this temperature, thermal agitation causes 
the polymer’s structure to become looser and less crystalline, opening gaps for the dye 
molecules to enter. The interactions between dye and polymer are thought to be Van-der- 
Waals and dipole forces.69
Anthracene-9,10-dione reactive dyes are the second most important type of reactive dyes. 
Most of these types are derived from Bromamine acid (1 -amino-4-bromoanthracene-
9,10-dione-2-sulphonic acid) and by variation of the substituents, a wide range of colours 
can be obtained, such as Reactive Blue Seven (95).
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Cl
There are three steps in the reactive dyeing procedure, adsorption of dye on the fibre, 
diffusion into the fibre and the covalent reaction with the particular nucleophilic groups 
present in the substrate70.
1.4.2 Dithianon
Dithianon or l,4-dithianthracene-9,10-dione (96) (5,10-dihydro-5,10-dioxo-naphto-[2,3]- 
p-dithio-2,3-dicaronitrile) is a protective and nonphytotoxic fungicide with a broad- 
spectrum activity for the control of diseases of pomes and stone fruit, small fruit, citrus, 
coffee and wine growing71.
o
o
(96)
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E.Merck introduced Dithianon in 1962 under the trade name Delan®. It forms odourless 
crystals, which melt at 225°C. It is produced from the reaction of the sodium salt of 1,2- 
dicyano-1,2-dimercaptoethylene and napthaquinone72 (Scheme 1-12).
O
,CN
O
HS. CN
HS CN
O
'CN
(97) (98) (96)
Scheme 1-12. Synthesis of dithianon.
It is insoluble in water but soluble in dioxanes, chlorobenzene and chloroform. The 
compound is stable in weak acid and neutral media. In alkaline conditions ring opening 
occurs.
1.4.3 Hydrogen peroxide Synthesis
2-Ethylanthracene-9,10-dione (99) is used in the commercial production of hydrogen 
peroxide. By an initial reduction with hydrogen and palladium to 2-ethylanthraquinol 
(100). Oxygen is then bubbled through the solution to oxidize the reduced molecule back 
to 2-ethylanthracene-9,10-dione (99) with the subsequent production of hydrogen 
peroxide (Scheme 1-13).
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OH
XoH2n 5
H./Pd X 2 H 5
o2
h 2o 2
(99)
OH
(100)
Scheme 1-13. Synthesis of hydrogen peroxide with anthracene-9,10-dione
This process is much cheaper than the electrochemical production of hydrogen peroxide.
1.4.4 Laxatives
Anthracene-9,10-diones have also been used as laxatives, for example the polyhydroxy 
derivatives such as Rufigallic or 1,2,3,5,6,7-hexahydroxyanthracene-9,10-dione (101), 
an abstract of rhubarb has been used in Chinese herbal medicine since 2400 BC73.
(101)
1.4.5 Inhibition of HIV-1 proteinase74
HIV-1 proteinase is a key enzyme in the replication of the HIV virus, which causes the 
disease, AIDS. Several inhibitors have been developed some, which compete for the 
substrate-binding grove of the enzymes. The most effective inhibitors have one or more 
hydroxyl substituents and are usually peptides. To develop non-peptide drugs the
55
hydroxy-quinones were chosen for test for proteinase inhibition, it was found that the 
anthracene-9,10-dione derivatives were very effective, alizarin (92) in particular. 
Hydroxyanthracene-9,10-diones might therefore be a useful component in the 
development of a potent and selective drug against HIV viruses.
1.4.6 Multiple sclerosis
Multiple sclerosis is considered an autoimmune disease associated with immune activity 
directed against the central nervous system. Based on this concept immunosupression 
has been the therapeutic strategy to combat the disease, which has lead to the 
development of understanding and treatment of the disease. Mitoxantrone has shown to 
be effective for active multiple sclerosis because of its ability to depress the immune 
system. The only real problem with the drug is again its cumulative cardiotoxicity .
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2.0 Aims and objectives
Anthracene-9,10-dione forms a wide and important class of dyes though they have by and 
large, been superseded by Azo dyes which are cheaper and easier to produce. However, 
there has been renewed interest in anthracene-9,10-dione due the discovery that some 
derivatives can be used in the treatment of cancer (such as the anthracycline Adriamycin 
and more recently some N-alkyl derivatives such as Mitoxantrone). The aim of this 
project was to synthesis some novel anthracene-9,10-dione type drugs containing sulfur 
and to explore their activity.
2.1 Effect of sulfur upon quinones
It is well documented that the addition of substituents to quinones leads to a significant 
effect on their redox potentials. In particular the addition of thiols to quinones has been 
the subject of a number of studies, as thioether formation is an important process in the 
detoxification and excretion of potentially toxic electrophiles within biological system. 
The addition of thiols to quinones can lead to an increase or decrease in the oxidation 
potentials1. This could lead to Mitoxantrone derivatives with reduced cardiotoxicity, as 
the one electron reduction of Mitoxantrone leads to free radicals that can then go on to 
damage heart tissue (see section 1.1.4 part II)
While the insertion of thiols to some quinones has led to deactivation of the biological 
activity, in some cases it has been shown that quinone-thioethers possess new biological 
activity and toxicological properties. There is substantial evidence supporting the 
interaction of quinone-thioethers with enzymes that have either quinones as substrates or 
with enzymes that have either quinones as substrates or with enzymes that utilize
63
glutathione. Quinone-thioethers have been show to interact with DNA and have also 
been identified as compounds that play important role in various physical and behavioral 
changes that accompany chronic alcoholism1.
2.2 Sulfur biocides
The ability of sulfur to interact within a biological systems, is illustrated by the chemistry 
of phenylcyanate (102) and phenylthiocyanate (103). Neither unsubstituted compound 
(102a, 103a) displays any sign of biological activity though by the insertion of a nitro 
group at the 2 position of the benzene ring, results in a remarkable increase in efficacy of 
the phenylthiocynate (103b)2. In fact, such is the increase in biocidal nature that the 
resulting molecules have been patented as antivirals, antifungal, and antibacterials3, in 
particular the 2,4-dinitrophenyl thiocyanate derivative (103c) discovered by Dupont. The 
2-nitrophenylcyanate (102b) on the other hand remains relatively inactive leading to the 
conclusion that the sulfur atom appears essential for biological action.
OCN SCN
R'
(102) (103)
(a) R= H L r =R’= h
(b) R=N02 (b) r =N02,R’=H
(c)R=R’=N02
Some thiocyanates have also been reported to act as anti-tumour and anti-hormonal
agents .
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The reasons for the success and activity of sulfur containing compounds as biocides may 
be due to a number of factors. The ability of elemental sulfur to control pests and fungi 
has been known since 1000 BC and sulfur compounds have always been regarded as 
making good biocides. The capability of the sulfur atom to bond with the intracellular 
thiols is obviously a huge benefit as this and the resulting reactions in vivo may lead to 
the death of the cell. In other instances the organosulfur compounds will be broken down 
in a cell, yet the simple sulfur by-products e.g. H2S, elemental S, or SO2, are often just as 
toxic. Another group of important sulfur biocides include the isothiazolones of which 
some compounds possess unparalleled biocidal efficacy at low concentrations. The 4,5- 
benzo-3-isothiazolones (104) were first synthesized in 1923 by McKibben and 
McClelland4 but the isothiazolones biocidal properties remained undiscovered until their 
anti-microbial properties were reported and patented in 1957 by Katz and Schroeder5. In 
1973, the benzo-isothiazolones were joined in the biocide marketplace by substituted 3- 
isothiazolones which, as can be seen in the patent by Lewis6, have a very broad spectrum 
of activity and yet are still active at extremely low concentrations. The Rohm and Haas 
product Kathon® contains a mixture of 5 -chloro-7V-methy 1-3 - isothiazo lone (105) and N- 
methyl-3-isothiazolone (106) as its active ingredients.
H N CH
(104)
Cl
(106)
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2.3 Sulpha drugs
Other important sulfur containing drugs include the Sulphonamides, also known as 
Sulpha drugs, which is common name applied to a group of chemotherapeutic agents that 
are effective against a number of infectious diseases. In 1935 the German chemist, 
Gerhard Johannes Paul Domagk, discovered that an azo dye, Prontosil (107), cured 
streptococcal infections in mice. The active principle in Prontosil was found to be 4- 
aminobenzenesulphonamide (108), commonly known as sulphanilamide7, formed by the 
degradation of the azo linkage.
Scheme 2-1. The breakdown of Prontsil to give Sulfanilamide
Clinical trials with sulphanilamide proved effective in arresting various bacterial 
diseases. Many derivatives of sulphanilamide have proved effective against such 
conditions as scarlet fever, meningitis and pneumonia. All the sulphonamides are 
somewhat toxic, producing blood abnormalities and kidney damage when used 
indiscriminately. Since the discovery of penicillin, which is as effective as the 
sulphonamides although far less toxic, the use of sulphonamides has somewhat declined. 
Because bacteria often develop resistance to a particular kind of treatment, however, they 
are used when bacterial tolerance for penicillin has developed.
6 6
2.4 Conclusion
Sulfur is an important element within biological systems and is an essential dietary 
ingredient8. The introduction of sulfur into anthracene-9,10-dione drugs leads to a 
change in the electronic, steric and physical properties, which in turn effect how the 
molecule would interact with a biological system. The sulfur atom within in these drugs 
could also introduce another mode of action, as they may have the ability to undergo 
nucleophilic reaction with intracellular thiols. The present studies have been carried out 
therefore to synthesize a number of new anthracene-9,10-dione systems containing sulfur 
and to model their activity. It was planned to submit some of the derivatives for testing 
by AstraZeneca.
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3.0 Preparation of l,4-bis(amino)-5,8-(siilfanyI)anthracene-9,10- 
diones
Both Amentantrone (24a) and Mitoxantrone (24b) are effective as anticancer drugs.
R O N
"OH
,OH
(24)
(a) R= H
(b) R= OH
As discussed earlier, these drugs are used clinically in the treatment of many cancers but 
they have associated side effects. As cardiotoxicity is the most serious side effect it is 
therefore the major dose limiting factor. Cardiotoxicity can be attributed to the ability of 
the anthracene-9,10-dione moiety to undergo a one electron reduction to form a radical 
species (see section 1.1.2.).
The introduction of sulfur instead of oxygen at the 5- and 8- positions would lead to 
derivatives such as (110), these 1,4-bis(amino)-5,8-(sulfanyl)anthracene-9,l 0-diones 
would have different electronic and steric properties to the parent drug which, could be 
potentially beneficial, i.e. a reduced ability to form free radicals or improved binding
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characteristics. The sulfur atom may also act as a reactive centre for important cellular 
thiols such as glutathione (see section 1.2.3).
. s  o  HN.
R R‘
(110)
In principle the l,4-bis(amino)-5,8-(sulfanyl)anthiacene-9,10-diones (110) derivatives are 
obtainable from 1,4-dihydroxy-5,8-dichloroanthracene-9,l 0-dione (109) by two routes:
1. Displacement of the chlorine atoms of 1,4-dihydroxy-5,8-dichloroanthracene-
9,10-dione (109) with appropriately selected thiolate ions, followed by the 
subsequent reduction and amination with selected amines..
2. The reduction of 1,4-dihydroxyanthracene-9,10-dione (109), which could then be 
aminated with the appropriate amines and thiolated, with selected thiols.
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OH
OH
SR'
SR OH
SR OH
[H]
109
SR OH
r ' n
' T
SR OH
N H jr N v
SR O NHR
OH
OH
n h 2r
Cl OH O Cl O NHR
Scheme 3-1. Proposed synthetic routes
The starting material l,4-dihydroxy-5,8-dichloroanthracene-9,l 0-dione can be 
synthesised from the condensation reaction of 3,6-dichlorophthalic anhydride with 
benzene-1,4-diol in concentrated sulphuric acid with boric acid1.
.0 +
B(OH>3
h 2so4
OH
OH
OH
+ H ,0
Scheme 3-2. Condensation of 3,6-dichlorophthalic anhydride with benzoquinone
using boric acid in sulphuric acid.
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Alternatively l,4-dihydroxy-5,8-dichloroanthracene-9,l 0-dione can be synthesised by the 
direct chlorination of 1,4-dihydroxyanthracene-9,10-dione2,3’4,5’6 (see section 3.2).
3.1 Oxidation of 2,3-dihydro-9,10-dihydroxyanthracene-l,4-dione
2,3-Dihydro-9,10-dihydroxyanthracene-l ,4-dione (110) was used as a starting material as 
it was readily available from an industrial source (some l,4-dihydroxyanthracene-9,10- 
dione was also purchased from Aldrich). It is the reduced or leuco form of 1,4- 
dihydroxyanthracene-9,10-dione (Quinizarin). It can exist in four possible tautomers 
(Scheme 3-3).
OH XH OH X XH
OH XH XH XH
OH
OH
i n m iv
x = O, NH, N Q H , or NNHj
Scheme 3-3. Possible tautomers of leuco anthracene-9,10-diones
The leuco form of 1,4-dihydroxyanthracene-9,l 0-dione however occurs preferentially in 
only one tautomeric form 2,3-dihydro-9,10-dihydroxyanthracene-1,4-dione (I)7. The 
preparation of l,4-dihydroxyanthracene-9,l0-dione by oxidation of 2,3-dihydro-9,10- 
dihydroxyanthracene-1,4-dione (110) was achieved under reflux with nitrobenzene 
(Scheme 3-4) following the known industrial process8.
72
NO, OH
3
OH
NH,
+ 2H20
(111)
Scheme 3-4. Oxidation of 2,3-dihydro-9,10-dihydroxy-l,4-anthracene-9,l0-dione
using nitrobenzene
The major draw back of using nitrobenzene is the work up procedure, due to its high 
boiling point it needs to be removed via steam distillation for product recovery. A much 
more convenient method of oxidation involves the use of 3-nitrobenzenesulfonic acid 
sodium salt under alkaline conditions using water as the solvent9. The mixture is then 
heated to reflux and the product is simply collected by acidification of the mixture.
OH
3
OH
NO j OH
10%NaOH
++
OH
(110) (H I)
Scheme 3-5. The oxidation of 2,3-dihydro-9,10-dihydroxy-l,4-anthracene-9,10- 
dione using sodium 3-nitrobenzenesulfonate
Oxidation was also achieved using activated manganese dioxide and concentrated 
sulphuric acid with boric acid, but the use of sodium 3-nitrobenzenesulfonate was much 
more efficient and convenient.
73
3.2 Chlorination of l,4-dihydroxyanthracene-9,10-dione
The chlorination of l,4-dihydroxyanthracene-9,l 0-dione (111) in acetic acid leads to the 
oxidation of 1,4-dihydroxyanthracene-9,l 0-dione to the tetra-quinone followed by the 
addition of one mole of chlorine10 (112).
Cl2/CH3COOH
OH
OH
(111) (112)
If the same reaction is carried out in a sealed tube at 130°C, chlorination occurs at 
positions two and three of the anthracenedione nucleus, with the formation of 1,4- 
dihydroxy-2,3 -dichloroanthracene-9,10-dione10 (113).
O OH
ci2 / c h 3c o o h
130°C in a sealed tube
OH
OH
O OH
(113)
The chlorination at both the 2- and 3- positions of the anthracene-9,10-dione ring is 
expected due to the mesomeric effect of the hydroxyl groups which direct chlorination to 
these positions (Scheme 3-6).
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OHOH
+CI
.Cl
H
O OHOH OH
Scheme 3-6. Chlorination mechanism for 1 *4-dihydroxyanthracene-9,10-dione in
acetic acid
If the reaction is carried out in DMF with the thionyl chloride under reflux for four hours
l,4-dihydroxy-2-chloroanthracene-9,l 0-dione is obtained. However, 1,4- 
dihydroxyanthracene-9,10-dione in boiling thionyl chloride results in the formation of 
10-chloro-l-hydroxyanthracene-9-dione (115). The literature suggests that 1,4- 
dihydroxyanthracene-9,10-dione exists in an ortho-quininiod (114) state, in which the 
two hydroxyl groups are in the one and ten positions11 (Scheme 3-7).
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Cs
o OH
cr 'JOCl OH JCI
o
(114)
OH
'OH
OHO
OH
(115)
Cl
OH
-HC1
0 OH OHO
Scheme 3-7. (I) The action thionyl chloride on 1,4-dihydro xyanthracene-9,10-dione
The replacement of a hydroxyl group by a chlorine atom by means of thionyl chloride 
denotes an acidic proton and this is a well known method for the preparation of acyl 
chlorides from carboxylic acids. 10-Chloro-1 -hydroxyanthracene-9-dione shows 
properties similar to that of an acyl chloride, such as the rapid reaction with amines.11 
The mechanism does not take into account why only one of the carbonyl groups of 1,4- 
dihydroxyanthracene-9,10-dione appears to take part in the reaction11.
Synthesis of 1,4-dihydroxy-5,8-dichloroanthracene-9,l 0-dione can be achieved by the 
chlorination of l,4-dihydroxyanthracene-9,l0-dione in 65% oleum and boric acid, with a 
catalyst of iodine. The reaction is thought to proceed via a boric acid intermediate (116)
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which prevents oxidation and directs chlorination to the 5- and 8- positions. The 
chlorinating species in the reaction is iodine monochloride.
OH
o OH
B(0 SOjH^
HO3SO OSO3H
OSO3HHO3SO
(116)
The boric acid intermediate (116) deactivates the right hand ring towards substitution but 
also activates the left hand ring towards substitution (Scheme 3-8).
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OS03H
5q
HO3S0 0SO3H
H O 3S0. .0SO 3H
° \o B
\  \  ho3so " /  ' v' s' oso3h
HCkSCX .OSO3H
HO3SO OSO3H
HO3SO'
Scheme 3-8. Mechanism of chlorination of l,4-dihydroxyanthracene-9,10-dione via
boric ester intermediate
This mechanism does not account for the selectivity of chlorination at the 5- and 8- 
positions.
3.3 Reaction of 1,4-dihydroxy-5,8-dichlo roan thracene-9,10-dione with 
thiols
The attempted displacement of the chlorine atoms of l,4-dihydroxy-5,8- 
dichloroanthracene-9,10-dione with various thiols was unsuccessful. The reaction using 
sodium hydroxide and thiophenol in ethanol leads only to the formation of diphenyl 
disulphide (117).
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s s
(117)
The formation of the disulphides is caused by molecular oxygen. This process occurs due 
the electron transfer from the thiol anion to molecular oxygen leading to the formation of 
a thiol radical and peroxide anion (Scheme 3-9)
Scheme 3-9. Reaction of thiolate ion with molecular oxygen
The thiol radical formed then goes on to react with another thiol radical which leads to 
the formation of the disulphide (Scheme 3-10).
To avoid disulphide formation the reaction was carried out in a nitrogen atmosphere,
although this did reduce the formation of the disulphide it did not prevent the disulphide
formation. This can be attributed to 1,4-dihydroxy-5,8-dichloroanthracene-9,10-done
acting as the electron accepting species, in place of molecular oxygen.
The formation of disulphides due to the presence of molecular oxygen has been studied
extensively, as this type of reaction effects the stability of hydrocarbon fuels, since the
10oxidation of thiols found in these fuels leads to colour and sediment formation .
RSSR
Scheme 3-10. Disulphide formation from thyinyl radicals
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Reaction of l,4-dihydroxy-5,8-dichloroanthracene-9,l0-dione in ethanol with other thiols 
such as 2-methyl-2-propanethiol and potassium thiocyanate was also unsuccessful and 
resulted in the recovery of the starting material. The base used in the reactions to 
generate the thiolate ion was also modified in type and concentration, for example 
potassium type bases such as potassium hydroxide and potassium carbonate have been 
shown to facilitate thiolation reactions that are difficult or don’t occur when the 
analogous sodium type bases are employed13 but this had no effect and only the starting 
material was recovered. Propanol was used to increase the reaction temperature: 
however this still didn’t result in the formation of the desired product and only yielded 
the starting material. Polar aprotic solvents such as DMF or DMSO were also employed 
to make the thiolate ion more effective but again only the starting material was recovered 
from the reaction mixture.
Although this type of reaction is achievable with l,4-dichloroanthracene-9,l 0-dione14 
(118) with thiophenol to yield l,4-bis(phenylsulfanyl)anthracene-9,l0-dione (119), the 
presence of hydroxyl groups results in the molecule being less reactive towards 
nucleophilic substitution.
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EtOH
Scheme 3-11. Thiolation of l,4-dich!oroanthracene-9,l0-dione
A similar observation was reported with reaction of l,4-dichloro-8-hydroxy-5- 
methylanthracene-9,10-dione in which thiophenol does not displace the chlorine atoms15. 
It was also noted that the two chlorine atoms of 1,4-dichloro-8-hydroxy-5- 
methylanthracene-9,10-dione were not as easily displaced by phenoxy groups to yield
l,4-bis(phenoxy)-8-hydroxy-5-methylanthracene-9,l 0-dione in comparison to 1,4- 
dichloroanthracene-9,10-dione (118). This decrease in reactivity can be attributed to 
delocalisation of the charge onto the quinone moiety, resulting in a lowered reactivity 
towards thiolation. The first step is abstraction of the acidic proton from the anthracene- 
9, 10-dione (Scheme 3-12).
Cl O OH
OH
r i i
Cl c) O'
N
J
Cl c) c3
SH
\  /
Scheme 3-12. Proton abstraction of
l,4-dihydroxy-5,8-dichloroanthracene-9,l 0-dione
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This then leads to resonance stabilized intermediate with the charge delocalised between 
the two oxygen atoms, which would reduce the reactivity of the chlorine atoms towards 
nucleophilic substitution.
Scheme 3*13. Delocalisation of charge onto the anthracene-9,10-dione moiety
In an attempt to prevent the delocalisation of the charge on to the quinone moiety, the 
hydroxyl groups were protected using dimethyl sulphate with potassium carbonate in 
acetone for 64 h16 to give l,4-dimethoxy-5,8-dichloroanthracene-9,l 0-dione (120)
OH OMeOX
OH OMe
(120)
The thiolation of l,4-dimethoxy-5,8-dichloroanthracene-9,l0-dione was then attempted 
with thiophenol in ethanol, DMF and then DMSO but only the starting material was 
recovered. The base used to generate the thiolate was also modified (NaOH, KOH, 
Na2CC>3 and K2CO3) but these reactions only yielded the starting material. The reactions 
were repeated using 2-methyl-2-propanethiol and potassium thiocyanate using ethanol,
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DMF, and DMSO under reflux but all were unsuccessful and only yielded the starting 
materials.
3.4 Reduction of l,4-dihydroxy-5,8-dichloroanthracene-9,l0-dione
As the thiolation reactions were not achieved with l,4-dihydroxy-5,8-dichloroanthracene-
9,10-dione or l,4-dimethoxyanthracene-9,l0-dione with thiophenol, 2-methyl-2- 
propanethiol or potassium thiocyanate, another pathway was sought, due to the suspected 
deactivation of the molecule by the hydroxyl groups. It was decided next to eliminate 
this problem by reduction of the l,4-dihydroxy-5,8-dichloroanthracene-9,l 0-dione (109) 
to 2,3-dihydro-9,10-dihydroxy-5,8-dichloroanthracene-l,4-dione (121) followed by the 
subsequent animation
OH
OH
(109)
OH NHR
[H]
OHOH NHR
(121)
[O]
NHR
NHR
Scheme 3-14. Reduction and subsequent animation of 1,4-dihydroxy-5,8- 
dichloroanthracene-9,10-dione
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Reduction of l,4-dihydroxy-5,8-dichloroanthracene-9,l0-dione can be achieved via tin in 
acetic acid17 or sodium dithionite under alkali conditions18, the latter being the more 
convenient method due to the fester reaction time.
(121)
Scheme 3-15. Reduction of l,4-dihydroxy-5,8-dichloroanthracene-9,l0-dione
As with leuco l,4-dihydroxyanthracene-9,l0-dione, leuco 1,4-dihydroxy-5,8- 
dichloroanthracene-9,10-dione can exist in several tautomers, however the NMR 
(Figure 3-1) shows that it prefers to exist solely as the 2,3-dihydro-9,10-dihydroxy-5,8- 
dichloroanthracene-1,4-dione tautomer (see section 3.1).
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IPPM
Figure 3-1. *H NHR for 2,3-dihydro-5,8-dichloro-9,10-dihydroxyanthracene-9,10-
dione (in CDCI3)
3.5 Animation of 9,10-dihydroxy-5,8-dichloro-2,3-dihydroanthracene-
1,4-dione
The amination of l,4-dihydroxy-5,8-dichloroanthracene-9,l 0-dione can be achieved by 
reaction with the leuco or reduced form (121) followed by the subsequent air oxidation,
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which is analogous to the amination of l,4-dihydroxyanthracene-9,l0-dione19. The 
reaction proceeds via an addition elimination mechanism, involving a polar 
intermediate20 (Scheme 3-16).
OH OH NH2F
OH OH OH O
Scheme 3-16. Amination of 2,3-dihydro-9,10-dihydrosyanthracene-l,4-dione
3.5.1 Amination of 2,3-dihydro-9,10-dihydroxy-5,8“dichloroanthracene-l ,4- 
dione with alkylamines
The amination of 2,3-dihydro-9,10-dihydroxy-5,8-dichloroanthracene-l,4-dione (121) 
with an excess of propylamine to act as a solvent occurs readily to yield 1,4- 
bis(propylamino)-5,8-dichloroanthracene-9,l0-dione (123) in 32% yield. The reaction is 
improved by employing a solvent such as ethanol which improves the workup and 
increases the yield to 48%.
OH OH
2 HjN'
OH OH
(121) (122)
OH HN'
OH HN.
(123)
The reaction is an addition elimination mechanism followed by the air oxidation of the 
reduced intermediate (123).
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OH OH OH
OH OH OH
Scheme 3-17. Addition and elimination of propylamine to 2,3-dihydro-9,10-
dihydroxy anthracene-9,10-dione
Attempts to isolate the reduced product by carrying out the reaction under a nitrogen 
atmosphere were unsuccessful. The oxidation of (122) takes place with relative ease and 
the reduced product is difficult to isolate, this is also the case for related 1,4- 
bis(alky lamino)anthracene-9,10-diones21.
The reaction of 2,3-dihydro-9,10-dihydroxy-5,8-dichloroanthracene-l,4-dione with 
isobutylamine also occurs readily to form l,4-bis(isobutylamino)-5,8-dichloroanthracene-
9,10-dione (124) in 52% yield.
OH HN
OH HN
(124)
Similarly, the reaction of 2-aminoethanol with 2,3-dihydro-9,10-dihydroxy-5,8- 
dichloroanthracene-l,4-dione in ethanol gives l,4-bis(2-hydroxyethylamino)-5,8- 
dichloroanthracene-9,10-dione (125) in 64% yield.
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Methylamine solution (20% in water) also reacts readily with 2,3-dihydro-9,10- 
dihydroxy-5,8-dichloroanthracene-l ,4-dione to yield l,4-bis(methylamino)-5,8- 
dichloroanthracene-9,10-dione (126) in 43% yield.
UNOH
HNOH
(126)
The reaction of 2,3-dihydro-9,10-dihydroxy-5,8-dichloroanthracene-l ,4-dione with 
amines containing a secondary nitrogen atom especially 2-[(2-aminoethyl)amino]ethanol 
leads to problems at the purification stage. The reaction mixtures yield tar-like solids that 
were difficult to purify, especially since amino-anthracene-9,10-diones are known to be 
difficult to purify by normal methods22,23.
The amination of 2,3-dihydro-9,10-dihydroxy-5,8-dichloroanthracene-l ,4-dione with 
N,N-dimethylethylenediamine and N,N-diethylethylenediamine also occurs to give 1,4- 
bis{[2-(dimethylamino)ethyl]amino}-5,8-dichloroanthracene-9,10-dione (127) and 1,4-
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bis{[2-(diethylamino)ethyl]amino}-5,8-dichloroanthracene-9,10-dione (128) in 29% and 
22% yield respectively.
The NMR data for all the l,4-bis(alkylamino)-5,8-dichloroathracene-9,10-diones 
shows that the peak attributed to the NH proton is split into a triplet
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Figure 3-2. Splitting pattern for NH proton
This is of significance as it confirms the tautomeric preference of 1,4-bis(alkylamino)-
5,8-dichloroathracene-9,10-diones is structure (I) in Figure 3-2 ( see section 3.1).
HN
HN
OH
OH
(D <“>
Scheme 3-18. Potential tautomers of l,4-bis(aIkylamino)-5,8-dichloroathracene-9,10-
diones.
3.5.2 Amination of 2,3-dihydro-9,10-dihydroxy-5,8-dichloroanthracene-ly4- 
dione with aniline
The amination of 2,3-dihydro-9,10-dihydroxy-5,8-dichloroanthracene-l,4-dione with 
aniline was unsuccessful under varying conditions but the reaction can be achieved if 
boric acid is used as a catalyst. This lack of reactivity towards 2,3-dihydro-9,10- 
dihydroxy-5,8-dichloroanthracene-l,4-dione as compared to the other alkylamines used 
can be attributed to the feet that aniline is a weaker nucleophile due to delocalisation of 
the electron lone pair of the nitrogen atom into the aromatic ring (Scheme 3-19).
(r +nh2 +nh2 +nh2
Scheme 3-19. Delocalisation of the electron pair in aniline
Thus the addition of boric acid as a catalyst is required to facilitate the reaction with the 
formation of a boric ester intermediate (129).
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OH
OH
HO. HO.OH .OH
- I f
(OH)2
(129)
-H+/+ lf  
(OH ),
NHR
NHR
NR
Thus the synthesis of 1,4-bis(phenylamino)-5,8-dichloroanthracene-9,l O-dione (131) was 
achieved from the reaction of 2,3-dihydro-9,10-dihydroxy-5,8-dichloroanthracene-l,4- 
dione (119) with aniline in the presence of boric acid.
OH H jN
+ 2 B(OH)3
OH NH
[O]
OH NH
(131)
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3.6 Thiolation of 1,4-bis(aIkylamino)-5,8-dichloroathracene-9,l 0- 
diones
Despite the deactivating effects of the alkylamino groups, the reaction of 1,4- 
bis(propylamino)-5,8-dichloroanthracene-9,l 0-dione (123) with thiophenol in ethanol 
and an appropriate base gives l,4-bis(propylamino)-5,8-bis(phenylsulfanyl)anthracene-
9,10-dione (132) in 41% yield. The yield of the reaction is improved to 66% by 
employing DMF as the solvent.
NaOH in Ethanol
The reaction is a nucleophilic addition elimination reaction (SNAr Mechanism) involving 
the formation of a delocalised intermediate.
NHR NHR NHR NHR SR
•SR .SR
RS
NHR NHR NHR NHR
However, the reaction of 2-ethanethiol under similar conditions yields the 1,4- 
bis(propylamino)-5,8-bis(ethylsulfanyl)anthracene-9,l 0-dione (133) in 62 % yield.
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SH
K2C03 in DMF
The reaction of 2-methyl-2-propanethiol with 1,4-bis(propylamino)-5,8- 
dichloroanthracene-9,10-dione in ethanol doesn’t yield the expected 1,4- 
bis(aminopropyl)-5,8-bis(2-methyl-2-propanethiol)anthracene-9,10-dione (134).
SH
K2C03 in DMF
NH
,S O HN.
(134)
Although 2-methyl-2-propanethiol will react with activated benzenes such as l-chloro-2- 
nitrobenzene (135) in 2-propanol as the sodium salt at 50°C to yield l-(tert- 
butylsulfanyl)-2-nitrobenzene (136)24,
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(135) (136)
the use of DMF or DMSO for the 1,4-bis(propylamino)-5,8-dichloroanthracene-9,l 0- 
dione reaction still doesn’t facilitate the reaction, nor does the modification of the base 
used. The lack of reaction in this case can be attributed to the steric effects of the 
nucleophile. The sulphur atom of 2-methyl-2-propanethiol is sterically hindered by the 
three surrounding methyl groups making it a less effective nucleophile.
The reaction of potassium thiocyanate with l,4-bis(propylamino)-5,8-dichloroanthracene-
9,10-dione in various solvents was also fruitless, even though potassium thiocyanate does 
undergo reaction with activated chlorobenzenes such as 1 -chloro-2,4-dinitrobenzene 
(137) to yield 2,4-dinitrophenyl thiocyanate (138).
The lack of reaction may be attributable to the poor nucleophilic character of the 
attacking thiocyanate, due to the delocalisation of charge across the molecule.
ci
KSCN
(137) (138)
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N ^=C —— S Nrrrrcrrrrs
Figure 3-3 Charge delocalisation in thiocyanate nucleophile
l,4-Bis(isobutylamino)-5,8-dichloroanthracene-9,l 0-dione also under goes thiolation 
with thiophenol and 2-ethanethiol to yield l,4-bis(isobutylamino)-5,8- 
bis(phenylsulfanyl)-9,l 0-dione (139) and l,4-bis(isobutylamino)-5,8-bis(ethylsulfanyl)-
9,10-dione (140) in 37% and 41% yield respectively. However, there is no reaction 
between l,4-bis(isobutylamino)-5,8-dichloroanthracene-9,l0-dione with either 2-methyl- 
2-propanethiol or potassium thiocyanate.
Ph.
Ph'
(139)
(140)
Similarly, thiolation of l,4-bis[2-(hydroxyethyl)amino]-5,8-dichloroanthracene-9,10- 
dione with thiophenol and 2-ethanethiol in DMF gives l,4-bis[2-(hydroxyethyl)amino]-
5.8-bis(phenylsulfanyl)anthracene-9,l0-dione (141) and l,4-bis[2-(hydroxyethyl)amino]-
5.8-bis(ethylsulfanyl)anthracene-9,l 0-dione (142) in 67% and 51% yield respectively. 
Again no reaction is observed with 2-methyl-2-propanethiol and potassium thiocyanate.
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OHPh
OHPh'
.OH
OH
(141) (142)
1,4-Bis(phenylamino)-5,8-bis(phenylsul£anyl)anthracene-9,10-dione (143) and 1,4- 
bis(phenylamino)-5,8-bis(ethylsulfanyl)anthracene-9,l 0-dione (144) were synthesised in 
yields of 60% and 52% respectively, from l,4-bis(phenylamino)-5,8-dichloroanthracene-
9,10-dione and the appropriate thiols.
Ph> H Ph
O N
Ph' Ph
(143)
Ph
(144)
Again no reaction occurred between either 2-methyl-2-propanethiol or potassium 
thiocyanate with l,4-bis(phenylamino)-5,8-dichloroanthracene-9,l0-dione.
The thiolation of l,4-bis{[2-(dimethylamino)ethyl]amino}-5,8-dichloroanthracene-9,10- 
dione (127) and 1,4-bis {[2-(diethylamino)ethyl]amino} -5,8-dichloroanthracene-9,l 0- 
dione (128) with thiophenol and ethanethiol was unsuccessful in both ethanol and DMF, 
and only led to recovery of the starting materials.
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(127) (U8>
This can only be attributed to the presence of the nitrogen atom in the side chain. This 
may be causing solubility problems or there may be electronic factors at work. For 
example abstraction of the proton from the amino group, leads to delocalisation of 
negative charge on to the ring carbon next to the chlorine atoms, making the molecule 
less reactive towards attacking nucleophiles (145).
ci
a
ci
(145)
\
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3.7 Autoxidation of (alkylamino)aiithraceiie-9,10-dioiies
The attempted thiolation of l,4-bis(alkylamino)-5,8-anthracene-9,10-diones in DMF for 
prolonged periods lead to some interesting results. Firstly, the 1,4-bis(aminoethanol)-
5,8-dichloroanthracene-9,l 0-dione (125) heated in DMF with potassium thiocyanate did 
not produce the expected 1,4- diisothiocynato-5,8- bis[2-
(hydroxyethyl)amino]anthracene-9,l 0-dione even after 36 hours, but dealkylation occurs 
to give l,4-diamino-5,8-dichloroanthracene-9,l 0-dione (146), which was recovered from 
the reaction mixture.
.OH
HN
KSCN in DMF
HN
‘OH
(125)
NH-
NH-
l,4-Bis[2-(hydroxyethyl)amino]-5,8-dichloroanthracene-9,l0-dione (125) was heated in 
DMF to asses the importance of the thiol in the decomposition reaction, this had no effect 
indicating that the thiol plays no part in the decomposition of l,4-bis[2- 
(hydroxyethyl)amino]-5,8-dichloroanthracene-9,10-dione (125).
The reaction of l,4-bis(propylamino)-5,8-dichloroanthracene-9,l0-dione (123) with 2- 
ethanethiol and potassium hydroxide in DMF yields l,4-bis(propylamino)-5,8- 
bis(ethylsulfanyl)anthracene-9,10-dione (133), but if the reaction is allowed to continue 
two other products are produced, l-(propylamino)-4-amino-5,8-
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bis(ethylsulfanyl)anthracene-9,l 0-dione (147) and l,4-diamino-5,8-bis(ethylsulfanyl)-
9,10-dione (148).
A similar type of reaction occurs when amino containing dyes are faded by light27. The 
reaction is attributed to singlet oxygen and is widely acknowledged as a fading 
mechanism for many amino containing dyes27. One possible mechanism for the reaction 
is shown in (Figure 3-4).
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Figure 3-4. Autoxidation of amino compounds by singlet oxygen
Singlet oxygen (102) is a higher energy state of molecular oxygen and is one of the most 
active intermediates in biological reactions. It was first observed in 1924 and defined as 
a more reactive species of oxygen28. Singlet oxygen is generated when two unpaired 
electrons of molecular oxygen in its ground state rearrange and become paired in a single 
orbit. This excited state is 23 kcal mol*1 higher in energy than ground state. It can be 
seen from the reaction mechanism, that the initial proton abstraction occurs a to the 
nitrogen atom and therefore a hydrogen atom must be present for oxidation to take place. 
Taking this into consideration l,4-bis(phenylamino)-5,8-dichloroanthracene-9,l 0-dione 
(131) was heated in DMF for prolonged periods of time and did not yield 1,4-diamino-
5,8-dichloroanthracene-9,l 0-dione.
LIBRARY
nh2
DMF
HN
(131)
In an attempt to asses the importance of the chlorine atom present at the five and eight 
positions l,4-bis(propylamino)anthracene-9,l 0-dione (149), l,4-bis[2- 
(hydroxyethyl)amino]anthracene-9,10-dione (150), 1,4-bis(benzylamino)anthracene-
9,10-dione (151) were synthesised from 2,3-dihydro-9,10-dihydroxyanthracene-9,10- 
dione.
,OH
HN' HNHN'
HN. NHHN
‘OH
(149> (150) (151)
l,4-Bis(propylamino)anthracene-9,l0-dione (149), l,4-bis[2-
(hydroxyethyl)amino]anthracene-9,l 0-dione (150), and 1,4-bis(benzylamino)anthracene-
9,10-dione (151) were refluxed in DMF and all resulted in dealkylation to give 1,4- 
diaminoanthracene-9,10-dione (152).
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When the reactions were repeated under a nitrogen atmosphere, this prevented the 
formation of the degradation product, suggesting that oxygen was essential for the 
degradation to occur. Conversely when hydrogen peroxide was added to the reaction 
mixtures the degradation was accelerated. The addition of hydrogen peroxide is a good 
indicator that the reaction is of a free radical nature.
To asses the role of light in the decomposition reaction the afore mentioned reactions 
were repeated in the absence of daylight, however this had no effect.
As light plays no part in the reaction the generation of a reactive species must occur 
through some other pathway. The most likely explanation is that the anthracene-9,10- 
dione moiety is undergoing a one electron reduction to form the anthracene-9,10-dione 
radical. This can then undergo an electron transfer reaction with molecular oxygen to 
form the superoxide anion29. The superoxide radical could then undergo a nucleophilic 
addition elimination reaction leading to the degradation of the amino side chain.
3.8 Synthesis of amido analogous
The synthesis of amido analogous with the general formula (153) was also attempted.
o
SR HN. ,R'
(153) u
Amido analogous such as (153) should be obtainable from the acylation of 1,4-diamino-
5,8-dichloroanthracene-9,l 0-dione.
Two methods were selected for the synthesis of 1,4-diamino-5,8-dichloroanthracene-
9,10-dione (a) amination of 2,3-dihydro-9,10-dihydroxy-5,8-dichloroanthracene-9,10- 
dione using ammonia and (b) chlorination of l,4-diaminoanthracene-9,l0-dione (148). 
The amination was attempted by bubbling ammonia gas through an ethanol solution of
2,3-dihydro-9,10-dihydroxyanthracene-9,l 0-dione heated to 50°C, but no reaction 
occurred.
OH
OH
NH,
 7 V
EtOH
NH-
(121) (146)
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In an alternative strategy l,4-diaminoanthracene-9,l 0-dione (152) was chlorinated using 
boric acid, 65% oleum, iodine and a chlorinating agent as described previously for 1,4- 
dihydroxyanthracene-9,10-dione (see section 3.10).
n h 2n h 2
Cl o n h 2o
(152) (146)
Analysis of the product showed that a mixture of chlorination products was present, 
which was difficult to separate effectively. Acylation of the mixed chlorination product 
was attempted with benzoyl chloride but led to an intractable tar.
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3.9 Experimental
3.9.1 Oxidation of 2,3-dihydro-9,10-dihydroxyanthracene-l,4-dione
3.9.2 Using nitrobenzene
2.3-Dihydro-9,10-dihydroxyanthracene-l,4-dione (0.50g, 2.1 mmol) was refluxed for 19 
h in nitrobenzene (10 ml). The nitrobenzene was removed by steam distillation, the 
residue were collected by filtration, washed with water and air-dried. The solid was 
recrystallised from glacial acetic acid (8 ml) to give l,4-dihydroxy-9,10-anthracene-9,10- 
dione (0.30g, 59%), mp 190°C, (lit 200-2°C 30), SH (CDC13) 7.2(2H,s), 7.8(2H,m), 
8.2(2H,m), 12.8(2H,0/7,s)
3.9.3 Using sodium 3-nitrobenzenesulphonate
2.3-Dihydro-9,10-dihydroxyanthracene-l,4-dione (l.OOg, 4.1 mmol) and 3- 
nitrobenzenesulphonate (lO.Og, 49 mmol) were added to a solution of sodium hydroxide 
(1,00g, 25 mmol) in water (50 ml). The mixture was heated under reflux for 2 h and the 
solution was allowed to cool. It was acidified with conc. sulphuric acid (10 ml), the 
precipitate was filtered off and dried. The solid was then recrystallised from glacial 
acetic acid (15 ml) to give l,4-dihydroxy-9,10-anthracene-9,l0-dione (0 .6g, 61%), mp 
192°C, (lit 200-2°C30), 8H (CDCb) 7.2(2H,s), 7.8(2H,m), 8.2(2H,m), 12.8(2H,Qff,s)
3.9.4 Using concentrated sulphuric acid
2.3-Dihydro-9,10-dihydroxyanthracene-l,4-dione (l.OOg, 4.1 mmol), boric acid (0.30g, 
4.8 mmol) and concentrated sulphuric acid (5 ml) was heated to 50°C for 24 h. The
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solution was cooled, diluted with water (50 ml) and the precipitate was filtered off and 
recrystallised form glacial acetic acid (15 ml) to give l,4-dihydroxy-9,10-anthracene-
9.10-dione (0.40g, 41%), mp 187°C, (lit 200-2°C30), 6h (CDC13) 7.2(2H,s), 7.8(2H,m), 
8.2(2H,m), 12.8(2H,0//,s)
3.9.5 Using activated manganese dioxide
Activated manganese dioxide (0.50g, 5.9 mmol) was added to a solution of 2,3-dihydro-
9.10-dihydroxyanthracene-l,4-dione (0.35g, 1.4 mmol) in chloroform (25 ml). The 
reaction mixture was stirred at room temperature for 48h, the manganese dioxide was 
removed by filtration and the filtrate was concentrated by rotary evaporation to yield 1,4- 
dihydroxy-9,10-anthracene-9,10-dione(0.28g, 81%)%), mp 189°C, (lit 200-2°C30), 8h 
(CDCI3) 7.2(2H,s), 7.8(2H,m), 8.2(2H,m), 12.8(2H,0tf,s)
3.10 Chlorination of l,4-dihydroxyanthracene-9,l0-dione
3.10.1 Using thionyl chloride
l,4-Dihydroxyanthracene-9,l0-dione (5.0g, 20.1 mmol) was refluxed in thionyl chloride 
(40.0g, 30 mmol) for 2 h and allowed to cool, a mixture of boric acid (2.6g, 4.2 mmol), 
65% oleum (40g)and iodine (1.00g, 3.9 mmol) was added. The mixture was heated to 
70°C for 24 h and then poured onto ice (1 OOOg), the precipitate was collected by 
filtration, washed with water, and recrystallised from DMF (150 ml) to give 1,4- 
dihydroxy-5,8-dichloroanthracene-9,l0-dione (1.8g, 28%), mp 272-3 °C, (lit 283-4°C31), 
5 h (CDCI3) 7.3(2H,s), 7.7(2H,s), 12.6(2H,Oi/,s), m/z (El) molecular ion 308.
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3.10.2 Using chlorine gas
1.4-Dihydroxyanthracene-9,l 0-dione (5.0g, 20.1 mmol) was added to a mixture of boric 
acid (2.6g, 4.2 mmol), 65% oleum (80g) and iodine (1.00g, 3.9 mmol). The mixture was 
heated to 70°C for 24 h, while chlorine gas was bubbled through. The mixture was 
allowed to cool and poured onto ice (lOOOg), the resulting precipitate was collected by 
filtration, washed with water and recrystallised from DMF (150 ml) to give 1,4- 
dihydroxy-5,8-dichloroanthracene-9,l 0-dione (2g, 31%), mp 270-2 °C, (Iit283-4°C31), 
5h (CDCls) 7.3(2H,s), 7.7(2H,s), 12.6(2H,0i/,s), m/z (El) 308.
Chlorine gas was generated by the drop wise addition of concentrated hydrochloric acid 
(35 ml) to potassium permanganate (5.0g) from a pressure equalising funnel. The 
chlorine gas evolved was passed through a solution of water and then concentrated 
sulphuric acid.
3.103 Using chlorosulphonic acid
1.4-Dihydroxyanthracene-9,l 0-dione (5.0g, 20.1 mmol) was added to a mixture of boric 
acid (2.6g, 4.2 mmol), 65% oleum (80.0g), chlorosulphonic acid (80 ml, 0.3 mol) and 
iodine (1 00g, 3.9 mmol). The mixture was heated to 70°C for 24 h. The mixture was 
allowed to cool, poured onto ice (lOOOg), the precipitate was collected by filtration, 
washed with water and dried. The solid was recrystallised from DMF (150 ml) to yield
1.4-dihydroxy-5,8-dichloroanthracene-9,l0-dione (3.00g, 47%), mp 276-8 °C, (lit 283- 
4°C31), 8h (CDC13) 7.3(2H,s), 7.7(2H,s), 12.6(2H,Otf,s) m/z (El) 308.
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3.11 Reaction of l,4-dihydroxy-5,8-dichloroanthracene-9,10-dione with 
thiols
3.11.1 With thiophenol
1.4-Dihydroxy-5,8-dichloroanthracene-9,l0-dione (0.50g, 1.6 mmol) was added to a 
solution of sodium hydroxide (0.65g, 16 mmol) and thiophenol (1.73g, 16 mmol) in 
ethanol (25 ml), the mixture was heated under reflux for 24 h and then allowed to cool. 
The precipitate was filtered off to give a mixture of the starting material and benzene 
disulphide, mp 55°C (lit 59°C32), SH (CDCI3) 7.3 (3H, m), 7.5 (2H, m).
1.4-Dihydroxy-5,8-dichloroanthracene-9,l 0-dione (0.50g, 1.6 mmol) was added to a 
solution of sodium hydroxide (0.65g, 16 mmol) and thiophenol (1.73g, 16 mmol) in 
propanol (25 ml). The solution was heated under reflux for 24 h and then allowed to 
cool. The precipitate was then filtered off to give a mixture of the starting material and 
benzene disulphide, mp 55°C (lit 59°C32), 8H(CDC13) 7.3 (3H, m), 7.5 (2H, m).
1.4-Dihydroxy-5,8-dichloroanthracene-9,l0-dione (0.50g, 1.6 mmol) was added to a 
solution of sodium hydroxide (0.65g, 16 mmol) and thiophenol (1.73g, 16 mmol) in 
DMSO (25 ml). The solution was heated under reflux for 24 h and then allowed to cool. 
The precipitate was then filtered off to give a mixture of the starting material and benzene 
disulphide, mp 55°C (lit 59°C32), 5h(CDC13) 7.3 (3H, m), 7.5 (2H, m). The reaction was 
repeated varying concentration of sodium hydroxide and l,4-dihydroxy-5,8- 
dichloroanthracene-9,10-dione but to no avail.
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1.4-Dihydroxy-5,8-dichloroanthracene-9,l0-dione (0.50g, 1.6 mmol) was added to a 
solution of sodium hydroxide (0.65g, 16 mmol) and thiophenol (1.73g, 16 mmol) in DMF 
(25 ml). The solution was heated under reflux for 24 h and then allowed to cool. The 
precipitate was then filtered off to give a mixture of the starting material and benzene 
disulphide, mp 55°C (lit 59°C32), § h  (CDC13) 7.3 (3H, m), 7.5 (2H, m).
1.4-Dihydroxy-5,8-dichloroanthracene-9,l 0-dione (0.5Qg, 1.6 mmol) was added to a 
solution of sodium hydroxide (0.65g, 16 mmol) and thiophenol (1.73g, 16 mmol) in DMF 
(25 ml) under a nitrogen atmosphere. The solution was heated under reflux for 24 h and 
then allowed to cool. The precipitate was then filtered off to give the starting material. 
Identification was via TLC, using a mixture of 95% toluene and 5% chloroform (Rf= 
0.65).
1.4-Dihydroxy-5,8-dichloroanthracene-9,l 0-dione (0.50g, 1.6 mmol) was added to a 
solution of sodium carbonate (3.8g, 32 mmol) and thiophenol (1.73g, 16 mmol) in DMF 
(25 ml) under a nitrogen atmosphere. The solution was heated under reflux for 24 h and 
then allowed to cool. The precipitate was then filtered off to give the starting material. 
Identification was via TLC, using a mixture of 95% toluene and 5% chloroform (Rf= 
0.65).
1.4-Dihydroxy-5,8-dichloroanthracene-9,l0-dione (0.50g, 1.6 mmol) was added to a 
solution of potassium carbonate (4.6g, 32 mmol) and thiophenol (1.73g, 16 mmol) in 
DMF (25 ml). The solution was heated under reflux for 24 h and then allowed to cool.
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The precipitate was then filtered off to give the starting material. Identification was via 
TLC, using a mixture of 95% toluene and 5% chloroform (Rf= 0.65).
1.4-Dihydroxy-5,8-dichloroanthracene-9,l 0-dione (0.50g, 1.6 mmol) was added to a 
solution of potassium hydroxide (1.8g, 32 mmol) and thiophenol (1.73g, 16 mmol) in 
DMF (25 ml). The solution was heated under reflux for 24 h and then allowed to cool. 
The precipitate was then filtered off to give the starting material. Identification was via 
TLC, using a mixture of 95% toluene and 5% chloroform (Rf= 0.65).
1.4-Dihydroxy-5,8-dichloroanthracene-9,l 0-dione (0.2g, 0.8 mmol), thiophenol (0.14g), 
copper acetate33 (0.40g) and sodium acetate was refluxed in amyl alcohol (25 ml) for 16 
h. Amyl alcohol was removed by distillation to yield the starting material and benzene 
disulphide, mp 55°C (lit 59°C32), 6 h(C D C 13) 7.3 (3H, m), 7.5 (2H, m).
3.11.2 With 2-methyl-2-propanethiol
1.4-Dihydroxy-5,8-dichloroanthracene-9,l0-dione (0.50g, 1.6 mmol) was added to a 
solution of sodium hydroxide (0.65g, 16 mmol) and 2-methyl-2-propanethiol (1.50g, 16 
mmol) in ethanol (25 ml). The solution was heated under reflux for 24 h and then 
allowed to cool. The precipitate was then filtered off, to give the starting material. The 
reaction was also repeated in propanol, DMF and DMSO to yield the starting materials. 
Identification was via TLC, using a mixture of 95% toluene and 5% chloroform (Rf= 
0.65).
I l l
1.4-Dihydroxy-5,8-dichloroanthracene-9,l0-dione (0.50g, 1.6 mmol) was added to a 
solution of potassium hydroxide (0.90g, 16 mmol) and 2-methyl-2-propanethiol (1.50g, 
16 mmol) in DMF (25 ml). The solution was heated under reflux for 24 h and then 
allowed to cool. The precipitate was then filtered off to give the starting material. 
Identification was via TLC, using a mixture of 95% toluene and 5% chloroform (Rf= 
0.65).
1.4-Dihydroxy-5,8-dichloroanthracene-9,l 0-dione (0.50g, 1.6 mmol) was added to a 
solution of potassium carbonate (2.30g, 16 mmol) and 2-methyl-2-propanethiol (1.50g,
16 mmol) in DMF (25 ml). The solution was heated under reflux for 24 h and then 
allowed to cool. The precipitate was then filtered off to yield the starting material. 
Identification was via TLC, using a mixture of 95% toluene and 5% chloroform (Rf= 
0.65).
3.113 With Potassium thiocyanate
1.4-Dihydroxy-5,8-dichloroanthracene-9,l0-dione (0.50g, 1.6 mmol) was added to a 
solution of potassium thiocyanate (0.78g, 16 mmol) in ethanol (25 ml). The solution was 
heated under reflux for 24 h and then allowed to cool. The precipitate was then filtered 
off to give the starting materials. The reaction was repeated using propanol, DMF and 
DMSO as the solvent to yield the starting material. Identification was via TLC, using a 
mixture of 95% toluene and 5% chloroform (Rf= 0.65).
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3.12 Synthesis of l,4-dimethoxy-5,8-dichloroanthracene-9,l0-dione
1.4-Dihydroxy-5,8-dichloroanthracene-9,l0-dione (0.50g, 1.6 mmol) was added to a 
solution DMF (25 ml), dimethylsulphate (0.60g, 4.8 mmol) and potassium carbonate 
(1,00g, 7.2 mmol). The mixture under a nitrogen atmosphere was stirred and heated 
under reflux for 64 h. The hot solution was filtered and concentrated to give a dark solid, 
which was triturated with boiling petroleum ether. After standing the solid was collected 
by filtration to yield l,4-dimethoxy-5,8-dichloroanthracene-9,l0-dione (0.43g, 80%), mp 
315°C (lit16 320-325°C), SH (CDCI3) 3.9(6H, s), 7.1(2H, s), 7.5 (2H, s).
3.12.1 Reaction of thiols with l,4-dimethoxy-5,8-dichIoroanthracene-9,10-dione
3.12.2 With Thiophenol
1.4-Dimethoxy-5,8-dichloroanthracene-9,l0-dione (0.50g, 1.5 mmol) was added to a 
solution of sodium hydroxide (0.65g, 16 mmol) and thiophenol(1.73g, 16 mmol) in 
ethanol (25 ml). The solution was heated under reflux for 24 h and then allowed to cool. 
The precipitate was then filtered off to give the starting material. The reaction was also 
repeated in propanol, DMF and DMSO, to yield the starting material, mp 310°C, 5h 
(CDCI3) 3.9(6H, s), 7.1 (2H, s), 7.5 (2H, s).
1.4-Dimethoxy-5,8-dichloroanthracene-9,l0-dione (0.50g, 1.5 mmol) was added to a 
solution of sodium carbonate (0.65g, 16 mmol) and thiophenol (1.73g, 16 mmol) in 
DMF. The solution was heated under reflux for 24 h and then allowed to cool. The 
precipitate was then filtered off to yield the starting material, mp 310°C, 8h (CDCI3) 
3.9(6H, s), 7.1 (2H, s), 7.5 (2H, s).
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1.4-Dimethoxy-5,8-dichloroanthracene-9,10-dione (0.50g, 1.5 mmol) was added to a 
solution of potassium hydroxide (0.90g, 16 mmol) and thiophenol (1.73g, 16 mmol) in 
DMF. The solution was heated under reflux for 24 h and then allowed to cool. The 
precipitate was then filtered off to yield the starting material, mp 3 10°C, 5H(CDCl3) 
3.9(6H, s), 7.1(2H, s), 7.5 (2H, s).
1.4-Dimethoxy-5,8-dichloroanthracene-9,l 0-dione (0.50g, 1.5 mmol) was added to a 
solution of potassium carbonate (2.30g, 16 mmol) and thiophenol (1.73g, 16 mmol) in 
DMF. The solution was heated under reflux for 24 h and then allowed to cool. The 
precipitate was then filtered off to yield the starting material, mp 3 10°C, 5 h (CDCI3) 
3.9(6H, s), 7.1 (2H, s), 7.5 (2H, s).
3.123 With Potassium thiocyanate
1.4-Dimethoxy-5,8-dichloroanthracene-9,10-dione (0.50g, 1.5 mmol) was added to a 
solution potassium thiocyanate (0.78g, 16 mmol) in ethanol (25 ml). The solution was 
heated under reflux for 24 h and then allowed to cool. The precipitate was then filtered 
off to give the starting material. The reaction was repeated using propanol, DMF and 
DMSO, to yield the starting materials, mp 310°C, 5h(CDC13) 3.9(6H, s ) ,  7.1(2H, s) 7.5, 
(2H, s).
3.12.4 With 2-methyl-2-propanethioI
1.4-Dimethoxy-5,8-dichloroanthracene-9,l0-dione (0.50g, 1.5 mmol) was added to a 
solution of sodium hydroxide (0.65g, 16 mmol) and 2-methyl-2-propanethiol (1.50g, 16 
mmol) in ethanol (25 ml). The solution was heated under reflux for 24 h and then 
allowed to cool. The precipitate was then filtered off to give the starting material. The
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reaction was also repeated in propanol, DMF and DMSO to yield the starting materials, 
mp 310°C, 6h(CDC13) 3.9(6H, s), 7.1(2H, s), 7.5 (2H, s).
1.4-Dimethoxy-5,8-dichloroanthracene-9,l 0-dione (0.50g, 1.5 mmol) was added to a 
solution of potassium hydroxide (0.90g 16 mmol) and 2-methyl-2-propanethiol (1.50g, 
16 mmol) in DMF. The solution was heated under reflux for 24 h and then allowed to 
cool. The precipitate was then filtered off to give the starting material, mp 310°C, 5h 
(CDC13) 3.9(6H, s), 7.1(2H, s), 7.5 (2H, s).
1.4-Dimethoxy-5,8-dichloroanthracene-9,l0-dione (0.50g, 1.5 mmol) was added to a 
solution of potassium carbonate (2.30g, 16 mmol) and 2-methyl-2-propanethiol (1.50g, 
16 mmol) in DMF. The solution was heated under reflux for 24 h and then allowed to 
cool. The precipitate was then filtered off to give the starting material, mp 310°C, 5h 
(CDCI3) 3.9(6H, s), 7.1(2H, s), 7.5 (2H, s).
3.13 Reduction of l,4-dihydroxy-5,8-dichloroanthracene-9,l0-dione
3.13.1 Tin in acetic acid 34
1.4-Dihydroxy-5,8-dichloroanthracene-9,l0-dione (l.OOg, 3.3 mmol) was added to a 
mixture of tin (3.00g, 24.4 mmol) and HC1 (70 ml) in acetic acid (50 ml). The mixture 
was heated to 90-95°C for 24 hrs. The solution was allowed to cool and the precipitate 
was filtered off, the solid was washed with water and dried in vacuo to yield 2,3-dihydro-
9,10-dihydroxy-5,8-dichloroanthracene-l,4-dione (0.65, 64%), mp 147°C, 8h (CDCI3) 
3.0(4H,s), 7.6(2H,s), 14.5(2H,Otf,s).
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3.13.2 Sodium dithionite 35 36
l,4-Dihydroxy-5,8-dichloroanthracene-9,l 0-dione (l.OOg, 3.3 mmol) was added to a 
solution of sodium carbonate (1.4g, 13.2 mmol) and water (125 ml). The solution was 
heated until boiling, to which was added sodium dithionite (1.7g, 9.8 mmol). An 
additional quantity of sodium dithionite (0.50g, 2.9 mmol) was added to the solution to 
complete the reduction. The precipitate was filtered off, washed with dilute acetic acid 
until alkali free and dried in vacuo to yield 2,3-dihydro-9,10-dihydroxy-5,8- 
dichloroanthracene-1,4-dione (0.90g 96%), mp 145°C, (lit36150°C), 5h (CDCI3) 
3.0(4H,s), 7.6(2H,s), 14.5(2H,0//,s).
3.14 Animation of 9,10-dihydroxy-5,8-dichloro-2,3-dihydroanthracene- 
1,4-dione
3.14.1 Using Aniline
2.3-Dihydro-9,10-dihydroxy-5,8-dichloroanthracene-l,4-dione (l.OOg, 3.2 mmol) was 
added to a solution of aniline (4.10g, 44 mmol) and was heated for 4 h at 90-95°C. The 
solution was allowed to cool, the precipitate was filtered off, washed with ethanol and 
dried to yield the starting material 9,10-dihydroxy-5,8-dichloro-2,3-dihydroanthracene-
1.4-dione. Identification was via TLC using 95% toluene & 5% chloroform (Rf= 0.55).
2,3-Dihydro-9,10-dihydroxy-5,8-dichloroanthracene-l,4-dione (l.OOg, 3.2 mmol) was 
added to a solution of aniline (4. lOg, 44 mmol) in ethanol (25 ml) and was heated for 4 h 
at 90-95°C. The solution was allowed to cool and the precipitate was filtered off. The 
solid was washed with ethanol and dried to yield the starting material 9,10-dihydroxy-
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5,8-dichloro-2,3-dihydro-anthracene-l,4-dione. Identification was via TLC using 95% 
toluene & 5% chloroform (Rf = 0.55).
2.3-Dihydro-9,10-dihydroxy-5,8-dichloroanthracene-l,4-dione (l.OOg, 3.2 mmol) was 
added to a solution of aniline (3.00g, 32 mmol) and boric acid (0.40g, 6.4 mmol) and was 
heated for 4 h at 90-95°C. The solution was allowed to cool, the precipitate filtered off, 
and purified by column chromatography using an eluent of toluene 95% and chloroform 
5% to yield the l,4-bis(phenylamino)-5,8-dichloro-anthracene-9,l0-dione (0.35g, 24%), 
mp 230°C (lit34 234-5°C), 5 h(C D C 13) 7.00-7.30 (10H m), 7.40(2H s), 7.50(2H s), 11.40 
(2H NH s), 5C 182.26,142.77, 139.97, 136.43,133.60, 133.26,129.92, 126.51,125.30, 
123.92, 113.42
2.3-Dihydro-9,10-dihydroxy-5,8-dichloroanthracene-l,4-dione (l.OOg, 3.2 mmol) was 
added to a solution of aniline (3.00g, 32 mmol) and boric acid (0.40g, 6.4 mmol) in 
ethanol (30 ml) and was heated for 4 h at 90-95°C. The solution was allowed to cool, the 
precipitate was filtered off and purified by column chromatography using a eluent of 
toluene 95% and chloroform 5% to yield the l,4-bis(phenylamino)-5,8-dichloro- 
anthracene-9,10-dione (0.75g, 51%), mp 225-8°C (lit34 234-5°C), 5H(CDC13) 7.00-7.30 
(1 OH m), 7.40(2H s), 7.50(2H s), 11.40 (2H NH s).
3.14.2 Using Isobutylamine
2.3-Dihydro-9,10-dihydroxy-5,8-dichloroanthracene-l,4-dione (l.OOg, 3.2 mmol) was 
added to a solution of isobutylamine (2.40g, 32 mmol) and was heated for 1 h at 50-5°C. 
The solution was allowed to cool to which was added petroleum ether 40-60 (25 ml).
The mixture was stirred for 1 h and the solid was filtered off, purified by column
117
chromatography using an eluent of toluene 95% and chloroform 5% to yield 1,4- 
bis(isobutylamino)-5,8-dichloro-anthracene-9,10-dione(0.30g, 22%), mp 152 °C, 8H 
(CDCls) 1.00(12H, d), 2.00 (2H, m), 3.10(4H, t), 7.10(2H,s), 7.50(2H,s), 10.40 (2H,NH  
t), 80 180.80, 145.75, 135.69,133.44, 133.30, 123.70,110.68, 61.55,29.09, 20.92.
2.3-Dihydro-9,10-dihydroxy-5,8-dichloroanthracene-l,4-dione (l.OOg, 3.2 mmol) was 
added to a solution of isobutylamine (1.00g, 17 mmol) in ethanol (25 ml) and was heated 
for 1 h at 50-5°C. The solution was allowed to cool to which was added petroleum ether 
40-60 (25 ml). The mixture was stirred for overnight and the solid was filtered off, 
purified by column chromatography using an eluent of toluene 95% and chloroform 95% 
to yield l,4-bis(isobutylamino)-5,8-dichloro-anthracene-9,l0-dione (0.70g, 52%), mp 
154°C, 5h (CDC13) 1.00(12H, d), 2.00 (2H, m) 3.10 (4H, t), 7.10 (2H,s), 7.50 (2H,s), 
10.40 (2H, N H t), 8C 180.80, 145.75,135.69, 133.44, 113.30, 123.70,110.68,61.55, 
29.09, 20.92.
3.143 Using 2-Aminoethanol
2.3-Dihydro-9,10-dihydroxy-5,8-dichloroanthracene-l,4-dione (l.OOg, 3.2 mmol) was 
added to a solution of 2-aminoethanol (2.10g, 34 mmol) and was heated for 4 h at 50- 
55°C. The solution was allowed to cool to which was added petroleum ether 40-60 (25 
ml). The mixture was stirred for 1 h and the solid was filtered off, the solid was purified 
via column chromatography using an eluent of toluene 95% and chloroform 5% to yield
1.4-bis[2-(hydroxyethyl)amino]-5,8-dichloro-anthracene-9,l0-dione (0.40g, 31%), mp
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190°C, 5h (CDCI3) 3.40(4H, q), 3.60 (4H,t) 4.90(2H, OHs), 7.35 (2H,s) 7.60(2H,s),
10.30 (2H ,M /t).
2.3-Dihydro-9,10-dihydroxy-5,8-dichloroanthracene-l,4-dione (l.OOg, 3.2 mmol) was 
added to a solution of 2-aminoethanol (l.OOg, 17 mmol) in ethanol (25 ml) and was 
heated for 1 h at 50-5°C. The solution was allowed to cool to which was added 
petroleum ether 40-60 (25 ml). The mixture was stirred for overnight and the solid was 
filtered off and was recrystallised from ethanol to yield l,4-bis[2-(hydroxyethyl)amino]-
5,8-dichloroanthracene-9,10-dione(0.8g, 64%), mp 197°C, 5H (CDCI3) 3.40(2H,t), 3.60 
(2H, q) 4.90 (2H, OHs), 7.35 (4H, s) 7.60(4H, s), 10.30 (2H, NHt).
3.14.4 Using Propylamine
2.3-Dihydro-9,10-dihydroxy-5,8-dichloroanthracene-l,4-dione (l.OOg, 3.2 mmol) was 
added to a solution of propylamine (2g, 34 mmol) and was heated for 1 h at 50°C. The 
solution was allowed to cool to which was added petroleum ether 40-60 (25 ml). The 
mixture was stirred for 1 h and the precipitate was filtered off The solid was purified via 
column chromatography using an eluent of toluene 95% and chloroform 5%, to yield 1,4- 
bis(propylamino)-5,8-dichloroanthracene-9,l0-dione (0.40g, 32%), mp 150°C, 5h 
(CDCI3) 1.00 (6H,t), 1.50 (4H,m) 3.30 (4H, q), 7.10 (2H,s) 7.40 (2H,s), 10.30 (2H,NH 
t).
2.3-Dihydro-9,10-dihydroxy-5,8-dichloroanthracene-l,4-dione (l.OOg, 3.2 mmol) was 
added to a solution of propylamine (l.OOg, 17 mmol) in ethanol (25 ml) and was heated 
for 1 h at 50-5°C. The solution was allowed to cool to which was added petroleum ether 
40-60 (25 ml) and was stirred for overnight. The solid was filtered off and purified via
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column chromatography using an eluent of toluene 95% and chloroform 5% to yield 1,4- 
bis(propylamino)-5,8-dichloroanthracene-9,10-dione (0.6g, 48%), mp 150°C, SH (CDCI3) 
1.00 (6H,t), 1.50 (4H,m) 3.30 (4H, q), 7.10 (2H,s) 7.40 (2H,s), 10.30 (2H ,M /t).
3.14.5 Using Methylamine
2.3-Dihydro-9,10-dihydroxy-5,8-dichloroanthracene-l,4-dione (l.OOg, 3.2 mmol) was 
added to a solution of 20% methylamine in water (4.96g, 32 mmol) and was heated for 1 
h at 50-5°C. The solution was allowed to cool and the solid was collected by filtration. 
The solid was washed with water (50 ml) and purified by column chromatography using 
an eluent of toluene 95% and chloroform 5% to yield 1,4-bis(methylamino)-5,8- 
dichloroanthracene-9,10-dione (0.50g, 47%), mp 145 °C, 5H (CDCI3) 3.00 (6H, d), 
7.15(2H,s) 7.45(2H,s), 10.10 (2H, NH ).
3.14.6 Using N,N-Dimethylethylenediamine
2.3-Dihydro-9,10-dihydroxy-5,8-dichloroanthracene-l,4-dione (l.OOg, 3.2 mmol) was 
added to N,N-dimethylethylenediamine (2.8g, 32 mmol) and was heated for 1 h at 50- 
5°C. The solution was allowed to cool, to which was added petroleum ether 40-60 (25 
ml). The mixture was refrigerated for 7 days to yield a tar like solid, further attempts to 
purify the mixture where unsuccessful
2.3-Dihydro-9,10-dihydroxy-5,8-dichloroanthracene-l,4-dione (l.OOg, 3.2 mmol) was 
added to a solution of N,N-dimethylethylenediamine (2.8g, 16 mmol) in ethanol (25 ml) 
and was heated for 2 h at 50-5°C. The solution was allowed to cool to which was added 
petroleum ether 40-60 (25 ml). The mixture was refrigerated, the solid was filtered off
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and added to a solution of diethylether (25 ml) and methanol (25 ml) saturated with HC1 
(HC1 gas was generated by adding conc. hydrochloric acid 50 ml, dropwise to 
concentrated sulphuric acid 50 ml, and the gas evolved was bubbled through the 
solution). The solid was purified using column chromatography via column 
chromatography with an eluent of 10% methanol and 90% chloroform to yield 1,4- 
bis {[2-(dimethylamino)ethyl]amino} -5,8-dichloroanthracene-9,10-dione37 (0.40g, 29%), 
mp 255°C, 6h (DMSO d6) 3.20 (12H, s), 3.30 (4H, t), 3.50 (4H, q), 7.35 (2H,s) 7.65 
(2H,s), 10.10 (2H, N H t), 80 179.91, 144.45,136.03,132.23,132.09, 124.66,109.78, 
55.55,51.74,46.79.
3.14.7 Using NJV-Diethylethylenediamine
2.3-Dihydro-9,10-dihydroxy-5,8-dichloroanthracene-l,4-dione (l.OOg, 3.2 mmol) was 
added to N,N-diethylethylenediamine (2.8g, 32 mmol) and heated for 1 h at 50-5°C. The 
solution was allowed to cool to which was added petroleum ether 40-60 (25 ml) the 
mixture was refrigerated for 7 days to yield a tar like solid, further attempts to purify the 
mixture was unsuccessful.
2.3-Dihydro-9,10-dihydroxy-5,8-dichloroanthracene-l,4-dione (l.OOg, 3.2 mmol) was 
added to a solution of N,N-diethylethylenediamine (2.8g, 16 mmol) in ethanol (25 ml) 
and was heated for 2 h at 50-5°C. The solution was allowed to cool to which was added 
petroleum ether 40-60 (25 ml). The mixture was refrigerated, the solid was filtered off 
and added to a solution of diethylether (25 ml) and methanol (25 ml) saturated with HC1 
(HC1 gas was generated by adding conc. hydrochloric acid 50 ml, dropwise to 
concentrated sulphuric acid 50 ml, and the gas evolved was bubbled through the
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solution). The solid was purified using column chromatography via column 
chromatography with an eluent of 10% methanol and 90% chloroform to yield 1,4- 
bis {[2-(diethylamino)ethyl]amino} -5,8-dichloroanthracene-9,10-dione. HC1 (0.30g, 
22%), mp 265°C, SH (DMSO d6) 1.25 (12H, t), 3.20 (8H, q), 3.40 (4H, t) 3.90 (4H, q), 
7.60 (2H, s) 7.80 (2H, s), 9.90 (2H, NH t), 10.90 (2H, HCl), 80 180.51,144.04,136.61, 
132.54,132.26,124.20,111.04,49.94,46.75, 37.36,8.69
3.14.8 Using 2-[2-(aminoethyl)amino]ethanol
2,3-Dihydro-9,10-dihydroxy-5,8-dichloroanthracene-l,4-dione (l.OOg, 3.2 mmol) was 
added to a solution of 2-[2-(aminoethyl)amino]ethanol (3.3g, 32 mmol). The solution 
was heated for 1 h at 50-5°C and then allowed to cool, to which was added petroleum 
ether 40-60 (25 ml). The mixture was refrigerated for 7 days to yield a tar like solid, 
further attempts to purify the mixture were unsuccessful. The reaction was repeated 
altering the molar ratios of reactants, the reaction time and the solvent employed i.e. 
methanol, ethanol, propanol, butanol and 2-methoxyethanol but only yielded tarry solid. 
Purification of the tarry solid was attempted via column chromatography using eluting 
solvent systems of 90% chloroform & 10% methanol or 70% THF, 20% acetic acid & 
10% water but unsuccessful.
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3.15 Reaction of l,4-bis(phenylamino) -5,8-dichloroanthracene-9,10- 
dione
3.15.1 With Thiophenol
1.4-Bis(phenylamino) -5,8-dichloroanthracene-9,l0-dione (0.50 g, 1.1 mmol) was added 
to a solution of thiophenol (1.20g, 11 mmol) and potassium hydroxide (0.62g, 11 mmol) 
in DMF (25 ml) and was heated under reflux for 2h. The DMF was removed under 
vacuum distillation, the solid was washed with 10% potassium hydroxide solution (50 
ml) and then methanol. The solid was purified via column chromatography using an 
eluent of 90% toluene and 10% chloroform to yield l,4-bis(phenylamino)-5,8- 
bis(phenylsulfanyl)anthracene-9,l0-dione38, (0.40g, 60%), mp 225°C, 5H (CDCI3) 6.65 
(2Hs), 7.00-7.50 (22Hm), 11.85 (2 H M s), 50 184.56, 143.46, 141.60, 137.44,133.51, 
131.34, 130.32, 130.29,129.85, 129.49,129.43,127.91, 125.03,124.38, 112.25.
3.15.2 With 2-Ethanethiol
1.4-Bis(phenylamino) -5,8-dichloroanthracene-9,l0-dione (0.50g, 1.1 mmol) was added 
to a solution of 2-ethanethiol (0.68g, 11 mmol) and potassium hydroxide (0.62g, 11 
mmol) in DMF (25 ml) and was heated under reflux for 2h. The DMF was removed 
under vacuum distillation, the solid was washed with 10% potassium hydroxide solution 
(50 ml) and then methanol. The solid was purified via column chromatography using an 
eluent of 90% toluene and 10% chloroform to yield (0.30g, 52%) l,4-bis(phenylamino)-
5,8-bis(ethylsulfanyl) anthracene-9,10-dione, mp 215°C, 5h(CDC13), 1.35 (6H, t), 2.90 
(4H, q), 7.00-7.50 (14H, m), 11.75 (2H, NH, s), 5C 184.74, 140.26, 139.77,132.77,
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132.22, 129.89,129.79,128.50, 124.85,124.79,112.43, 26.79, 13.23. m/z calculated 
510.1436 found 510.1434
3.153 With Potassium thiocyanate
1.4-Bis(phenylamino) -5,8-dichloroanthracene-9,l0-dione (0.50g, 1.1 mmol) was added 
to a solution of potassium thiocyanate (1. lOg, 11 mmol) in DMF (25 ml) and was heated 
under reflux for 48 h. The DMF was removed under vacuum distillation, the solid was 
washed with 10% potassium hydroxide solution (50 ml) to yield the starting material, 
identification was via TLC using 95% methanol and 5% chloroform( Rf=0.88)
3.15.4 With 2-methyl-2-propanethiol
1.4-Bis(phenylamino) -5,8-dichloroanthracene-9,l 0-dione (0.50g, 1.1 mmol) was added 
to a solution of 2-methyl-propanethiol (0.99g, 11 mmol) and potassium hydroxide 
(0.62g, 11 mmol) in DMF (25 ml) and was heated under reflux for 24h. The DMF was 
then removed under vacuum distillation, the solid was washed with 10% potassium 
hydroxide solution (50 ml) and then methanol to yield the starting material, identification 
was via TLC using 95% methanol and 5% chloroform( Rf=0 .88).
3.16 Reaction of l,4-bis(propylamino)-5,8-dichloroanthracene-9,10- 
dione
3.16.1 With Thiophenol
1.4- Bis(propylamino)-5,8-dichloro-anthracene-9,l0-dione (0.43g, 1.1 mmol) was added 
to a solution of thiophenol (1.20g, 11 mmol) and potassium hydroxide (0.62g, 11 mmol)
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in ethanol (25 ml). The solution was heated under reflux for 2h and the ethanol was 
removed under vacuum distillation. The solid was washed with 10% potassium 
hydroxide solution (50 ml) and then methanol. The solid was purified via column 
chromatography using an eluent of 90% toluene and 10% chloroform to yield 1,4-bis 
bis(propylamino)-5,8-bis(phenylsulfanyl)anthracene-9,l 0-dione (0.25g, 41%), mp 240°C, 
5h (CDCIs) 1.00 (6H, t), 1.8 (4H, m), 3.30(4H, q), 6.60 (2H, s) 7.40 (12H,m), 10.50 (2H, 
NH, t), m/z (El) 538.3.
1.4- Bis(propylamino)-5,8-dichloro-anthracene-9,10-dione (0.43g, 1.1 mmol) was added 
to a solution of thiophenol (1.20g, 11 mmol) and potassium hydroxide (0.62g, 11 mmol) 
in DMF (25 ml). The solution was heated under reflux for 2h and then the DMF was 
removed under vacuum distillation. The solid was washed with 10% potassium 
hydroxide solution (50 ml) and then methanol. The solid was purified via column 
chromatography using an eluent of 90% toluene and 10% chloroform to yield 1,4-bis 
bis(propylamino)-5,8-bis(phenylsulfanyl)anthracene-9,l0-dione (0.40g, 66%), mp 240°C, 
5h (CDCIs) 1.00 (6H, t), 1.80 (4H, m), 3.30 (4H, q), 6.60 (2H, s) 7.40 (12H,m), 10.50 
(2H, NH, t), m/z (El) 538.3.
3.16.2 With Ethanethiol
1.4- Bis(propylamino) -5,8-dichloroanthracene-9,l0-dione (0.43g, 1.1 mmol) was added 
to a solution of ethanethiol (0.68g, 11 mmol) and potassium hydroxide (0.62g, 11 mmol) 
in DMF (25 ml). The solution was heated under reflux for 2h and then the DMF was 
removed under vacuum distillation. The solid was washed with 10% potassium 
hydroxide solution (50 ml) and then methanol. The solid was purified via column
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chromatography using an eluent of 90% toluene and 10% chloroform to yield 1,4- 
bis(propylamino) 5,8-bis(ethylsulfanyl) anthracene-9,10-dione (0.30g, 62%), mp 235°C, 
8h (CDCIs) 1.00 (6H, t) 1.30 (6H, t), 1.70 (4H, m), 2.80 (4H, q), 3.20 (4H, q), 6.90 (2H, 
s), 7.25 (2H, s), 10.30 (2H,M/, t).
1.4- Bis(propylamino) -5,8-dichloroanthracene-9,l0-dione (0.43g, 1.1 mmol) was added 
to a solution of ethanethiol (0.68g, 11 mmol) and potassium hydroxide (0.62g, 11 mmol) 
in DMF (25 ml). The solution was heated under reflux for 24h and then the DMF was 
removed under vacuum distillation. The solid was washed with 10% potassium 
hydroxide solution (50 ml) and then methanol. The solid was purified via column 
chromatography using an eluent of 90% toluene and 10% chloroform to yield 1,4- 
diamino-5,8-bis(ethylsulfanyl)anthracene-9,l0-dione (0.10g, 22%), mp 235°C, 5h 
(DMSO) 1.40 (6H, t), 3.00 (4H, q), 7.20 (2H s), 7.65 (2H, s), 8.20 (4H, s,) m/z (El) 358.1 
and l-(propylamino)-4-amino-5,8-bis(ethylsulfanyl) anthracene-9,10-dione, (0.12g,
25%), mp 210 °C, 8h(CDC13) 1.00 (3H, t), 1.40 (6H, t), 1.70 (2H,m), 2.9 (4H, m), 3.3 
(2H, q), 6.8 (2H, s ) 7.00 (2H, m), 7.5 (2H, m), 10.30 (1H, t), m/z (El) 400.2.
3.163 With Potassium thiocyanate
1.4- Bis(propylamino) -5,8-dichloroanthracene-9,l0-dione (0.43g, 1.1 mmol) was added 
to a solution of potassium thiocyanate (1. lOg, 11 mmol) in DMF (25 ml). The solution 
was heated under reflux for 2h and then the DMF was removed under vacuum 
distillation. The solid was washed with 10% potassium hydroxide solution (50 ml), to 
yield the starting material; identification was via TLC using 95% methanol and 5% 
chloroform.
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1.4- Bis(propylamino) -5,8-dichloroanthracene-9,l0-dione (0.43g, 1.1 mmol) was added 
to a solution of potassium thiocyanate (1.10g, 11 mmol) in DMF (25 ml). The solution 
was heated under reflux for 24 h and then the DMF was removed under vacuum 
distillation. The solid was washed with 10% potassium hydroxide solution (50 ml) and 
purified by column chromatography using an eluent of 10% methanol and 90% 
chloroform to yield l,4-diamino-5,8-dichloro-anthracene-9,l0-dione (0.08g, 25%), mp 
270°C, (lit31 280°C), m/z (El) 306.1, SH (CDCh) 6.75 (4H, s NH2), 6.80 (2H, s), 7.50 
(2H, s).
1.4-Bis(propylamino) -5,8-dichloroanthracene-9,l0-dione (0.43g, 1.1 mmol) in DMF (25 
ml) was heated under reflux for 24 h. The DMF was removed under vacuum distillation 
and the resulting solid was purified by column chromatography using an eluent of 10% 
methanol and 90% chloroform to yield l,4-diamino-5,8-dichloro-anthracene-9,l 0-dione 
(0.08g, 25%), mp 270°C, (lit31 280°C), m/z (El) 306.1, 5h (CDCI3) 6.75 (4H, s NH2),
6.80 (2H, s), 7.50 (2H, s).
1.4- Bis(propylamino) -5,8-dichloroanthracene-9,l 0-dione (0.43 g, 1.1 mmol) with 30% 
hydrogen peroxide solution (10 ml) in DMF (25 ml) was heated under reflux for 2 h. The 
DMF was removed under vacuum distillation and the resulting solid was purified by 
column chromatography using an eluent of 10% methanol and 90% chloroform to yield
1.4-diamino-5,8-dichloro-anthracene-9,l0-dione (0.1 Og, 32%), mp 270°C, (lit31 280°C), 
m/z (El) 306.1, 5h (CDC13) 6.75 (4H, s NH2), 6.80 (2H, s), 7.50 (2H, s).
127
1.4- Bis(propylamino) -5,8-dichloroanthracene-9,10-dione (0.43g, 1.1 mmol) in DMF (25 
ml) previously purged with nitrogen. The solution was heated under reflux for 48 h and 
nitrogen was bubbled through. The DMF was removed under vacuum distillation to yield 
the starting material. Identification was via TLC using 95% methanol and 5% 
chloroform.
3.17 Reaction of l,4-bis(isobutylamino)-5,8-dichloro-9,10- 
anthracenedione
3.17.1 With Thiophenol
1.4- Bis(isobutylamino)-5,8-dichloro-anthracene-9,l 0-dione (0.43 g, 1.1 mmol) was 
added to a solution of thiophenol (1.20g, 11 mmol) and potassium hydroxide (0.62g, 11 
mmol) in DMF (25 ml). The solution was heated under reflux for 2h and then the DMF 
was removed under vacuum distillation. The solid was washed with 10% potassium 
hydroxide solution (50 ml) and then methanol. The solid was purified via column 
chromatography using an eluent of 10% methanol and 90% chloroform to yield 1,4-bis 
bis(isobutylamino)-5,8-bis(phenylsulfanyl)anthracene-9,l0-dione (0.22g, 37%), mp 
240°C, 8h (CDC13) 1.00 (12H, d), 2.10 (2H, m), 3.30 (4H, t), 6.60 (2H, s) 7.50 (12H, m), 
10.60 (2H, NH, t).
3.17.2 With Ethanethiol
1.4-Bis(isobutylamino)-5,8-dichloro-anthracene-9,l 0-dione (0.43 g, 1.1 mmol) was 
added to a solution of ethanethiol (0.68g, 11 mmol) and potassium hydroxide (0.62g, 11 
mmol) in DMF (25 ml). The solution was heated under reflux for 2h and then the DMF 
was removed under vacuum distillation. The solid was washed with 10% potassium
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hydroxide solution (50 ml) and then methanol. The solid was purified via column 
chromatography using an eluent of 90% toluene and 10% chloroform to yield 1,4- 
bis(isobutylamino) 5,8-bis(ethylsulfanyl) anthracene-9,10-dione (0.2g 41%), mp 230 °C, 
8h 0.95 (12H, d), 1.30 (6H, t), 1.90 (2H, m), 2.80 (4H, q), 3.05(4H, t), 6.95 (2H, s), 7.30 
(2H,s), 10.40, (2H,t,M /), 5C182.17, 137.02, 131.11,128.23, 127.34, 124.48,108.4, 
49.63, 29.79, 28.79,19.53,11.80.
3.173 With Potassium thiocyanate
1.4-Bis(isobutylamino)-5,8-dichloro-anthracene-9,l 0-dione (0.43 g, 1.1 mmol) was 
added to a solution of potassium thiocyanate (1.1 Og, 11 mmol) in DMF (25 ml). The 
solution was heated under reflux for 2h and then the DMF was removed under vacuum 
distillation. The solid was washed with 10% potassium hydroxide solution (50 ml) to 
yield the starting material, identification was via TLC using 95% methanol and 5% 
chloroform( Rf =0.88).
1.4- Bis(isobutylamino)-5,8-dichloro-anthracene-9,l 0-dione (0.43g, 1.1 mmol) was 
added to a solution of potassium thiocyanate (1. lOg, 11 mmol) in DMF (25 ml). The 
solution was heated under reflux for 24 h and then the DMF was removed under vacuum 
distillation. The solid was washed with 10% potassium hydroxide solution (50 ml) to 
yield l,4-diamino-5,8-dichloro-anthracene-9,l0-dione (0.05 g, 13%), mp 270°C, (lit31 
280°C), m/z (El) 306.1.
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3.18 Reaction of l,4-bis[2-(hydroxyethyl)amiiio]-5,8-dichloro-9,10- 
anthracenedione
3.18.1 With Thiophenol
1.4- Bis[2-(hydroxyethyl)amino]-5,8-dichloro-anthracene-9,l 0-dione (0.43 g, 1.1 mmol) 
was added to a solution of thiophenol (1.20g, 11 mmol) and potassium hydroxide (0.62g, 
11 mmol) in DMF (25 ml). The solution was heated under reflux for 2h and then the 
DMF was removed under vacuum distillation. The solid was washed with 10% 
potassium hydroxide solution (50 ml) and then methanol. The solid was purified via 
column chromatography to yield 1,4-bis bis[2-(hydroxyethyl)amino]-5,8- 
bis(phenylsulfanyl)anthracene-9,l0-dione (0.40g, 67%), mp 260°C, 8h (DMSO) 3.40 
(4H, q), 3.75 (4Ht), 5.10 (2H, OHs), 6.70 (2H s), 7.50 (12Hm), 10.50 (2 H M s), 5C 
181.64, 145.64,139.88,135.95,133.33, 130.50,130.45, 129.87, 129.17,124.56,108.77, 
60.27, 45.19.
3.18.2 With Ethanethiol
1.4-Bis[2-(hydroxyethyl)amino]-5,8-dichloro-anthracene-9,10-dione(0.43g, 1.1 mmol) 
was added to a solution of ethanethiol (0.68g, 11 mmol) and potassium hydroxide 
(0.62g, 11 mmol) in DMF (25 ml). The solution was heated under reflux for 2h and the 
DMF was then removed under vacuum distillation. The solid was washed with 10% 
potassium hydroxide solution (50 ml) and then methanol. The solid was purified via 
column chromatography using an eluent of 90% toluene and 10% chloroform to yield
1.4-bis[2-(hydroxyethyl)amino]-5,8-bis(ethylsulfanyl) anthracene-9,10-dione (0.25g,
130
51%), mp 254°C, 5H(CDC13) 1.10 (6H, t), 2.70 (4H, q), 3.30 (4H, q), 3.50 (4H, t), 7.20 
(2H, s), 7.4 (2H, s), 10.10 (2H, NH), m/z (El) 446.2.
1.4-Bis[2-(hydroxyethyl)amino]-5,8-dichloro-anthracene-9,10-dione(0.43g, 1.1 mmol) 
was added to a solution of ethanethiol (0.68g, 11 mmol) and potassium hydroxide 
(0.62g, 11 mmol) in DMF (25 ml). The solution was heated under reflux for 24h and the 
DMF was then removed under vacuum distillation. The solid was washed with 10% 
potassium hydroxide solution (50 ml) and then methanol. The solid was purified via 
column chromatography using an eluent of 90% toluene and 10% chloroform to yield
1.4-diamino-5,8- bis(ethylsulfanyl) anthracene-9,10-dione (0.13g, 25%), mp 256°C, 5h 
(DMSO), 1.40 (6H, t), 3.00 (4H, q), 7.20 (2H s), 7.65 (2H, s), 8.20 (4H, s,), m/z (El) 
358.1.
3.183 With Potassium thiocyanate
1.4-Bis[2-(hydroxyethyl)amino]-5,8-dichloro-anthracene-9,10-dione(0.43g, 1.1 mmol) 
was added to a solution of potassium thiocyanate (1.1 Og, 11 mmol) in DMF (25 ml). The 
solution was heated under reflux for 24 h and was then the DMF was removed under 
vacuum distillation. The solid was washed with 10% potassium hydroxide solution (50 
ml) and purified by column chromatography using an eluent of 10% methanol and 90% 
chloroform to yield l,4-diamino-5,8-dichloro-anthracene-9,l0-dione (0.1 Og, 27%), mp 
270°C, (lit31 280°C), m/z (El) 306.1.
1.4-Bis[2-(hydroxyethyl)amino]-5,8-dichloro-anthracene-9,10-dione(0.43g, 1.1 mmol) in 
DMF (25 ml) and was heated under reflux for 24 h. The DMF was then removed under 
vacuum distillation and the solid was purified by column chromatography using an eluent
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of 10% methanol and 90% chloroform to yield l,4-diamino-5,8-dichloro-anthracene-
9,10-dione (0.12g, 31%), mp 270°C, (lit31 280°C), m/z (El) 306.1.
1.4-Bis[2-(hydroxyethyl)amino]-5,8-dichloro-anthracene-9,10-dione(0.43g, 1.1 mmol) 
with 30% hydrogen peroxide solution (10 ml) in DMF (25 ml)and was heated under 
reflux for 2 h. The DMF was then removed under vacuum distillation and the solid was 
purified by column chromatography using an eluent of 10% methanol and 90% 
chloroform to yield l,4-diamino-5,8-dichloro-anthracene-9,l 0-dione (0.12g, 31%), mp 
270°C, (lit31280°C), m/z (El) 306.1.
1.4-Bis[2-(hydroxyethyl)amino]-5,8-dichloro-anthracene-9,10-dione(0.43g, 1.1 mmol) 
was added to DMF (25 ml) previously purged with nitrogen and was heated under reflux 
for 24h under a nitrogen atmosphere. The DMF was then removed by vacuum 
distillation to yield the starting material; identification was via TLC using 95% 
chloroform and 5% methanol.
3.19 Reaction of l,4-bis{[2-(dimethyIamino)ethyl]amino}-5,8- 
dichloroanthracene-9,10-dione and l,4-bis{[2- 
(diethylaniino)ethyl] amino]-5,8-dichloro-anthracene-9,l 0-dione
1.4-Bis{[2-(dimethylamino)ethyl]amino]-5,8-dichloro-anthracene-9,l 0-dione (0.43 g, 1.1 
mmol) was added to a solution of thiophenol (1.20g, 11 mmol) and potassium hydroxide 
(0.62g, 11 mmol) in DMF (25 ml) and was heated under reflux for 2h. The DMF was 
then removed under vacuum distillation. The solid was washed with 10% potassium 
hydroxide solution (50 ml) to yield the starting material, identification was via TLC using
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an eluent of 10% methanol and 90% chloroform (Rf =0.40). The reaction was repeated 
with 2-ethanethiol, and potassium thiocyanate but to no avail. Prolonged reaction times 
only led to the previously isolated decomposition product l,4-diamino-5,8- 
dichloroanthracene-9,10-dione.
The above reaction was also repeated with l,4-bis{[2-(diethylamino)ethyl]amino]-5,8- 
dichloro-anthracene-9,10-dione and yielded the same outcome.
3.20 Synthesis of l,4-bis(amino)anthracene-9,10-diones
2.3-Dihydro-9,10-dihydroxyanthracene-l,4-dione (l.OOg, 4.1 mmol) was added to a 
solution of 2-aminoethanol (1.20g, 20 mmol) in ethanol (25 ml). The solution was heated 
for 1 h at 50-5°C. The solution was allowed to cool, the solid was filtered off and 
recrystallised from ethanol to yield l,4-bis[2-(hydroxyethyl)amino]anthracene-9,l 0-dione 
(0.6g, 45%), mp 225 °C (lit39 237°C).
2.3-Dihydro-9,10-dihydroxyanthracene-l,4-dione (l.OOg, 4.1 mmol) was added to a 
solution of benzylamine (1,90g, 20 mmol) in ethanol (25 ml). The solution was heated 
for 1 h at 50-5°C. The solution was allowed to cool, the solid was filtered off and 
recrystallised from ethanol to yield l,4-bis(benzylamino)anthracene-9,l0-dione (0.8, 
49%), mp 195°C,( lit40 205°C).
2.3-Dihydro-9,10-dihydroxyanthracene-l,4-dione (l.OOg, 4.1 mmol) was added to a 
solution of propylamine (1.20g, 20 mmol) in ethanol (25 ml). The solution was heated 
for 1 h at 50-5°C. The solution was allowed to cool, the solid was filtered off and 
recrystallised from ethanol to yield l,4-bis(propylamino)anthracene-9,l 0-dione 
(0.6g, 45%), mp 127°C, (lit41 132°C).
133
1.4-Bis[2-(hydroxyethyl)amino]anthracene-9,l 0-dione (0.50g, 2.1 mmol) was heated 
under reflux in DMF (25 ml) for 24 hours. The DMF was then removed under vacuum 
distillation to and purified by column chromatography using an eluent of 10% methanol 
and 90% chloroform to yield l,4-diaminoanthracene-9,l 0-dione (0.1 Og, 20%) mp 250°C 
(lit42 265°C), 5h(CDC13) 6.7 (2H, s), 7.0 (4H, NH), 7.6 (2H, m), 8.4, (2H, m).
The above reaction was repeated with l,4-bis(propylamino)anthracene-9,l0-dione and
1.4-bis(benzylamino)anthracene-9,l0-dione to yield l,4-diaminoanthracene-9,l0-dione.
3.21 Synthesis of l,4-diamino-5,8-dichIoroanthracene-9,10-dione
3.21.1 Amination of 2,3-dihy d ro-9,10-dihydroxy-5,8-dichloroanthracene-9,10- 
dione
2.3-Dihydro-9,10-dihydroxy-5,8-dichloroanthracene-9,l0-dione (0.50g, 1.5 mmol) was 
dissolved in ethanol 25 ml, the mixture was heated to 50°C and ammonia gas was 
bubbled through over 24h. The solution was cooled and the precipitate was filtered off to 
yield the starting material, identification was performed using TLC with an eluent of 5% 
chloroform and 95% toluene (Rf =0.50).
3.22 Chlorination of l,4-diaminoanthracene-9,10-diones
1.4-Diaminoanthracene-9,l 0-dione (5.0g, 21 mmol) was added to a mixture of boric acid 
(2.6g, 4.2 mmol), 65% oleum (80g), chlorosulphonic acid (80 ml, 0.3 mol) and iodine
(1,00g, 3.9 mmol). The mixture was heated to 70°C for 24 h. The mixture was allowed 
to cool and poured onto ice (lOOOg). The precipitate was collected by filtration and 
washed with water. The solid was reciystallised from DMF (150 ml) to give a mixture of 
chlorinated products, m/z (El) 306.1, 340.1, 375.0.
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3.23 Instrumentation
NMR were recorded on a Bruker AC spectrometer at 400 MHz. All chemical shifts in 
parts per million (8) relative to tetramethylsilane in deuturated dimethylsulphoxide 
(DMSO) or Chloroform (CDCI3). Mass spectra were recorded using the EPSRC Mass 
spectrometry centre using a VG analytical Quatro II triple quadrupole mass spectrometer. 
The accurate masses were obtained on a Finngan MAT 900 XL using a perflurotributyl 
amine as the reference compound for electron ionisation and polyethyleneimine for 
chemical ionisations. Melting points were obtained on an electrothermal digital melting 
point apparatus.
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4.0 Heterocyclic anthracene-9,10-dione systems
Heterocyclic analogues such as (51 and 65) have shown potential as highly effect agents 
in the treatment of cancer1,2.
N(CH2>2N(CH3)
o
(65)
N(CH2)2N(CH3)
(51)
(a) X= H 
(b) X= OH
Although their activity does not exceed the parent drugs Mitoxantrone (24a) and 
Amentantrone (24b) (see section 1.2, p i4), they have shown activity on cells which are 
MDR (multi drug resistant, see section 1.3.1, p33) and they have also shown a reduced 
cardiotoxicity.
o NR
(24)
(a)R=H Ametantrone 
(b) R= OH Mitoxantrone
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The study of the heterocyclic anthracene-9,10-dione nucleus is a relatively unexplored 
area3, though they would be expected to retain the same spatial and planar characteristics 
for DNA interaction. The presence of hetero atoms introduces extra bonding or basic or 
reactive sites, and therefore, hetero-analogues potentially have improved activity, and 
possibly reduced cardiotoxicity. For example, 7-hydroxy-14H-naptho [2,3- 
a]phenothiazine-8,13-dione (151b) was developed as a blue dye for synthetic polymer 
fibres but its biological activity has not been reported.
1-^ 3
HN
O R
(151)
(a)R=H
(b)R=OH
(c)R=NHC6H5
If the appropriate aminoalkyl side chains were introduced into the 14H-naptho[2,3- 
a]phenothiazine-8,13-dione at position seven, it would offer the possibility of some 
biological effect, perhaps similar to the activity displayed by Mitoxantrone (24b) and 
Amentantrone (24a) (see section 1.2, pi 4). The presence of the nitrogen atom in the 
molecule might increase the anthracene-9,10-dione molecules affinity for DNA and 
improve the ability of the chromophore to intercalate2, which the presence of sulfur 
would have significant effect on the electronic properties of the anthracene-9,10-dione
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moiety and act as an additional biologically reactive centre4 (see section 2.2). Attempts 
were made therefore to synthesis the parent molecule (151) and some of its derivatives.
4.1 Chemistry of 7-hydroxy-14H-naptho[2,3-a]phenothiazine-8,13- 
diones
The reported synthesis of 7-hydroxy-14H-naptho[2,3-a]phenothiazine-8,13-dione (151b) 
is achieved by the condensation reaction of 2-substituted-l ,4-dihydroxyanthracene-9,10- 
diones (150) with 2-aminothiophenol followed by the elimination of the 2-substituents5.
OH
o OH
X HzN
HN
OHO
(150) (151b)
Scheme 4-1. Synthesis of 7-hydroxy-14H-naptho[2,3-a]phenothiazine-8,13-dione
(151)
The formation of 7-hydroxy-14H-naptho[2,3-a]phenothiazine-8,13-dione proceeds via 
the intermediate 2-thioether (152).
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O OH
(152)
Figure 4-1. l,4-Dihydroxy-2-(2-aminophenyI)thioanthracene-9,10-dione
intermediate
The substituents at position two (150) do not need to be electron attracting substituents 
such as halogen, as the elimination of electron donating substituents also occurs and 
includes methoxy, hydroxyl, and ethylamino groups. The presence of methyl substituent 
at position two, however leads to the formation of the 6-alkyl derivative (153).
HN-
OH
(153)
142
1,4-Dihydroxy-, 1-hydroxy-4-amino-, and-l-hydroxy-4-arylamino- anthracene-9,10- 
diones all undergo a direct thiolation and ring closure to yield 7-hydroxy-14H- 
naptho[2,3-a]phenothiazine-8,l 3-dione (151b).
7-Hydroxy-14H-naptho[2,3-a]phenothiazine-8,13-dione (151b) can also be obtained from 
the irradiation of 6-hydroxy-3-phenylsulfanyl-anthra(l,9-ca)isoxazol-5-one (154) in 
dioxane.
Dioxane
The same product (151b) can also be obtained from the cyclisation of l-azido-4-hydroxy- 
2-phenylsulfanylanthracene-9,l0-dione (155) in DMF under reflux6.
J I J
o \
DMF
o
(15 5 )
OH
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4.2 Synthetic strategy
In this work three strategies were attempted in the synthesis of the 7-(alkylamino)-14H- 
naptho[2,3 -a]phenothiazine-8,13 -diones (151 e,f,g).
These were;
1. Replacement of the hydroxyl group in position seven of 7-(alkylamino)-14H- 
naptho[2,3-a]phenothiazine-8,13-dione (151b) with an alkyl amine.
2. Alkylation of7-amino-14H-naptho[2,3-a]phenothiazine-8,13-dione (151d)
3. Direct thiolation of 1 -(alkylamino)-4-hydroxyanthracene-9,10-diones (154) with 
2-aminothiophenol.
N H j C H tKR
W ^tlC C H thR
HN‘
(151)
(e) R=CH„
(0 R=N(CHj>2 
(g)R=OH
(a) R’=R"-NH(CH2)2N(CHj)2  (b) R'=R"=NII(CHj)jOH
(c) R’=R"=NH(CH2)2CHj (d)R'=OIl, R ^ N H tC H j^ C H jh
(e)R’=OH, R'^NHCCHjJjOH (f>R'=OH, R ’^ NHfCHJjCHj
Each will be discussed in turn.
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4.2.1 Synthetic strategy (I)
The synthesis of 7-hydroxy-14H-naptho [2,3-a]phenothiazine-8,13-dione was achieved in 
this work from the reaction 1,4-dihydroxyanthracene-9,l 0-dione with 2-aminothiophenol 
in DMF at 140-145°C (yield, 28%) or 2-methoxyethanol and boric acid under reflux 
(yield, 63%). It was also synthesised using 2,3-dihydro-9,10-dihydroxyanthracene-1,4- 
dione (the reduced or leuco form of l,4-dihydroxyanthracene-9,l0-dione) with 2- 
aminothiophenol in 2-methoxyethanol with boric acid leading to a greater yield ( 71%)
HN'
OH
(156b)
OH
OH
+
h 2n -
SH
Scheme 4-2. Synthesis of 7-hydroxy-14H-naptho[2y3-a]phenothiazine-8,13-dione 
(151b) from l,4-dihydroxyanthracene-9,10-dione (111)
Once 7-hydroxy-14H-naptho[2,3-a]phenothiazine-8,13-dione (151b) was synthesised and 
purified, the replacement of the hydroxyl group with an alkylamine was attempted.
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HN
NH,R
OH
(151b)
Scheme 4-3. Attempted replacement of the hydroxyl group by an amino group.
This reaction is analogous to the reaction of l,4-dihydroxyanthracene-9,l0-dione (111) 
with alkylamines using a mixture of sodium carbonate with phenol in ethanol7, to yield 
the corresponding l,4-bis(aminoalkyl)anthracene-9,l 0-dione (Scheme 4-4),
OH NHR
OH NHRO 
(111)
Scheme 4-4. Synthesis of l,4-bis(aminoalkyl)anthracene-9,10-diones from 1,4-
dihydroxyanthracene-9,10-dione
However unlike the 1.4-dihydroxyanthracene-9,10-dione the attempted displacement of 
the hydroxyl group was unsuccessful as the reaction only yielded the starting materials. 
The synthesis of l,4-bis(aminoalkyl)anthracene-9,10-diones can be improved by using 
the reduced form of the 1,4-dihydroxyanthracene-9,l 0-dione (2,3-dihydro-9,10- 
dihydroxyanthracene-1,4-dione) (110) and then reacting it with the appropriate amine(
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see section 1.2.1.). Reduction of 1,4-dihydroxyanthracene-9,10-dione is achieved using 
tin in acetic acid or aqueous sodium dithionite to yield 2,3-dihydro-9,10- 
dihydroxyanthracene-1,4-dione (110)8,9,10
The reduction of 7-hydroxy-14H-naptho[2,3-a]phenothiazine-8,13-dione (151b) was 
attempted using (Scheme 4-5) firstly sodium dithionite and then tin in acetic acid, 
however both of these methods were unsuccessful, and the starting material was 
recovered unchanged from the reaction mixture.
OH
OH o
Scheme 4-5. The attempted reduction of 7-hydroxy-14H-naptho[2,3- 
a]phenothiazine-8,13-dione
4.2.2 Synthetic strategy (II)
Although 7-hydroxy-14H-naptho[2,3-a]phenothiazine-8,13-dione does not react, the 
alternative possibility of using the accessible l-amino-14H-naptho[2,3-a]phenothiazine-
8,13-dione (151 d) was explored.
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7-Amino-l 4H-naptho[2,3-a]phenothiazine-8,13-dione11 (151d) was synthesised in 39% 
yield from the reported reaction of l,4-diaminoanthracene-9,l0-dione (148) with 2- 
aminothiophenol and boric acid in 2-methoxyethanol under reflux12
n h 2
2-methoxyethanol/ B(OH)3
HN'
NH2
(148) (151d)
Once synthesised it was proposed to react 7-amino-14H-naptho[2,3-a]phenothiazine-
8,13-dione (151d) with 2-chloroethanol in an attempt to produce 7-[2- 
(hydroxyethyl)amino]-l 4H-naptho[2,3-a]phenothiazine-8,13-dione (157) by 
displacement of the chlorine atom.
\  /
(151d) ^ -----  (157)
As it is well established that alkyl or aryl amines will react with alkyl halides to form 
secondary and tertiary amines
148
R X R X
R
Scheme 4-6. Reaction of amines with alkyl halides.
7-Amino-14H-naptho[2,3-a]phenothiazine-8,13-dione and 2-chloroethanol were refluxed 
in ethanol (bp 79°C), but no reaction occurred and the starting material was recovered. 
The same reaction was also carried out using 2-methoxyethanol (bp 125°C) as the solvent 
to raise the temperature of the reaction mixture but again this resulted in the recovery of 
the starting material. DMF (bp 153°C) was then employed as the solvent but this also 
proved fruitless as again only the starting material was recovered.
The failure of this reaction can be attributed to the size of the attacking nucleophile and 
electronic factors. Firstly the size hinders its effectiveness as a nucleophile and steric 
effects play a part in nucleophilic attack on the carbon containing the chlorine atom; the 
energy of the transition state is increased the more crowded it becomes, therefore there is 
a higher energy barrier to overcome before the reaction can proceed. Secondly, 
electronic effects reduce the nucleophilic character of the amino group by delocalisation 
of electron density on the anthracene-9,10-dione chromophore (Scheme 4-7).
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Scheme 4-7. Delocalisation of electron density on the anthracene-9,10-dione
chromophore
Thirdly, the molecule has the ability to exist in two tautomeric forms (Scheme 4-8).
HN'
NH
Keto form
O HN
OH NH
Tmine form
Scheme 4-8. Tautomerisation of-amino-14H-naptho[2,3-a]phenothiazine-8,13-dione
If the molecule is in the imine form the reaction will not proceed.
150
4.2.3 Synthetic strategy (IHa)
After failing to displace the hydroxyl group of 7-hydroxy-14H-naptho[2,3- 
a]phenothiazine-8,l 3-dione (151b) with alkylamines and the failure to effect the 
nucleophilic attack on 2-chloroethanol with 7-amino-14H-naptho[2,3-a]phenothiazine-
8,13-dione (151 d), it was decided to introduce a propylamino group onto anthracene-
9,10-dione moiety to give l-propylamino-4-hydroxyanthracene-9,l 0-dione (156f) and 
then react it with 2-aminothiophenol to give 7-propylamino-14H-naptho[2,3- 
a]phenothia2;ine-8,13-dione(151e) . A similar type of reaction is known to occur with 1- 
aminophenyl-4-hydroxyanthracene-9,l 0-dione (156g) and 2-aminothiophenol leading to 
a mixture of 7-hydroxy-14H-naptho[2,3-a]phenothiazine-8,13-dione(151b) and 7- 
aminophenyl-14H-naptho[2,3-a]phenothiazine-8,13-dione (151c)13.
The synthesis of l-(propylamino)-4-hydroxyanthracene-9,l 0-dione (1561) was achieved 
by reacting 2,3-dihydro-9,10-dihydroxyanthracene-l,4-dione (119) in ethanol at 50°C 
with propylamine in an equimolar or less ratio, to give a mixture of l-(propylamino)-4- 
hydroxyanthracene-9,10-dione (156c) in 65% yield and l,4-bis(propylamino)anthracene-
9,10-dione (1561) in 25% yield. The desired product, l-(propylamino)-4-
O HN.
(156) R
(OR^CHj^CHa
R
(151) 
(c )R = Q H j  
(e) R ^C H ihC H j
(151b)
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hydroxyanthracene-9,10-dione (156c) was then isolated by column chromatography 
using a eluent of 95% toluene and 5% chloroform.
OH
+
OH OOH
(119) (156c)
Scheme 4-9. Synthesis of l-hydroxy-4-(propylamino)anthracene-9,10-dione
The product was identified by its well resolved NMR spectrum, which showed an 
interesting splitting pattern in the aromatic region (Figure 4-2).
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Figure 4 -2 .5H aromatic region for l-hydroxy-4-(propylamino)anthracene-9,
dione in CDCb
OHHa
HxHb
He
NHRHd
The assignments are shown on the next page.
Hb He
Ha Hd
Ja-b
Ja-c
Jd-c
A  A Jd-b
Jb-c Jc-b
Ja-b Jc-d
Hx Hy
A  A A \ A  A  Jk,
Jd-b Jc-a Jx-y Jy-x
Figure 4-3.8H aromatic splitting pattern for l-hydroxy-4- 
(propy la mino)anth racene-9,10-dione
Although the reaction of l-aminopropyl-4-hydroxyanthracene-9,l 0-dione (1561) with 2- 
aminothiophenol in DMF did not yield any product and resulted in the recovery of the 
starting material, the corresponding reaction of l-aminopropyl-4-hydroxyanthracene-
9,10-dione and 2-aminothiophenol (156f) in 2-methoxyethanol with boric acid yielded 7- 
hydroxy-14H-naptho[2,3-a]phenothiazine-8,l 3-dione and 7-aminopopyl-14H-naptho[2,3- 
a]phenothiazine-8,13-dione in 35% yield.
This would be consistent with the results found for the reaction of 1 -aminophenyl-4- 
hydroxy-anthracene-9,10-dione (156g) to yield 7-aminophenyl-14H-naptho[2,3- 
a]phenothiazine-8,13-dione (151c) and 7-hydroxy-14H-naptho[2,3-a]phenothiazine-8,13- 
dione (151b).
The reaction is thought to proceed via a boric ester complex (Scheme 4-10)
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,OHHO,
H2N R
.NRO,
OHHO
,NR
OHHO
-B(OH)3
Scheme 4-10. Attack 2-aminothiophenol via a boric acid complex.
The nucleophilic character of 2-aminothiophenol is increased due to the resonance effect
of the sulfur atom on the amino group (Scheme 4-11).
,nh2
IR
Scheme 4-11. Sulfur inductive effect.
After the nucleophilic attack on the boric ester intermediate by 2-aminothiophenol, the 
cyclisation of the ring can occur. Nucleophilic attack of the ring system by sulfur is
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driven by the inductive effect of the carbonyl group which is para to the incoming 
nucleophile.
HN'
NHR
HN
OH NHR
HN'
NHR
[OJ/-2H*
HN'
NHRQ
HN'
,NR
l-[2-(hydroxyethyl)amino]-4-hydroxy-anthracene-9,l 0-dione was also synthesised from 
the reaction 2,3 -dihydro-9,10-dihydroxyanthracene-1,4-dione and 2-ethanolamine in 
ethanol to give l-[2-(hydroxyethyl)amino]-4-hydroxy-anthracene-9,l 0-dione (156e) in 
65% yield and l,4-bis[2-(hydroxyethyl)amino]anthracene-9,l0-dione in 25% yield 
(156b).
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OH
+
OHOH
(119) (156e) (156b)
l-[2-(hydroxyethyl)amino]-4-hydroxy-anthracene-9,l 0-dione (156e) also reacted with 2- 
aminothiophenol using boric acid in 2-methoxyethanol to give 7-[2- 
(hydroxyethyl)amino]-14H-naptho[2,3a]phenothiazine-8,13-dione in 32% yield (151g)) 
and 7-hydroxy-I4H-naptho[2,3a]phenothiazine-8,13-dione (151b) in (35%) yield.
HN' HN'
OH
(151b)
OH
(156c)
1 -Hydroxy-4- {[2-(dimethylamino)ethyl]amino} anthracene-9,10-dione (156f) and 1,4- 
bis{[2-(dimethylamino)ethyl]amino} anthracene-9,10-dione (156a) from 2,3-dihydro-
9,10-dihydroxyanthracene-l,4-dione with N,N-dimethylethylenediamine in ethanol in 
55% and 25% yield respectively.
NH(CH2)2N(CH3)2OH
I. NH2(CH2)2N(CH3: 
N  n. [O] ( ,
OH NH(CH2)2N(CH3)2OH
(119) (156f) (156a)
1 -Hydroxy-4- {[2-(dimethylamino)ethyl]amino} anthracene-9,10-dione (156f) was 
reacted with 2-aminothiophenol and boric acid in 2-methoxyethanol to give 7-{[2-
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(dimethylamino)ethyl]amino}-14H-naptho[2,3a]phenothiazine-8,13-dione (151f) in 30% 
yield and 7-hydroxy-14H-naptho[2,3a]phenothiazine-8,13-dione (151b) in 35% yield.
Formation of 7-hydroxy-14H-naptho[2,3a]phenothiazine-8,13-dione (151b) occurs due to 
the attack by the 2-aminothiophenol at the carbon containing the aminoalkyl group.
4.3 Synthetic strategy (Mb)
l,4-Bis(aminophenyl)anthracene-9,l 0-dione (157) undergoes thiolation with 2- 
aminothiophenol in 2-methoxyethanol with boric acid to yield 7-aminophenyl-14H- 
naptho[2,3-a]phenothiazine-8,13-dione13 (151c).
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oHN‘
(151c)(157)
l,4-Bis(propylamino)anthracene-9,l0-dione (156c), l,4-bis[2- 
(hydroxyethyl)amino]anthracene-9,l0-dione(156b)and l,4-bis{{2- 
(dimethylamino)ethyl]amino} anthracene-9,10-dione (156a), were synthesised in an 
attempt to repeat the afore mentioned reaction with alkylamino substituents, however it 
was unsuccessful and only resulted in the recovery of the starting materials
HN
HN.
(156c)
,OH
HNHN
HN.HN.
N--------‘OH (156a)
(156b)
The reaction of the alkylamino anthracene-9,10-diones with 2-aminothiophenol probably 
does not occur as the alkylamino substituents would push more electron density into the 
anthracene-9,10-dione moiety when compared to aminoaryl substituents, making the 
anthracene-9,10-dione moiety less susceptible to nucleophilic attack.
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4.4 Experimental
4.4.1 Synthesis of 7-hydroxy-14H-naptho[2,3a]phenothiazine-8,13-dione (151b)
HN
OH
(151b)
1.4-Dihydroxyanthracene-9,l 0-dione (0.5g, 2mmol) was added to a solution of 2- 
aminothiophenol (2.48g, 20mmol) in DMF (15ml). The mixture was heated under reflux 
for 2 h, allowed to cool, and methanol was added (50ml). The resulting precipitate was 
filtered off and washed with warm methanol (50ml) to yield 7-hydroxy-14H- 
naptho[2,3a]phenothiazine-8,13-dione (0.2g, 28%), mp 257°C lit14 261 °C, 5h (CDCI3) 
6.80-7.00(5H, m) 7.75 (2H, m), 8.30 (2H, m), 12.65 (1H,NH, s), 14.15 (1H, OH, s).
1.4-Dihydroxyanthracene-9,l0-dione (0.5g 2mmol) was refluxed in a solution of 2- 
methoxyethanol (20ml) and boric acid (0.62g lOmmol) for 30 min13. The solution was 
allowed to cool and 2-aminothiophenol was added (2.5g 20mmol), The mixture was 
heated under reflux for 30 min and then allowed to cool, methanol (50ml) was added to 
the resulting precipitate which was filtered off and washed with warm methanol (50ml), 
to yield 7-hydroxy-14H-naptho[2,3a]phenothiazine-8,13-dione (0.45g, 63%), mp 257°C
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lit15 261 °C, 6h (CDCI3) 6.80-7.00 (5H, m) 7.75 (2H, m), 8.30 (2H, m), 12.65 (1H,NH, s), 
14.15 (1H, OH, s).
4.4.2 Attempted reduction of 7-hydroxy-14H-naptho[2,3a]phenothiazine-8,13- 
dione (131b)
7-Hydroxy-14H-naptho[2,3a]phenothiazine-8,13-dione (l.lg , 3.3 mmol) was added to a 
mixture of tin (3g, 24.4mmol) and HC1 (70ml) in acetic acid (50ml). The mixture was 
heated to 90-95°C for 24 hrs, the solution was allowed to cool and the precipitate was 
filtered off, the solid was washed with water and dried in vacuo to yield the starting 
material 7-hydroxy-14H-naptho[2,3a]phenothiazine-8,13-dione (0.8g, 72%), 
identification was achieved via tic using a eluent of 5% chloroform and 95% toluene(Rf 
=0.61).
7-Hydroxy-14H-naptho[2,3a]phenothiazine-8,13-dione (l.lg , 3.3mmol) was added to a 
solution of sodium carbonate (1.4g, 13.2mmol) and water (125ml). The solution was 
boiled and sodium dithionite (1.7g, 9.8mmol) was added, the precipitate was filtered off 
and washed with dilute acetic acid until alkali free, to yield the starting material 7- 
hydroxy-14H-naptho[2,3a]phenothiazine-8,13-dione (0.7g, 63%), identification was 
achieved via tic using a eluent of 5% chloroform and 95% toluene(Rf =0.61).
4.4.3 Reaction of 7-hydroxy-14H-naptho[2,3a]phenothiazine-8,13-dione
4.4.4 Propylamine
7-Hydroxy-14H-naptho[2,3a]phenothiazine-8,13-dione (0.5g, 1.3mmol) was added to a 
solution of propylamine (0.77g, 13mmol) and sodium carbonate (0.5g, 4.3mmol), in
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ethanol (25ml), and the mixture was heated under reflux for 24 h, allowed to cool and the 
precipitate was filtered off to yield the starting material 7-hydroxy-14H- 
naptho[2,3a]phenothiazine-8,13-dione (0.3g, 60%), identification was achieved via tic 
using a eluent of 5% chloroform and 95% toluene(Rf=0.61).
4.4.5 N,N-dimethyIethylenediamine
7-Hydroxy-14H-naptho[2,3a]phenothiazine-8,13-dione (0.5g, 1.3mmol) was added to a 
solution of N,N-dimethylethylenediamine (1.51 g 13mmol) and sodium carbonate (0.5g,
4.3mmol), in ethanol (25ml), and the mixture was heated under reflux for 24 h. The 
solution was allowed to cool and the precipitate was filtered off to yield the starting 
material 7-hydroxy-14H-naptho[2,3a]phenothiazine-8,13-dione (0.2g, 40%), 
identification was achieved via tic using a eluent of 5% chloroform and 95% toluene(Rf 
=0.61).
4.4.6 2-Aminoethanol
7-Hydroxy-14H-naptho[2,3a]phenothiazine-8,13-dione (0.5g, 1.3mmol) was added to a 
solution of 2-aminoethanol (0.79g 13mmol) and sodium carbonate (0.5g), in ethanol 
(25ml) and the mixture was heated under reflux for 24 h. The solution was allowed to 
cool and the precipitate was filtered off to yield the starting material 7-hydroxy-l 4H- 
naptho[2,3a]phenothiazine-8,13-dione (0.3g, 60%), identification was achieved via tic 
using a eluent of 5% chloroform and 95% toluene(Rf=0.61).
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4.4.7 Synthesis of 7-amino-14H-naptho[2,3a]phenothiazine-8,13-dione15 (151d)
o  n h 2
(151d)
l,4-Diaminoanthracene-9,l 0-dione (0.5g, 2.1 mmol) was added to a solution of 2- 
methoxyethanol (20ml) and boric acid (0.62g, lOmmol), and the mixture was heated 
under reflux for 30 min. The solution was allowed to cool, 2-aminothiophenol was added 
(2.5g, 20mmol), and the resulting mixture was heated under reflux for 20 min and then 
allowed to cool, and methanol (50ml) was added. The precipitate was filtered off and 
washed with warm methanol (50ml), to yield 7-amino-14H-naptho[2,3a]phenothiazine-
8,13-dione (0.28g, 39%), mp 308°C, (lit16 310-312 °C).
4.4.8 Reaction of 7-amino-14H-naptho[2,3a]phenothiazine-8,13-dione with 2- 
chloroethanol
7-Amino-14H-naptho[2,3a]phenothiazine-8,13-dione (0.5g, 1.45mmol) and 2- 
chloroethanol (1.16g, 14.5mmol) were added to ethanol (25ml), the mixture was heated 
under reflux for 24 h and allowed to cool. The precipitate was collected by filtration to 
yield the starting material 7-amino-14H-naptho[2,3a]phenothiazine-8,13-dione (0.4g, 
80%), identification was achieved via tic using a eluent of 5% chloroform and 95% 
toluene(Rf =0.61).
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7-Amino-14H-naptho[2,3a]phenothiazine-8,13-dione (0.5g, 1.45mmol) and 2- 
chloroethanol (1.16g 14.5mmol) were added to 2-methoxyethanol (25ml), the mixture 
was heated under reflux for 24 h and allowed to cool. The precipitate was collected by 
filtration to yield the starting material 7-amino-14H-naptho[2,3a]phenothiazine-8,13- 
dione (0.4g, 80%), identification was achieved via tic using a eluent of 5% chloroform 
and 95% toluene(Rf =0.61).
7-Amino-14H-naptho[2,3a]phenothiazine-8,13-dione (0.5g, 1.45mmol) and 2- 
chloroethanol (1.16g 14.5mmol) were added to DMF (25ml), the mixture was heated 
under reflux for 24 h and allowed to cool. The precipitate was collected by filtration to 
yield the starting material 7-amino-l 4H-naptho[2,3a]phenothiazine-8,13-dione (0.2g 
40%) identification by TLC.
4.4.9 l-Hydroxy-4-(propyIamino)anthracene-9,l 0-dione
2,3-Dihydro-9,10-dihydroxyanthracene-l,4-dione (l.Og, 4.2mmol) was added to a 
solution of propylamine (0.2g 4.2mmol) in ethanol (25ml) and heated to 50°C. The 
reaction mixture was allowed to cool and the precipitate was filtered off, washed with 
ethanol and then purified via column chromatography using an eluent of 95% toluene 5% 
chloroform to yield 1 -hydroxy-4-(propylamino)anthracene-9,l 0-dione (0.50 g 45%) mp 
115 °C lit 116°C17 and l,4-bis(propylamino)anthracene-9,l 0-dione (0.28g 25%) mp 
176°C lit 179-180°C8.
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4.4.10 Synthesis of 7-( propylamino)14H-naptho[2y3a]phenothiazine-8,13-dione 
(151e)
HN
(151e)
l-Hydroxy-4-(propylamino)anthracene-9,l 0-dione (0.56g, 2mmol) and boric acid 
(0.62g, lOmmol) were refluxed in a solution of 2-methoxyethanol (20ml) for 30 min.
The solution was allowed to cool and 2-aminothiophenol was added (2.5g, 20mmol), the 
mixture was heated under reflux for 30 min and then allowed to cool, methanol (50ml) 
was added and the resulting precipitate was filtered off and washed with warm methanol 
(50ml). The solid was purified via column chromatography using an eluent of 95% 
toluene 5% chloroform to yield 7-hydroxy-14H-naptho[2,3a]phenothiazine-8,13-dione 
(0.24g 35%) and 7-(propylamino)14H-naptho[2,3a]phenothiazine-8,13-dione mp 250°C 
(0.25g 32%), mp 230 °C, 8H0.95 (3H, t), 1.60 (2H, m), 3.00 (2H, q), 6.35 (1H, s) 6.60 
(3H m), 6.85 (1H, m), 7.50 (2H, m), 8.10 (2H, m), 10.65 (1HJM , t), 12.95 (1H OHs). 5C 
182.93, 179.13,147.52, 134.95, 134.58,133.56,132.56, 132.00,131.55,130.48, 126.71, 
124.98, 124.77,124.26,121.79, 116.05,114.77,113.65, 108.47,106.43,43.51,21.50, 
10.72.
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4.4.11 1 -hydroxy-4- [2-(hy d roxy ethy l)amino] anthracene-9,10-dione
2,3-Dihydro-9,10-dihydroxy-l,4-anthracene-9,10-dione (l.Og, 4.2mmol) was added to a 
solution of ethanolamine (1.85g, 21mmol) in ethanol (25ml) and heated to 50°C. The 
reaction mixture was allowed to cool and the precipitate was filtered off. The solid was 
washed with ethanol and then purified via column chromatography using an eluent of 
95% toluene 5% chloroform to yield 1 -hydroxy-4-[2-(hydroxyethyl)amino]anthracene-
9,10-dione mp 148°C (lit 150°C18), (0.77g, 65%) and l,4-bis[2- 
(hydroxyethyl)amino]anthracene-9,10-dione (0.28g, 25%), mp 220°C (lit 242°C8)
4.4.12 Synthesis of 7-[2-(hydroxyethyl)amino]14H-naptho[2,3a]phenothiazine-8,13- 
dione (151g)
HN
l-Hydroxy-4[2-(hydroxyethyl)amino]anthracene-9,10-dione (0.57g, 2mmol) and boric 
acid (0.62g, lOmmol) were refluxed in a solution of 2-methoxyethanol (20ml) for 30 min. 
The solution was allowed to cool and 2-aminothiophenol (2.5g, 20mmol) was added.
The mixture was heated under reflux for 30 min and then allowed to cool, methanol 
(50ml) was added and the resulting precipitate was filtered off and washed with warm 
methanol (50ml). The solid was purified via column chromatography using an eluent of 
95% toluene 5% chloroform to yield 7-hydroxy 14H-naptho[2,3a]phenothiazine-8,13-
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dione mp 255°C (0.24g 35%) and 7-[2-(hydroxyethyl)amino]14H- 
naptho[2,3a]phenothiazine-8,13-dione (0.25g 32%) 8H2.70 (2H, t), 3.45 (2H, q) 7.15 
(3H, m), 7.70 (3H, m), 8.30 (3H, m), 10.35 (1H, t), 13.65 (1H, s).
4.4.13 l-hydrosy-4-{[2-(dimethyIainino)ethyI]ainino}anthracene-9,10-dione
2,3-Dihydro-9,10-dihydroxy-anthracene-l,4-dione (l.Og, 4.2mmol) was added to a 
solution ofN,N-dimethylethylenediamine (1.85g 21mmol) in ethanol (25ml) and heated 
to 50°C. The reaction mixture was allowed to cool and the precipitate was filtered off. 
The solid was washed with ethanol and then purified via column chromatography with an 
eluent of 10% methanol and 90% chloroform, to yield 1-hydroxy-4-{[2- 
(dimethylamino)ethyl]amino}anthracene-9,10-dione (0.72g 55%) mp 118°C lit19 120°C 
and l,4-bis{[2-(dimethylamino)ethyl]amino}anthracene-9,10-dione (0.4g 25%) mp 
165°C lit20 172°C.
4.4.14 Synthesis of 7{[2-(dimethyIamino)ethyl]amino}-14H- 
naptho[2,3a]phenothiazine-8,13-dione (151f)
HN
NH(CH2)2N(CH3)2
(151f)
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1 -Hydroxy-4- {[2-(dimethy lamino)ethyl]amino} anthracene-9,10-dione (0.57g 2mmol) 
was refluxed in a solution of 2-methoxyethanol (20ml) and boric acid (0.62g lOmmol) 
for 30 min. The solution was allowed to cool and 2-aminothiophenol was added (2.5g 
20mmol). The mixture was heated under reflux for 30 min and then allowed to cool, to 
which was added methanol (50ml). The precipitate was filtered off and washed with 
warm methanol (50ml), the solid was purified via column chromatography with an eluent 
of 10% methanol and 90% chloroform to yield 7-hydroxy 14H- 
naptho[2,3a]phenothiazine-8,13-dione (0.24g 35%) mp 210°C and 7-{[2- 
(dimethylamino)ethyl]amino} 14H-naptho[2,3a]phenothiazine-8,13-dione (0.25g 30%) 
mp 220°C, 8h 2.25 (6H, s), 2.60 (2H, t), 3.40 (2H, q) 7.15 (3H, m), 7.70 (3H, m), 8.30 
(3H, m), 10.30 (1H,t), 13.65 (1H, s)5c 182.90, 179.18, 147.50,134.90, 134.58, 133.56, 
132.60, 132.00, 131.55,130.48, 126.71,124.98,124.77, 124.26, 121.79, 116.05, 114.77, 
113.65, 109.47,106.43, 51.70,46.80, 12.30. m/z (M+H) measured 416.1427 required 
416.1427
4.5 References
1 Beylin.V., Colbry.N., Goel.O., Haky.J., Johson.D., Kanter.G., Leeds.R., J.Heterocyclic.Chem. (1989) 26, 
85.
2 GourlartM., Euzeibo.A., 01iveira.A., Oliveira. G.,Maia.J., Photochemistry (1986) 25, 1691.
3 Krapacho.P., Petry.M., Getaham.Z., Landi.J., Stallman.!, PolsenbergJ., Gallagher.C., Maresch.M., 
Hacker.P., Giullani.F., Beggiolin.G., Pezzoni.M., Manzotti.C., Olivia.A., Spinelli.S., Tognella.S., 
J.Med.Chem.(1994) 37,828.
4 Monks.T., Lau.S., Critical reviews in Toxicology, (1992) 22,243.
5 Chem. Abs. 65:2391 (1965)
168
6 Gorostaen.M., J.Org.Chem. (USSR), (1979)15,1692.
7 Simon.M., J.Chem.Soc., (1963) 85,1974
8 Zahn.,Ochwat., Chem.Ber. (1930) 90.
9 Clar.E., McAndrew.A., Tetrahedron (1972) 1239.
10 Thomas.H., Hans-Joachim.N., Stephan.D.,ZECEAL:Z.Chem. (1989) 4,139. 
n Chem. Abs. 94:48803g
12 Peters.A., Wang.N., Chang.T., Dyes and pigments (1996) 32,61
13 Peters.A., Wang.N., Chang.t, Dyes and pigments (1995) 28,139.
14 Masaru.M., Hoon.,K., Teijiro.K., J.Chem.Soc.Chemm.Commun. (1985) 1195-1196.
15 Chem. Abs. 94:48803g
16 Chem.Abs. (1970) 73,121548.
17 FaikR  Muller.N, Obeneiter.M., Chem.Abs. (1957) 722 
I8 Naiki.Y., Kyokaisi.N., Chem.Abs., (1957) 1612.
1 9 Murdock.C., J.Med.Chem. (1979), 22, 501.
169
CHAPTER 
FIVE
C o m p u t a t i o n a l
S t u d i e s
170
5.0 Computational Studies
Computational chemistry may be defined as the application of mathematical and theoretical 
principles to the solution of chemical problems. Molecular modeling concentrates on 
predicting the behavior of individual molecules within a chemical system. The most accurate 
molecular models use ab initio (from first principles) methods, which are based upon the 
principles of quantum mechanics, and are generally very computer-intensive. Semi-empirical 
methods were therefore developed to increase the speed of computation by using 
approximations for large molecule systems. These methods use valence electrons only, and 
calculate the interactions of overlapping orbitals using preset parameters characteristic for 
each of the constituent elements of the system.
5.1.1 Background to Quantum Mechanics
The starting point of molecular orbital theory is the SchrOdinger equation which in its 
simplest form can be written as (Equation 5-1)
H\j/=E\p Equation 5-1
Where:
H= The Hamiltonian, which is an operator used on the wavefunction (\|/) to calculate 
both the kinetic and potential energies of the system of electrons and nuclei.
E= The energy of the system (also known as the eigenvalue).
\|7= The wave function (also known as an eigenfunction).
The SchrOdinger equation is a partial differential eigenvalue equation; the Hamiltonian is not 
merely a constant to multiply by \|/ and is used to obtain the energy of the system by 
evaluating the integral in equation 5-2
E= fq/Hq/dx Equation 5-2
Jq^dx
1 7 1
This equation is derived from equation 5-1 by multiplying by v|/ and integrating over all space
(dx).
The Hamiltonian operator is made up of two parts the kinetic operator - fiV2
2m
and the potential energy operator for an electron and a nucleus with Z protons V= Ze2
47t£oT
Exact solutions to the Schrodinger equation can only be solved for simple systems such as 
the hydrogen atom or a particle in a box. If we take the most basic molecular species such as 
H2+ which contains 2 protons and an electron the Schrodinger equation is unsolvable. This is 
because the calculation involves knowing how the movement of each particle affects every 
other particle. However with the introduction of sensible approximations, calculations can be 
performed.
The Bom-Oppenheimer approximation
As the mass of nuclei is much greater than the mass of an electron, the nuclei can be regarded 
as being stationery and the Bom Oppenheimer approximation treats nuclei as being fixed in 
space. The total wavefunction can then be split into nuclear and electronic parts which can be 
written as:
M'totai(nuclei, electrons)= \|/(nuclei) \|/(electrons) Equation 5-3
The total energy equals the sum of the nuclear energy (the electrostatic repulsion between 
positively charged nuclei) and the electronic energy (kinetic and potential energy of the 
electrons moving in the electrostatic field of the nuclei, together with electron-electron 
repulsion):
Etotai=E(electrons)+ E(nuclei) Equation 5-4
1 7 2
The next approximation is the variation principle which states that the energy of the system 
is either greater or equal to the lowest energy of the system.
E= J\[/H\|/dT > E0 Equation 5-5
Jxj^ dx
Molecular orbitals are constructed from a linear combination of atomic orbitals (LCAO) so
that:
V i  = C \ $  \ + C l $  2+ C 3 $  3 + .........C,<* ,
n
or V/i = 'Lci]4j Equation 5-6
J=i
where
fa = Atomic orbital located on each atom.
Ci-Cj = Mixing coefficients. These can have any value from -1 to +1 which
expresses how much the particular atomic orbital contributes to the one 
electron wave function (molecular orbital).
/ = Index number which labels the particular molecular orbital.
j  = Running index of all incorporated atomic orbitals.
Combination of LCAO with equation 5-5 then yields:
H
E = —------------    Equation 5-7
• j
Equation 5-7 is simplified by letting:
and
where Hy are the coulomb resonance integrals and Sij is the overlap integrals, thus:
I I ofijH,
E =   Equation 5-8I I
’ J
1 7 3
The equation can be expressed more generally as:
^  c j(H -  ES b ) = 0 Equation 5-9
I
To solve the secular equations for the coefficients, Ci, it is necessary to know the energy E of 
the orbital. As for any set of simultaneous equations the secular equations have a solution if 
the secular determinant (the determinant of the coefficients) is zero:
det|tf,-,E S ,| = 0 Equation 5-10
Molecular orbital calculations always make use of this equation
5.1.2 Huckel Molecular Orbital
Huckel molecular orbital1, theory is the simplest method for the calculation of molecular 
orbitals; it addresses the complexity of solving the Schrodinger equation by making some 
drastic assumptions. Firstly the conjugated rc-electrons are only considered as the electrons 
which occupy the sigma frame are assumed to be constant and unaffected by electrons in the 
rest of the molecule, as they are localised between the bonded atoms. For butadiene this 
reduces the basis set to one atomic orbital per conjugated atom leading to an interaction 
matrix of only 16 terms.
1 ‘ 1
0 0 0 0
 C2  C3 ---- C4
0 0 0 0
AO's fa fa fa fa 
Figure 5-1. Buta-l,3-dieiie
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The interaction matrix, permutating all pairs of AO’s, is:
A n A12 A13 A14
A2i A22 A23 A24
A3i A32 A33 A34
A41 A42 A43 A44
Aij is the interaction of orbital i with orbital j 
Figure 5-2. Interaction matrix for 1,3-butadiene
Since Ay=Ajithe number of interactions is reduced to 10 from 16.
if Ay takes the form from equation 5-10,
Ay=( Hy-ESij) Equation 5-11
and,
Hy= J <|>i H  <J)j5i and Sjj=J <J>i4>jSt (see equation 5-7)
where t  is a volume element and H  is the Hamiltonian operator.
The terms Hu physically represent the energy of an electron in the field of its own nucleus and 
are known as Columb integrals. When considering an all carbon Tt-system this term can be 
represented by the energy of an electron in a C-2pz orbital and is regarded as constant and 
represented by a. The off diagonal terms, Hij refer to the energy of electron in the field of 
nucleus and are known as die resonance integrals,
In the Huckel method,
For adjacent (i.e. bonded) atoms Hy= constant = p
For non adjacent atoms Hy = 0
1 7 5
The final assumption is that the overlap integrals,
Sii = 1 for the same atom 
Sij = 0 for different atoms 
where Sij is the spatial distribution or the amount of interpenetration or overlap. The 
interaction matrix for butadiene C-2pz can now be written as follows:
r a
(a-E) P O O  
P (a-E) p 0
0 p (a-E) p
^ 0  0 p (a
This is then simplified by dividing through by p and setting (a- E)/ p= x,
r
X 1 0 0
1 X 1 0
0 1 X 1
0 0 1 XV J
Multiplying out the determinant gives a polynomial of the form x4-  3x2 + 1 =0, the roots of 
which are,
x= -1.618, -0.618, +0.618, +1.618 Equation 5-12
The relative energies are therefore
Ei=a + 1.618p \|/i
Er=a + 0.618p \j/2
E3=a-0.618p i| / 3
E4=a-1.618p i| / 4
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And the 4 7c-electrons are accommodated in the two bonding molecular orbitals 
4 AO's (C-2pz)  ► 4 MO’s
a
Antibonding
V 4
Bonding
Attention is now drawn to the electron densities at each atom. Each MO can be considered as 
a linear combination of its constituents AOs:
y/i = cx<f>, + c2<f> 2+ c 3+ cA<f>A Equation 5-13
In which the coefficients Ci expresses the contribution of the ith AO. Each line of the 
interaction matrix relates to one of a set of simultaneous equation (secular equations) 
containing MO coefficients Ci, as follows:
Cix + C2 + 0 + 0 =  0
Cl + c2x + C3 + 0 =  0
0 + C2 + C3X + c4 =  0
0 + 0 + C3 + C4X =  0
together with the normalisation condition,
c\ + c\  + c 3 + c 4 ~ 1 Equation 5-14
These equations are solved to obtain values of the four coefficients for each orbital i.e. for
each of the four values of x.
1 7 7
Atom Cl c2 C3 c4
1 0.3717 0.6015 0.6015 0.3717
2 0.6015 0.3717 -0.3717 -0.6015
3 0.6015 -0.3717 -0.3717 0.6015
4 0.3717 -0.6015 0.6015 0.3717
The square of the coefficients multiplied by the orbital occupancy gives the electron density 
(charge) at each atom,
oca
Electron density at atom i,
i.e. qi= (2x c,2) + (2xc2) = (2x0.37172) + (2x0.60152) = 0.2763 + 0.7236 =0.9999 
Therefore the electron density atom 1 will be 1 electroa
5.2 The development of Semi-empirical methods 
The Huckel method from 1931 still has it uses, and is often used to find rough starting 
geometries or energies for more complex calculations. In 1965 Pople et al. 2,3 published their 
CNDO method which stood for “Complete Neglect of Differential Overlap”. The parameters 
adopted were acquired from Ab Initio calculations and the method could yield impressive 
results rapidly. Other methods soon followed (See Table 5-1), most notably the MINDO/3 
method devised by Dewar4 which obtained its parameters from actual experimental data sets. 
It is three modem variations of this method, known by their acronyms of AMI, PM3, and 
MNDO which were utilized in this research.
1 7 8
Table 5-1: Chronological development of Semi-empirical Methods
Acronym Method Electrons* Yearb Reference
HMO Huckel Molecular Orbital. ft only 1931 i
EH Extended Huckel Molecular 
Orbital.
Valence 1952 5
PPP Pople-Pariser-Parr 7i only 1957
6
CNDO/1 Complete Neglect 
of Differential Overlap.
Valence 1965 1
CNDO/2 Complete Neglect 
of Differential Overlap.
Valence 1966 7
INDO Intermediate Neglect 
of Differential Overlap.
Valence 1967 8
MINDO/1/2/3 Modified INDO Valence 1969 -1975 9,10
MNDO Modified Neglect 
of Diatomic Overlap
Valence 1977
... T 1 .
AMI Austin Method 1 
(modified MNDO)
Valence 1985 12
PM3 Parametric Method 3 
(modified MNDO)
Valence 1989. 13
a electrons considered in calculation ^Year that the method was published
5.3 Hardware and software
The molecular modelling in these studies was performed using the SYBYL14 package whilst
all the semi-empirical calculations themselves were carried out using the MOP AC 93
package15 run on a variety of Irix networked Silicon Graphics16 workstations. Crystal
Structure data were downloaded from the Cambridge Crystallographic Database17 and the
geometries measured and properties assessed using the SYBYL package.
Due to the limited memory and disc space on the Swansea SG machines further ab initio
calculations were run on the ESPRC Columbus Cluster at Rutherford Appleton laboratories.
The Columbus Cluster is a midrange computing facility, consisting of a cluster of 6 Compaq
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ES40 computers. Each AlphaServer ES40 machines has four 833MHz (EV68) processors 
with 8 GB of memory18. 1,4-Diamino-5,8-bis(ethylsulfanyl)anthracene-9,10-dione was run at 
the basis set level 4-31G** on the Columbus facility to asses the computational time required, 
which was two and a half hours. 1,4-diamino-5,8-bis(ethylsulfanyl)anthracene-9,l 0-dione 
was then run at the 6-31G** level, and took twenty hours to optimize. Also optimised were
1,4-bis(propylamino)-5,8-bis(ethylsulfanyl)anthracene-9,10-dione and 1,4-bis(propylamino)- 
5,8-bis(phenylsulfanyl)anthracene-9,10-dione at 6-31G** level.
5.4 Selection o f the best semi empirical method
MOP AC contains three semi empirical methods, MNDO, AMI and PM3 which could be used 
to predict properties of the anthracene-9,10-diones synthesised. To decide which method was 
best suited for modelling the anthracene-9,10-diones, six anthracene-9,10-dione derivatives 
were selected from Cambridge Structural Database17 (CSD). These compounds were then 
modelled using the three computational methods and the geometries obtained were compared 
with geometries from the CSD.
The CSD contains crystal structure data for 224,000 small organic and organometallic 
molecules. This information is retrieved using QUEST, a software package designed and 
developed by CSD to search, display and analyse the information. The crystallographic data 
of the structures is assigned an R-factor which indicates how accurate the data are. Six 
representative anthracene-9,10-diones with good R-factors were selected for this initial 
investigatioa These were: l,4-dihydroxyanthracene-9,10-dione, l,4-diaminoanthracene-9,10- 
dione, 1,4-bis(butylamino)anthracene-9,10-dione, 1,4-bis(isopropylamino)anthracene-9,10- 
dione, l,4-bis(4-toluidinio)anthracene-9,10-dione and l-(6-sulfanylhexylthio)anthracene-
9,10-dione; each will be considered in turn.
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5.4.1 l,4-Dihydroxyanthracene-9,10-dione
An examination of the computational data for l,4-dihydroxyanthracene-9,10-dione 
geometries in these studies for all three methods predicts the molecule is planar (Table 5-2).
Figure 5-3. Optimised structure l,4-dihydroxyanthracene-9,10-dione using PM3
A comparison of the bonds lengths of the actual x-ray data with the calculated data shows the 
differences in each of die selected methods. The most notable is the over-estimation of the 
hydrogen bond length 019-H25 and O20-H26 which are 1.934 and 1.932 A for AMI and 
2.134 and 2.134 for MNDO compared to an actual of 1.757 and 1.753 A for the x-ray data 
The same overestimation of the hydrogen bond length is not seen in PM3 results which 
predict die bond lengths to be 1.754 and 1.794 A  (because the PM3 method was designed to 
reduce the over-estimation of hydrogen bonds). The other bond lengths predicted by all three 
methods are fairly similar to the actual ones, though overall PM3 seems to be the best method.
181
Table 5-2. Experimental vs. calculated geometries for l,4-dihydroxyanthracene-9,10-
dione 19
Cambridge
Database
Reference
Code
DHXANT10
R-Factorf
0.039
1
1
26
24
0
1
3 9
O21\ h
25
20
D
1
6 ^
7 4 1
3
9
2
3
Distance a Cambridge AMI PM3 MNDO
C7-019 1.237 1.248 1.230 1.234
C10-C20 1.236 1.245 1.230 1.234
024-C14 1.352 1.366 1.356 1.351
C ll-021 1.352 1.366 1.356 1.351
021-H25 0.950 0.970 0.962 0.945
024-H26 0.950 0.970 0.962 0.945
C9-C10 1.457 1.472 1.478 1.503
C7-C8 1.457 1.472 1.478 1.503
C6-C10 1.476 1.475 1.485 1.501
C5-C7 1.471 1.475 1.485 1 501
019-H25 1.757 1.934 1.794 2.134
H26-O20 1.753 1.931 1.794 2.134
Angle b
C14-024-H26 109.0 111.2 108.7 117.7
Cl 1-021-C25 109.0 111.5 108.7 117.7
C8-C7-019 120.8 121.9 120.3 120.8
C9-C10-020 121.0 121.9 120.2 120.8
C9-C14-024 123.2 126.9 124.5 128.2
C8-C11-021 123.6 126.9 124.7 128.2
Torsion b
H26-024-C14-C9 -2.9 -0.8 -0.2 0.0
H25-021-C11-C8 -1.5 0.0 0.0 0.0
C9-C8-C7-019 -179.6 -179.6 -179.6 180.0
C8-C9-C10-020 -178.8 -179.8 179.9 180.0
024-C14-C9-C8 179.6 -179.9 180.0 180.0
021-C11-C8-C9 179.1 180.0 -179.9 180.0
Charge c
O19&O20 -0.446 -0.446 -0.446
021&O24 -0.081 -0.081 -0.081
H25&H26 0.303 0.303 0.262
Heat of formation d -95.59 -108.01 -98.71
Dipole * 1.793 2.268 1.581
d Bond lengths in angstroms. b Bond angles in degrees. c MOP AC charges d Heat o f formation in kcal mol'1. e
Dipole moment in Debyes. f R-factor is a measure o f  the agreement between the postulated structures relative to
the diffractometer data collected. 8
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5.4.2 l,4-Diaminoanthracene-9,10-dione
The modelling of 1,4-diaminoanthracene-9,10-dione by all three methods did not predict an 
accurate structure as, all three computational methods gave a non-planar structure, contrary to 
the x-ray data, which predicts a planar molecule (Table 5-3). The results show that the 
anthracene-9,10-dione moiety has been bent around the carbonyl atoms CIO and C7, with the 
oxygen atoms of the carbonyl group forced out of the plane of the molecule and perpendicular 
to the two aromatic rings of the anthracene-9,10-dione. This distortion arises because of a 
non-planar amino group which is bent out of the plane of the ring. The attached hydrogen 
atoms are out of plane also but the hydrogen bond distance (H28-019) is preferentially 
retained which is why the oxygen atoms are pushed out of plane causing the molecule to 
buckle. The extent of this buckling can be seen from the angle C14-C10-C1, which are 
177.3° for the CSD structure and 152.1° for the structure predicted by AMI.
Figure 5-4. Predicted structure of ly4-diaminoanthracene-9,10-dione by AMI
The distortion of the planar anthracene-9,10-dione moiety is prevented if the starting structure 
is totally planar. The structure used to cany out these calculations was taken from CSD. The 
initial torsion angles for the protons, show that they are slightly out of the molecules plane 
(C8-C11-N21-H28,2.7° and C9-C14-N24-H26 -2.7°) but if the calculations are repeated 
using a completely planar starting molecule, constructed in Sybyl, the problem is resolved as 
all three methods give a planar amino group (Table-5-4).
1 8 3
Figure 5-4. Structure of l,4-diaminoanthracene-9,10-dione predicted by PM3 using the
Sybyl starting structure
However, the planar conformer is higher in energy than the original structure, with values for 
the AMI method of 2.8 kcal mol'1, 6.9 kcal mol*1 for the PM3 method and 18.4 kcal mol'1 for 
the MNDO method.
Again a closer examination reveals that the PM3 method is more accurate at predicting die 
hydrogen bond length H28-019 and H26-O20 with values of 1.837 A, 2.102 A for the AMI 
method, and 2.169 A for the MNDO method. Other important bond lengths include O20-C10 
and 019-C7 with values 1.254 A for , N24-C14 and N21-C11 with values of, 1.254 A, 1.348 
A  and 1.348 A which are all more accurately predict by the AMI method which gave values 
of 1.247 A, 1.247 A, 1.391 A and 1.391 A respectively (Table 5-4).
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Table 5-3 Experimental vs. calculated geometries for 1,4-Diaminoanthracene-9,10- 
dione20 using the CSD starting structure
Cambridge 
Database 
Reference Code 
GICXOF
R-Factorf 
0.039
30 26 
H\  2 4 2 0  
N O
1 II
13 9 6 2 
I 7 41 n
N 0  
19
29 28
Torsion a Cambridge AMI8 PM3g MNDOh
020-C10-C9-C8 -176.0 -152.3 -158.6 152.2
019-C7-C8-C9 176.0 152.2 158.6 152.2
C8-C11-N21-H28 2.7 22.1 2.40 -22.1
C 9-C14-N24-H26 -2.7 22.1 -21.4 -22.1
C9-C8-C11-N21 -179.6 173.7 174.8 173.7
C8-C9-C14-N24 179.6 -173.8 -174.8 -173.7
Distance b
O20-C10 1.254 1.241 1.224 1.241
019-C7 1.254 1.241 1.224 1.241
N24-C14 1.348 1.391 1.423 1.391
N21-C11 1.348 1.391 1.423 1.391
H28-019 1.929 2.104 1.892 2.104
H26-O20 1.929 2.103 1.892 2.104
C9-C10 1.440 1.479 1.487 1.479
C8-C7 1.440 1.479 1.487 1.479
C10-C6 1.479 1.479 1.487 1.479
C7-C5 1.479 1.479 1.487 1.479
Angle a
C14-C10-C1 177.3 152.1 158.3 152.1
Cl 1-C7-C4 177.3 152.1 158.3 152.1
020-C10-C9 119.4 116.6 111.5 120.5
019-C7-C8 119.4 116.6 111.5 120.5
C9-C10-C6 122.7 123.6 121.7 116.0
C8-C7-C5 122.7 123.6 121.7 116.0
Cl 1-N21-H28 118.9 115.9 117.1 117.0
C14-N24-H26 118.9 115.9 117.1 117.0
Chaises c
O19&O20 -0.337 -0.343 -0.313
N21&N24 -0.050 -0.364 -0.338
H26&H26 0.120 0.183 0.223
Heat of formation d -9.85 -14.82 -9.85
Dipolee 1.649 0.424 1.649
Bond angles in  degrees.b Bond lengths in angstroms.c MOPAC charge d Heat o f formation in  kcal mol'1. e
Dipole moment in D eb yes.f R-factor is a measure o f  the agreement between the postulated structures relative to
the diffractometer data collected. Calculations carried out using keywords X YZ, Geo-ok and E F .J
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Table 5-4. Experimental vs. calculated geometries for l,4-Diaminoanthracene-9,10-dione20
using the planar Sybyl starting structure
Cambridge 
Database 
Reference Code 
GICXOF
30 26 
*"* \  24 20 
N O
1 II
13 6 2
I II
. N . O
19
29 28
R-Factorf 
0.039
Torsion a Cambridge AMI PM3 MNDO
020-C10-C9-C8 -176.0 -179.9 -180.0 180.0
019-C7-C8-C9 176.0 -180.0 -180.0 180.0
C8-C11-N21-H28 2.7 0.0 0.0 0.0
C9-C14-N24-H26 -2.7 0.0 0.0 0.0
C9-C8-C11-N21 -179.6 180.0 180.0 180.0
C8-C9-C14-N24 179.6 180.0 180.0 180.0
Distance b
O20-C10 1.254 1.247 1.231 1.234
019-C7 1.254 1.247 1.231 1.234
N24-C14 1.348 1.372 1.391 1.384
N21-C11 1.348 1.372 1.391 1.384
N21-020 2.617 2.690 2.584 2.761
N24-019 2.617 2.690 2.584 2.76!
H28-019 1.929 2.102 1.837 2.169
H26-O20 1.929 2.102 1.837 2.169
C9-C10 1.440 1.473 1.477 1.501
C8-C7 1.440 1.473 1.477 1.501
C10-C6 1.479 1.478 1.488 1.504
C7-C5 1.479 1.478 1.488 1.504
Angle a
C14-C10-C1 177.3 178.1 177.1 177.7
Cl 1-C7-C4 177.3 178.1 177.1 177.7
020-C10-C9 119.4 124.0 121.6 121.8
019-C7-C8 119.4 124.0 121.6 121.8
C9-C10-C6 122.7 119.1 118.9 120.5
C8-C7-C5 122.7 119.1 118.9 120.5
Cl 1-N21-H28 118.9 119.7 118.9 125.7
C14-N24-H26 118.9 119.7 118.9 125.7
Charges 0
O19&O20 -0.343 -0.337 -0.343
N21&N24 -0.390 -0.050 -0.364
H26&H26 0.260 0.120 0.183
Heat of formation d -7.02 -7.87 8.56
Dipole * 2.378 1.580 1.996
a Bond angles in degrees Bond lengths in angstroms. c MOP AC charge Heat o f formation in kcal mol' . e
Dipole moment in Debyes. f R-factor is a measure o f  the agreement between the postulated structures relative to
the diffractometer data collected. Calculations carried out using keywords XYZ, Geo-ok and EF.
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5 .43 l,4-bis(butyIamino)anthracene-9,10-dione
The same problem of the nitrogen atom being forced out of plane with the molecule bent 
around the carbonyi atoms also occurred when l,4-bis(butylamino)anthracene-9,10-dione was 
calculated.
Figure 5-5. Structure of l,4-bis(butylamino)anthracene-9,10-dione predicted by MNDO
using the Sybyl starting structure
The experimental angles C17-C5-C7 and C14-C12-00 of the molecule are 176.3° and 176.0° 
(Table 5-5), but with AMI they are predicted to be 148.7° and 153.4°, PM3 gives values of 
156.4° and 159.4° and MNDO, creates the greatest distortion, with values of 136.1° and 
137.0°. Again the calculations were carried out using the CSD starting structure (Table 5-5), 
which is also not completely planar, as shown by the torsion angles H28-N4-C14-C18 and 
H27-N3-C17-C13 which have values of 1.2° and 9.6°.
The calculation were run again using a structure that was built in the Sybyl program (Table 5- 
6) but this was to no avail as the structure was again predicted to be non-planar and the 
nitrogen atom ended up in a tetrahedral conformation as opposed to trigonal planar 
arrangement in the starting structure. The tetrahedral conformation of nitrogen preferred by 
the AMI, PM3, and MNDO methods means the hydrogen atoms are pushed out of plane with
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respect to the anthracene-9,10-dione nucleus. In order to maintain the hydrogen bond lengths 
the carbonyl oxygen atoms are pulled out of the plane of the molecule, causing the molecule 
to buckle as the rings bend away in the opposite direction.
In order to prevent the molecule from buckling the ring, the carbons of the polycyclic system 
and the oxygen atoms were fixed in the Z-plane. This prevented the molecule from buckling 
at the carbonyl groups and therefore kept the molecule flat and planar but it did not prevent 
the nitrogen atom ending up in a tetrahedral conformation when using the PM3 method. It 
was necessary therefore to fix the nitrogen atoms also in the aromatic plane. Table 5-7 shows 
the energy differences produced in moving from an unconstrained calculation with a 
tetrahedral nitrogen conformation to the constrained case.
For AMI there is a difference of 3.2 kcal mol'1 between the planar and non-planar 
conformation, while the energy differences for MNDO is 18.7 kcal mol'1.
An examination of the corresponding data for PM3 shows the situation is complicated further, 
as there are three different energy levels. The total energy of the molecule is -49.1 kcal mof1 
if the nitrogen is in a tetrahedral conformation and the molecule is buckled. If the ring system 
is constrained the molecule remains flat but the nitrogen becomes distorted into a tetrahedral 
conformation, and the total energy of the molecule decreases to -48.1 kcal m ol1, a difference 
of 1.1 kcal mol'1. However if the nitrogen atom is also constrained the molecule remains 
planar but the penalty paid for this is a decrease in the total energy to -42.1 kcal mol'1. From 
this it can be deduced that the constrained planar nitrogen is 5.9 kcal mol'1 higher in energy 
that a tetrahedral unconstrained nitrogen and that the planar constrained molecule is 1.06 kcal 
mol'1 higher in energy than the buckled unconstrained molecule.
The calculated data for the constrained molecule shows that the hydrogen bond distance is 
again overestimated by AMI and more so by MNDO (Table 5-6) with the PM3 method being 
the most accurate. AMI is also more accurate at predicting the bond lengths 01-C5, N4-C14 
and N3-C17 with values of 1.240 A, 1.387 A and 1.376 A compared to 1.254 A, 1.347 A and 
1.359 A respectively (Table 5-6) in CSD.
1 8 8
Table 5-5. Experimental vs. calculated geometries for l,4-bis(butylamino)anthracene-
219,10-dione using the unconstrained AMI, PM3 and MNDO methods
Cambridge 
Database 
Reference Code 
CAMJOP
R-Factor1 
0.050
\  13 11 ^  .
\ 12^• i. 10
O
2
Torsion a Cambridge AMI PM3 MNDO
01-C5-C18-C13 177.7 147.3 163.6 133.7
02-C12-C13-C18 -178.9 157.1 -156.1 -136.9
N3-C17-C18-C13 179.5 -173.3 -170.2 175
N4-C14-C13-C18 -179.3 171.8 -175.5 -174.2
C30-N3-C17-C16 1.1 13.7 12.6 -48.5
C29-N4-C14-C15 -7.1 2.1 16.8 98.7
C17-C18-C5-C6 176.5 -147.6 160.6 136.1
C14-C13-C12-C11 -177.1 154.6 -156.9 -137.6
Distance
01-H27 1.781 2.099 1.881 3.91
02-H28 1.899 2.045 1.852 2.65
01-C5 1.254 1.240 1.224 1.22
02-C12 1.255 1.242 1.226 1.23
N3-C17 1.359 1.318 1.430 1.44
N4-C14 1.347 1.389 1.425 1.43
C18-C5 1.437 1.480 1.487 1.51
C13-C12 1.449 1.477 1.485 1.51
C12-C11 1.469 1.478 1.488 1.51
C5-C6 1.480 1.481 1.486 1.51
Angle *
C17-N3-H27 110.2 115.1 111.2 108.4
C14-N4-H28 110.4 116.8 112.1 111.6
C18-C5-01 123.1 123.7 121.8 124.1
C13-C12-02 122.4 124.2 122.0 123.4
N3-H27-01 142.7 129.8 135.7 25.89
N4-H28-02 142.7 128.9 134.9 110.5
C17-C5-C7 176.3 [f5&4 p67i|
C14-C12-C10 176.0 ^53.4 A59.4 >37.(1
Charges c
01&02 -0.309 -0.344 -0.342
N3&N4 -0.304 - 0.001 -0.385
H27&H28 0.238 0.107 0.206
Heat of formation d -40.91 -49.15 -31.97
Dipolee 3.077 1.905 2.38
a B o n d  an g les in  degrees. D B o n d  len g th s in  a n g s tro m s .c MOPAC charge Heat o f formation in kcal mol*1. 6 Dipole
moment in Debyes. f R-factor is a  measure o f  the agreement between the postulated structures relative to  the diffractometer
data collected. Calculations carried out using keywords XYZ, Geo-ok and EF.1
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Table 5-6. Experimental vs. calculated geometries for l,4-bis(butylamino)anthracene- 
9,10-dione21 using the constrained AMI, PM3 and MNDO methods
Cambridge Database 
Reference Code 
CAMJOP
R -F a c to r1 
0.050
1i
1!
30 27
\  / H 1 
N O 
31
II
^  10
Jl\L  O
H 2
^  28
Torsion a Cambridge AMI 8 PM3 8 MNDO h
H27-N3-C17-C18 9.6 180.0 180.0 180.0
H28-N4-C14-C13 -1.2 -180.0 -180.0 180.0
01-C5-C18-C13 177.7 180.0 180.0 180.0
02-C12-C13-C18 -178.9 -180.0 -180.0 180.0
N3-C17-C18-C13 179.5 180.0 180.0 180.0
N4-C14-C13-C18 -179.3 180.0 180.0 180.0
C30-N3-C17-C16 1.1 0.0 0.0 0.0
C29-N4-C14-C15 -7.1 0.1 0.1 0.0
C17-C18-C5-C6 176.5 180.0 180.0 180.0
C14-C13-C12-C11 -177.1 -180.0 -180.0 180.0
Distance b
N3H27 0.805 0.999 1.000 1.012
N4H28 0.930 1.000 1.000 1.007
01-H27 1.781 1.949 1.815 2.042
02-H28 1.899 1.956 1.805 2.038
01-C5 1.254 1.240 1.222 1.234
02-C12 1.255 1.220 1.244 1.234
N3-C17 1.359 1.376 1.409 1.396
N4-C14 1.347 1.387 1.391 1.396
N3-01 2.583 2.674 2.582 2.745
N4-02 2.586 2.681 2.579 2.747
C18-C5 1.437 1.474 1.494 1.505
C13-C12 1.449 1.486 1.470 1.505
C12-C11 1.469 1.475 1.466 1.503
C5-C6 1.480 1.476 1.477 1.504
Anglea
C17-N3-H27 110.2 118.7 117.8 119.2
C14-N4-H28 110.4 119.4 118.3 119.1
C18-C5-01 123.1 124.7 122.0 122.1
C13-C12-02 122.4 124.7 121.7 122.1
N3-H27-01 142.7 128.4 131.3 125.9
N4-H28-02 142.7 127.9 130.2 126.1
C17-C5-C7 176.3 178.2 177.4 136.6
C14-C 12-C10 176.0 178.0 177.5 137.0
Heat of formation d -37.76 -42.15 -13.31
Dipole * 2.383 1.547 1.796
a Bond angles in degrees. Bond lengths in angstroms. 0 MOP AC charge Heat of formation in kcal mol' . e 
Dipole moment in Debyes. f R-factor is a measure of the agreement between the postulated structure relative to the 
diffractometer data collected Molecule constrained in the Z plane at atoms 3,4,13,14,16,17,27,28,29 & 30. h Molecule 
constrained in the Z plane at atoms 3,4,5,12,13,14,16,17,27,28,29 & 30. Calculations carried out using keywords XYZ, Geo- 
ok and EF.
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Table 5-7. Summary of computational data for l,4-bis(butylamino)anthracene-9,10-
dione21
2730 ^  ^
0
1 |
I II II I 
|| 10
29 28
Method Atoms constrained in the Z plane3 N-H Bond Structure
Nitrogen
Conformation
Total
Energy
PM3 No
Out of 
plane Twisted Tetrahedral -49.15
PM3
01,02 ,05 ,06,07,08,09,010,011,012,013,014,
015,016,017,018
Out of 
plane Planar Tetrahedral -48.09
PM3
H27, N3,030, C17, C18, C15, C 14, N4, H28,029 In plane
Planar Planar -42.15
PM3
H27, N3,030, H28, N4,029 In plane
Planar Planar -42,15
PM3
H27,N3,H28,N4 In plane
Planar Planar -42,15
PM3
N3,N4 In plane
Planar Planar -42,15
AM1
No Out of 
plane Twisted Tetrahedral -40.91
AM1
05,06,07,08,09,010,011,012,013,014,015,016,017,018 In plane
Planar Planar -37.74
AM1
H27, N3,030,017,018, C15, C14, N4, H28,029 In plane
Planar Planar -37.74
AM1
H27, N3,030, H28, N4,029 In plane
Planar Planar -37.74
AM1
H27,N3,H28,N4 In plane
Planar Planar -37.74
AM1
N3,N4 In plane
Planar Planar -37.76
MNDO
No Out of 
plane Twisted Tetrahedral -31.97
MNDO
01,02 ,05 ,06 ,07 ,08 ,09 ,010 ,011 ,012,013 ,014 ,015,016 ,0
17,018 In plane Planar Planar -13.31
MNDO
H27, N3,030,017,018,015, C14, N4, H28,029
In plane Planar Planar -13.31
MNDO
H27,N3,H28,N4 In plane
Planar Planar -13.31
MNDO N3,N4 In plane Planar Planar -13.31
aThe input file for MOP AC is modified by freezing the position of the atoms in the Z plane for a particular atom
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5.4.4 Other l,4-Bis(alkylamino)anthracene-9,10-dione22
A similar distortion of the molecule is also found when l,4-bis(isopropylamino)anthracene-
9,10-dione is calculated by using the three methods (Table 5-8).
Figure 5-7. l,4-Bis(isopropylamino)anthracene-9,10-dione structure predicted by 
MNDO
The buckling of the molecule is again prevented by constraining the heavy atoms of the 
polycyclic system and the exocyclic nitrogen’s so they lie in the same plane (Table 5-9). . 
Again, this results in a difference of total energy for the constrained and unconstrained 
molecule, for the AMI method this is 3.1 kcal mol'1, for the PM3 method this is 8.5 kcal mol'1 
and for the MNDO method this is 20.7 kcal mol"'(see Table 5-10). A similar result was 
obtained for the simplest aminoalkyl-anthracene-9,10-dione, 1,4-
bis(methylamino)anthracene-9,10-dione. This molecule was also predicted to be non planar 
and resulted in the buckling of the molecule and shows that the longer alkyl chain is not 
responsible for the non-planar structure.
Figure 5-8. l,4-Bis(isopropylamino)anthracene-9,10-dione modelled by PM3 with the
heavy atoms of the polycyclic system constrained in the z-plane
19?
Examination of the data obtained when the molecule is constrained in the z-plane again 
(Table 5-9) shows that MNDO and AMI methods again overestimate the length of hydrogen 
bond, with the PM3 method being the most accurate. However, the bond length for O20-C10, 
and N24-C14 are more accurately predicted by the AMI method (Table 5-9) when compared 
to the CSD structure.
Table 5-8. Experimental vs. calculated geometries for 1,4- 
bis(isopropylamino)anthracene-9,10-dione22 using the unconstrained AMI, PM3 and
______________________  MNDO_methods____________________________
C am bridge
D atabase
Reference 2d H
24 /  20
Code n o
BOCM UB
R-Factor*
0.056
Torsion a Cambridge AMI PM3 MNDO
C13-C14-N24-C29 14.8 -160.3 34.7 -136.4
Cl 1-C12-N21-C30 1.8 -160.7 40.4 134.1
020-C10-C9-C8 178.9 -164.3 -155.8 171.5
019-C7-C8-C9 177.9 -164.3 162.9 175.7
N21-C11-C8-C9 -178.4 -13.4 -169.9 -24
N24-C14-C9-C8 179.3 -13.3 -175.5 -8
H26-N24-C14-C9 11.7 40.9 -19.8 37.7
H28-N21-C11-C8 -0.4 41.3 -11.2 22.4
Distance b
O20H26 1.776 1.962 1.883 2.456
019H28 1.747 1.962 1.854 2.58
N24-C14 1.362 1.382 1.430 1.425
N21-C11 1.351 1.382 1.425 1.427
C7-019 1.256 1.247 1.225 1.235
Cl 0-020 1.260 1.247 1.224 1.225
Cl 0-09 1.461 1.477 1.487 1.511
C7-C8 1.464 1.477 1.485 1.51
C6-C10 1.480 1.478 1.457 1.506
C5-C7 1.496 1.478 1.488 1.505
H26-N24 1.080 0.999 1.009 1.005
H28-N21 1.080 0.999 1.010 1.005
Angle a
H28-N21-C11 117.1 117.49 112.2 112.7
H26-N24-C14 117.0 117.5 111.2 113.1
019-C7-C8 123.7 124.05 122.1 123.7
020-C10-C9 122.7 124.04 121.9 123.7
C1-C10-C14 177.2 155.0 137.7
C4-C7-C11 178.2 158.8 136.7
Charge
N24&N21 -0.005 -0.383 -0.338
O19&O20 -0.368 -0.343 -0.345
H26&II28 0.146 0.204 0.262
Heat of formation d -20.18 -41.31 -15.37
Dipole e 1.443 1.977 3.405
11 Bond angles in degrees. Bond lengths in angstroms. c MOP AC charge Heat o f formation in kcal mol"1. e Dipole moment in Debyes. R- 
factor is a measure o f the agreement between the postulated structures relative to the diffractometer data collected.
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Table 5-9. Experimental vs. calculated geometries for 1,4- 
bis(isopropylamino)anthracene-9,10-dione22 using the constrained AM I, PM3 and
MNDO
Cambridge
Database
Reference
Code
BOCMUB
R -F a c to rf
0.056
22
1:
I
1:
30
26
S\ 2 4  20
N O 
1 ,11
1 1 II 1
11 7 4 ^
II
.N . O 
19
28
Torsion Cambridge PM3a AM la MNDOb
020-C10-C9-C8 178.9 179.6 -179.9 -179.9
019-C7-C8-C9 177.9 179.6 -179.9 -179.9
N21-C11-C8-C9 -178.4 180.0 180.0 180.0
N24-C14-C9-C8 179.3 180.0 180.0 180.0
H26-N24-C14-C9 179.3 0.0 0.0 0.0
H28-N21-C11-C8 -178.4 0.0 0.0 0.0
Distance
O20H26 1.776 1.800 1.969 2.027
019H28 1.747 1.801 1.969 2.027
N24-C14 1.362 1.399 1.377 1.396
N21-C11 1.351 1.400 1.377 1.396
N24-O20 2.595 2.583 2.684 2.743
N21-019 2.586 2.583 2.684 2.743
C7-019 1.256 1.231 1.247 1.234
Cl 0-020 1.260 1.231 1.247 1.234
C10-C9 1.461 1.480 1.474 1.505
C7-C8 1.464 1.479 1.474 1.505
C6-C10 1.480 1.488 1.479 1.503
C5-C7 1.496 1.487 1.479 1.503
H26-N24 1.080 1.009 0.955 0.997
H28-N21 1.080 1.009 0.955 0.997
Angle
H28-N21-C11 117.1 117.2 119.9 118.7
H26-N24-C14 117.0 117.2 119.9 118.7
019-C7-C8 123.7 122.1 124.1 122.2
020-C10-C9 122.7 122.1 124.1 122.2
C1-C10-C14 177.2 177.5 178.2 178.4
C4-C7-C11 178.2 177.6 178.3 178.4
Charges
N24&N21 -0.338 -0.005 -0.383
O19&O20 -0.345 -0.368 -0.343
H26&H28 0.262 0.146 0.204
Heat of formation -32.71 -17.10 3.08
Dipole 1.945 2.807 1.986
“Molecules constrained in the Z plane at atoms 8,11,12,14,21,24,26,28,29 & 30. Molecule constrained in the Z plane at atoms 
7,8,10,11,12,14,21,24,26,28,29 & 30. Calculations carried out using keywords XYZ, Geo-ok and EF.
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Table 5-10. Summary the computational data for l,4-bis(isopropylamino)anthracene-
9,10-dione
1:
1 :
30
26
" \ 2 4 20 
N O
I II
9 6 2
II 7 4
II
0
19
28
Method Atoms constrained in Z plane 3 N-H Bond Structure Nitrogen Energy
PM3 No Out of plane Twisted Tetrahedral -41.30
PM3
01,02 ,03 ,04 ,05,06,07,08,09,010,
C1,C12,C13,C14,O19,O20,N24,N21
Out of plane
Planar Tetrahedral -39.51
PM3
H26,N24,C14,C9,H28, N21,C11,C12 In plane
Planar Tetrahedral -38.06
PM3
C29H26,N24,C14,C9,C30,H28,N21,
011,012
In plane
Planar Planar -32.79
AM1
No Out of plane
Twisted Tetrahedral -20.18
AM1
01,02,03 ,04 ,05 ,06 ,07 ,08 ,09 ,010 , 
01,012,013,014
In plane
Planar Tetrahedral -17.63
AM1
C29H26,N24,C14,C9,C30,H28,N21,
011,012
In plane
Planar Planar -17.07
MNDO
No Out of plane
Twisted Tetrahedral -15.37
MNDO
01,02,03 ,04 ,05 ,06 ,07 ,08 ,09 ,010 , 
C1,C12,C13,014,019,020, N24.N21
Out of plane
Planar Tetrahedral 1.09
MNDO
H26, N24,014,09, H28, N21,011,012 In plane
Planar Tetrahedral 1.69
MNDO
C29H26,N24,C14,C9,C30,H28,N21,
011,012
In plane
Planar Planar 3.08
aThe input file for MOP AC is modified by freezing the position of the atoms in the Z plane for a particular atom
1 9 6
5.4.5 l,4-Bis(4-toluidinio)anthracene-9,10-dione
l,4-Bis(4-toluidinio)anthracene-9,10-dione again shows the same problems on calculation, as 
the alkylamino anthracene-9,10-diones with the nitrogen being pushed into a tetrahedral 
conformation and the molecule being buckled at the carbonyl groups (Table 5-11).
Figure 5-8. Predicted structure of l,4-bis(4-toluidinio)anthracene-9,IO-dione
using MNDO
The AMI method is further complicated as the nitrogen groups are predicted to be arranged in
a staggered conformation.
Figure 5-9. Predicted structure of l,4-bis(4-toluidinio)anthracene-9,10-dione using AML
The structural problem is again resolved by constraining the molecule in the z-plane (Table 5- 
12). This again leads to a difference in energy between the constrained and unconstrained
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molecules. For the AMI method this is 4.9 kcal mol"1, for the PM3 method this is 7.1 kcal 
mol'1 and for the MNDO method this is 17.2 kcal mol'1 (Table 5-13).
Examination of the data for the constrained molecule shows that the PM3 method is most 
accurate at predicting the hydrogen bond length 01-H34 (Table 5-12) 1.822 A  compared to 
1.882 A  for the CSD structure. However the AMI method is more accurate at predicting the 
bond lengths of carbon-hetero atoms. For example the bonds 0 1 -C l7 and N3-C5 are 
predicted to be 1.247 A, and 1.381 A  respectively, which compares to 1.254 A  and 1.369 A 
respectively for the CSD structure (Table 5-12).
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iab ie  5-11. iLxperimenia! vs. calculated geometries for l,4-bis(4-toluidinio) anthracene- 
9, 10-dione22 using the unconstrained AMI, PM3 and MNDO methods
Cambridge
Database
Reference
Code
NOHTIN
R-Factorf 
0.056
Torsion a Cambridge AM I PM3 MNDO
H34-N4-CS-C9 8.4 -7.5 -4.7 - 86.8
H33-N3-C5-C18 ■13.1 -29.0 -16.1 85.4
[N4-C8-C9-C18 177.0 174.2 -175.3 -176.2
N3-C5-C18-C9 177.0 175.7 175.9 176.2
O1-C10-C9-C18 -180.0 153.5 164.7 -135.3
02-C17-C18-C9 178.5 151.5 ■159.7 135.3
C8-C9-C10-C11 179.8 151.9 168.3 ■137.2
C5-C18-C17-C16 179.4 151.4 -164.0 137.2
Distance
01-H 34 1.882 2.14 1.855 2.906
D2-H33 1.886 2.115 1.854 2.890
N4-C8 1.369 1.401 1.440 1.430
N3-C5 1.359 1.413 1.446 1.430
O1-C10 1.240 1.24 1.225 1.220
0 2 -Cl 7 1.254 1.239 1.224 1.220
N3-H33 0.900 1.004 1.009 1.010
N4-H34 0.899 1.003 1.007 1.010
C9-C10 1.454 1.482 1.473 1.510
C18-C17 1.448 1.483 1.478 1.510
C10-C11 1.499 1.479 1.492 1.510
C17-C16 1.471 1.478 1.473 1.510
Angle
H34-N4-C8 116.1 115.2 111.7 110.3
H33-N3-C5 116.4 113.8 110.0 110.3
01-C10-C9 122.8 123.4 122.7 123.6
02-C17-C18 123.7 123.5 122.5 123.6
N3-H33-02 134.3 122.4 136.5 84.71
N4-H34-01 132.8 123.5 132.3 85.82
C8-C10-C12 177.6 150.9 162.2 136.9
C5-C17-C15 177.0 152.0 165.7 137.0
Charges
01&02 -0.298 -0.328 -0.342
N4&N3 -0.251 0.064 -0.343
H34&H33 0.233 0.106 0.216
Heat of formation 49.08 29.53 44.27
Dipole 2.283 1.611 3.387
Bond angles in degrees. 0 Bond lengths in angstroms0 MOP AC charged Heat o f  formation in kcal mol'1. e 
Dipole moment in Debyes. 1 R-factor is a measure o f the agreement between the postulated structures relative to 
the diffractometer data collected.'
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Table 5-12. Experimental vs. calculated geometries for 1,4-Bis(4-toluidinio) anthracene- 
9,10-dione22 using the constrained AMI, PM3 and MNDO methods
C am bridge
D atabase
R eference
C ode
N O H T IN
]
N O
4
^ 10\  ^12 ^
R -Factor 1 
=0.056
 ^/  11 7 9 11
ll
6 \  18 16 
\  h36 33
^ , 3
15
Torsion 1 Cambridge A M lg PM35 MNDOh
H34-N4-C8-C9 8.4 0.8 0.7 0.8
H33-N3-C5-C18 -13.1 -0.8 -0.7 -0.8
N4-C8-C9-C18 177.0 -179.4 -179.6 -179.2
N3-C5-C18-C9 177.0 179.4 179.6 -179.2
O1-C10-C9-C18 -180.0 -179.9 -179.7 -179.6
02-C17-C18-C9 178.5 179.9 179.7 179.6
C8-C9-C10-C11 179.8 179.7 -179.8 -179.7
C5-C18-C17-C16 179.4 179.7 179.9 179.7
Distance
01-H34 1.882 1.981 1.822 2.073
02-H33 1.886 1.981 1.822 2.073
N4-C8 1.369 1.381 1.401 1.396
N3-C5 1.359 1.381 1.401 1.396
O1-C10 1.240 1.247 1.231 1.234
0 2 -Cl 7 1.254 1.247 1.231 1.234
N3-H33 0.900 0.966 1.007 0.999
N4-H34 0.899 0.967 1.007 0.999
C9-C10 1.454 1.474 1.477 1.504
C18-C17 1.448 1.474 1.477 1.504
C10-C11 1.499 1.478 1.488 1.503
C17-C16 1.471 1.478 1.488 1.503
A ngle3
H34-N4-C8 116.1 120.7 118.8 121.3
H33-N3-C5 116.4 120.7 118.8 121.3
01-C10-C9 122.8 123.8 121.7 122.0
02-C17-C18 123.7 123.8 121.7 122.0
C8-C10-C12 177.6 178.0 177.4 178.1
C5-C17-C15 177.0 178.0 177.3 178.1
Chargesc
01& 02 -0.334 -0.081 -0.342
N4&N3 -0.288 -0.459 -0.343
H34&H33 0.262 0.389 0.216
Heat of formation d 54.01 33.95 61.44
Dipole e 3.420 3.420 2.211
a Bond angles in degrees Bond lengths in angstrom s.c MOPAC charge1 Heat o f formation in kcal mol . e 
Dipole moment in D ebyes.1 R-factor is a measure of the agreement between the postulated structures relative to 
the diffractometer data collected 8 Molecule constrained in the Z plane at atoms 3.4.5.6,8.9,33.34.35 and 3 6 .h 
Molecule constrained in the Z plane at atoms 3,4,5,8,9,10,17,18,33,34,35 and 36.
2 0 0
Fable >  j J>„ S lilllllla iy  o f  fh c  lO ii lp u ia u O iia l  t iata  fo r  l ,4 -D is(4 - io il i i t i l l iIO ; allliiraceile-
9,10-dione
4
Method Atoms constrained in the z-piane 3 N-H Bond Structure Nitrogen Energy
PM3 No Out of plane Twisted Tetrahedral 26 89
PM3
C5,C5,C7,C8,C9.C10,C11 ,C12 ,C13,C14.C 15,C16 ,0  
17 ,018
Out of plane
Planar Tetrahedral 27.98
PM3
C35,H34,N4,C8,C9,C6,C5,N3,H33,C36 in plane
Planar Planar 33.94
AM1
No Out of plane
Twisted Tetrahedral 49.08
AM1
0 5 , 0 5 ,0 7 ,0 8 ,0 9 ,0 1 0 ,0 1 1 ,0 1 2 ,0 1 3 ,0 1 4 ,0 1 5 ,0 1 6 ,0
17 ,018
Out of plane
Planar Tetrahedral 53.83
AMI
C35,H34,N4,C8,C9,C6,C5,N3,H33,C36 in plane
Planar Planar 54.02
MNDO
No Out of plane
Twisted Tetrahedral 44.27
MNDO
0 5 , 0 5 ,0 7 ,0 8 ,0 9 ,0 1 0 ,0 1 1 ,0 1 2 ,0 1 3 ,0 1 4 ,0 1 5 ,0 1 6 ,0  
17 ,018
Out of plane
Planar Tetrahedral 50.72
MNDO
C35,H34,N4,C8,C9,C6,C5,N3,H33,C36 In plane
Planar Planar 61 44
dThe input file for MOP AC is modified by freezing the position of the atoms in the Z plane for a particular atom.
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As the target molecules to be synthesised in these studies contain sulfur, it was necessary to 
checkout the accuracy of the AMI, PM3 and MNDO methods for predicting the geometries of 
the sulfur containing anthracene-9,10-dione systems. There are few examples of these 
systems in CSD with the exception of the well resolved structure of l-(6- 
sulfanylhexylthio)anthracene-9,10-dione.
5.4.6 l-(6-Sulfanylhexyithio) anthracene-9,10-dione
The modelling of l-(6-sulfanylhexylthio)anthracene-9,10-dione by AMI produced a 
satisfactory overall geometry and gave a planar structure in line with the x-ray 
crystallographie data (Table 5-14).
Figure 5-10. l-(6-sulfanylhexylthio)anthracene-9,10-dione predicted structure using the 
AMI method
However, calculations using the PM3 and MNDO methods did not give a planar geometry, 
and the molecule was again bent at the carbonyl groups (Table 5-14).
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Figure 5-11. l-(6-sulfanylhexylthio)anthracene-9,10-dione predicted structure using the 
MNDO method
The molecule was again constrained in the Z-plane to hold the heavy atoms in the same plane 
but this gave an energy penalty of 4.1 kcal m of1 for PM3 and 9.0 kcal mol'1 for MNDO 
(Table 5-15).
Comparison of the CSD data with the three methods shows that the PM3 method is more 
accurate, in particular with the prediction of the bond lengths of S17-C11 and the 015-C13, 
which are respectively 1.773 A and 1.218 A for PM3, and 1.752 and 1.218 for the CSD 
structure.
2 0 3
Figure 5-14. Experimental vs. calculated geometries for i-(6-Suiianyihexylthio) 
anthracene-9,10-dione22 using the unconstrained AMI, PM3 and MNDO methods
Cambridge
Database
Reference
Code
WOGRITOl
R-Factorf 
0.044
/ 8\
h s (C 5h 10x  s 17 o
11 13 .
10 ^ 12 14 ^ 2
8  6  4
II
o
16
Distance “ Cambridge AMI PM3 MNDO
S17-C11 1.752 1.685 1.771 1.698
015-C13 1.219 1.243 1.213 1.224
016-C6 1.214 1.240 1.216 1.225
S17-015 2 . 6 6 8 2.513 3.135 3.198
C12-C13 1.481 1.475 1.499 1.512
C7-C6 1.490 1.481 1.495 1.508
C13-C14 1.482 1.478 1.497 1.505
C5-C6 1.480 1.476 1.489 1.505
Torsionb
S17-C11-C12-C7 -178.4 -179.9 176.7 171.1
015-C13-C12-C7 -177.4 179.3 135.6 134.6
016-C6-C7-C12 -175.0 -179.2 -152.2 -146.1
C18-S17-C11-C10 - 1 . 0 0.5 22.9 -79,2
Angle b
015-C13-C12 1 2 1 . 2 121.4 124.1 123.7
016-C6-C7 120.5 1 2 1 . 2 122.7 122.7
S17-C11-C12 121.3 118.4 120.9 122.1
C1-C11-C13 175.7 176.8 140.6 138.6
C4-C6-C8 175.3 176.8 147.1 143.4
C18-C17-C11 103.7 105.9 104.9 108.2
Chargec
S17 0.380 0.093 0.111
015 -0.277 -0.267 -0.266
016 -.0286 -0.295 -0.277
Dipolee 1.036 3.195 2.641
Heat of formation d -28.20 -22.78 -34.32
a Bond lengths in angstroms. b Bond angles in degrees.c MOP AC charge d Heat o f formation in kcal mol'1. e 
Dipole moment in D ebyes.f R-factor is a measure o f the agreement between the postulated structures relative to 
the diffractometer data collected. Calculations carried out using keywords XYZ, Geo-ok and EF.
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Figure 5-15. Experimental vs. calculated geometries for l-(6-Sulfanylhexylthio) 
anthracene-9,10-dione23 using the unconstrained for AMI and constrained for PM3 and
MNDO methods
Cambridge
Database
Reference
Code
WOGR1T01
R -F a c to r 1 
0.044
/ 18\/  \  17 15HS(C5H 10/  s 17 0
11 13 
10 2
8 6 4
I Io
16
Torsion b Cambridge AMI PM38 MNDO8
S17-C11-C12-C7 -178.4 -179.9 -179.1 -177.4
015-C13-C12-C7 -177.4 179.3 176.9 176.6
016-C6-C7-C12 -175.0 -179.2 -176.0 -175.9
C18-S17-C11-C10 - 1 .0 0.5 - 1 .2 -0.5
Distance a
S17-C11 1.752 1.685 1.773 1.693
015-C13 1.219 1.243 1.218 1.228
016-C6 1.214 1.240 1 .2 2 1 1.230
S17-015 2 .6 6 8 2.513 2.781 2.728
C12-C13 1.481 1.475 1.498 1.512
C7-C6 1.490 1.481 1.495 1.509
C13-C14 1.482 1.478 1.493 1.507
C5-C6 1.480 1.476 1.483 1.499
Angle b
015-C13-C12 1 2 1 .2 121.4 122.3 1 2 1 .8
016-C6-C7 120.5 1 2 1 .2 1 2 1 .0 1 2 0 .6
S17-C11-C12 121.3 118.4 1 2 2 .0 1 2 0 .2
C l-C l 1-C13 175.7 176.8 175.3 175.5
C4-C6-C8 175.3 176.8 175.8 175.7
C18-C17-C11 103.7 105.9 106.7 112.7
Charge c
S17 0.380 0 . 1 2 2 0.183
015 -0.277 -0.280 -0.274
016 -.0286 -0.311 -0.296
Dipolee 1.036 1.910 1 .1 1 0
Heat of formation d -28.20 -18.71 -25.34
a Bond lengths in angstroms. 1 Bond angles in degrees.c MOP AC charged Heat o f formation in kcal mol"1. e 
Dipole moment in Debyes. 1 R-factor is a measure of the agreement between the postulated stmctures relative to 
the diffractometer data collected. g Molecules constrained in the Z plane at atoms 5,6, 7.11.12.13,14,17 & 18. 
Calculations carried out using keywords XYZ. Geo-ok and EF.
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5.4.7 Conclusion
Examination of the data shows that MNDO method is the least accurate method for the amino 
and sulfur anthracene-9,10-dione derivatives, in terms of the intramolecular hydrogen bond 
lengths and hetero atom carbon bond lengths and the general shape. The PM3 method is the 
most accurate at predicting the intramolecular hydrogen bond lengths, the heteroatom carbon 
bond lengths (i.e. Cl 1-S17 and 015-C13) in the sulfur anthracene-9,10-dione derivative but is 
poor at predicting the general planar shape of both the amino and sulfur anthracene-9,10- 
dione derivatives. The AMI method is not as accurate at predicting the hydrogen bond 
lengths in comparison to the PM3 method but it is much better than the MNDO method. It is 
also better at predicting the heteroatom carbon bond lengths in the amino derivatives for 
example Table 5-12 shows the bond length N4-C8 which is 1.369 A  for the CSD structure, 
the AMI method predicts this bond length to be 1.381 A and the length predict by the PM3 
method is worse, with a value of 1.401 A. The AMI method also predicts a good general 
shape for the sulfur derivatives i.e. planar, which is agreement with the CSD data.
It is widely believed that the mode of action of anthracene-9,10-dione based anti-cancer 
agents is due to the ability of the planar molecule to interact with DNA. It is therefore 
desirable that any computational method used to model these molecules should predict a 
structure which is planar. As the AMI method does correctly predict the sulfur anthracene-
9,10-dione derivative will be planar without any constraints on the optimisation, it was 
selected in preference to the other two methods and was used to model all the sulfur 
containing molecules synthesised in this work
5.5 A b initio calculations
Following the results obtained from the semi-empirical calculations it was decided to run a 
number of reference ab initio calculations. Due to the increased processor time required for 
the latter calculations as compared to the former, l,4-bis(methylaxnino)anthracene-9,10-dione,
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was selected as the simplest derivative of the amino-anthracene-9,10-diones that didn’t 
remain planar when modelled using the semi-empirical methods. The simplest basis set, 
STO-3G, was selected to give an idea of the time scale.
The computational time required to complete a geometry optimisation of 1,4- 
bis(methylamino)anthracene-9,10-dione using the PM3 method was 14 minutes (using a 
Silicon Graphics Indy R5000), but a comparable optimisation of the same molecule using the 
STO-3G basis set took 36 hours (using a direct SCF). In the latter however, the molecule 
remains planar in line with x-ray crystallographic data. The STO-3G basis set is a minimal 
basis set and has several drawbacks, which include the inability to properly represent non- 
spherical electron distributions, found in p orbitals. To overcome this problem higher level 
split basis sets are required such as the 3-21G basis set. l,4-Bis(methylamino)anthracene-
9,10-dione was therefore modelled using 3-21G basis set and the 6-31G** basis set. In the 
latter more basis functions per atom are included, such as d-orbitals on heavy atoms and p 
orbitals on hydrogen: these are known as polarisation functions which allow distortion of 
electron density across the molecule.
However the run time for 6-31G** calculation on l,4-bis(methylamino)anthracene-9,10- 
dione was three hundred and ninety six hours.
Although the STO-3G basis set is a minimal basis set it does actually produce some very good 
results. In particular the carbon nitrogen bond C1-N17, this is predicted to be 1.359 A, which 
compared to 1.359A for the CSD structure and 1.401 A  for the higher level 3-21G basis set, is 
an excellent result. The AMI method also fairs well in comparison to the ab initio methods, 
giving very reasonable results with the exception of the intramolecular hydrogen bond 
distance. In particular the 015-C13 bond length of 1.240 A  compared to a CSD with a value 
of 1.254 A  (Table 5-16).
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Table 5-16. 1,4-bis (methylamino) anthracene-9,10-dione modelled using 
ab initio methods, in comparison with CAMJOP CSD structure and the computed AMI
structure.
^17 jjl5  
4 6  8
I  I I
N19  0 16 
1 H 20
CAMJOP
CSD
CAMJOP
AMI STO-3G 3-21G 6-31G**
Distancea
C1N17 1.359 1.376 1.359 1.401 1.361
C4N19 1.347 1.387 1.359 1.401 1.361
H18N17 0.805 0.999 0.999 1.017 0.991
H20N19 0.930 1 . 0 0 0 0.999 1.017 0.991
015H 18 1.781 1.949 1.812 1.748 1.860
O16H20 1.899 1.956 1.812 1.748 1.860
015C13 1.254 1.240 1.233 1.234 1 .2 1 0
O I 6 C6 1.255 1 .2 2 0 1.233 1.234 1 .2 1 0
C6C5 1.449 1.486 1.465 1.516 1.478
C12C13 1.480 1.476 1.482 1.511 1.478
Angle b
H18N17C1 1 1 0 .2 118.7 115.9 114.7 116.2
H20N19C4 110.4 1119.4 115.9 114.7 116.2
015C13C14 123.1 124.7 123.4 123.1 122.9
016C6C5 122.4 124.7 123.4 123.1 122.9
C11C13C1 176.3 178.2 177.7 176.3 177.7
C8C6C4 176.0 178.0 177.7 176.3 177.7
Torsion b
H18N17C1C14 -9.6 180.0 0 .0 0.4 0 . 0
H20N19C4C5 - 1 .2 180.0 0 .0 0.5 0 . 0
015C13C14C5 177.7 180.0 180.0 179.9 180.0
016C6C5C12 -178.9 180.0 180.0 179.9 180.0
Dipole c 3.077 2.361 0.324 2.004
Total energy d -544563.3 -540760.7 -547590.6
HOMO e -6.808
LU M O ' 0.971
a Bond lengths in angstroms. b Bond angles in degrees.c. Dipole moment in Debyes d In A.U..e In eV
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5.6 Calculated properties
The AMI method was selected to model the sulfur containing anthracene-9,10-diones. The 
following calculated properties were selected to explore the likely activity of the molecules 
synthesised.
1. Energy o f the Highest Occupied Molecular Orbital (E ho m o) -  The E h om o or ionization 
potential (eV) is the energy required to remove an electron from the molecule. It 
should give an indication of the molecules ability; to undergo a one electron oxidation; 
the lower in energy the HOMO is the easier it would be to loose an electron. If the 
mode of action involves an oxidation step, then the HOMO should reflect this.
2 . Energy o f the Lowest Unoccupied Molecular Orbital (E l u m q ),' The E lu m o  (eV) can 
also be thought of as the compound’s electron affinity. It should give an indication of 
the molecules ability to undergo a one electron reduction; the lower in energy the 
LUMO is the easier it would be for the molecule to accept an electron. It is thought 
that the ability of anthracene-9,10-diones to undergo this one electron reduction is why 
anthracene-9,10-dione based drugs are cardiotoxic (see section 1.2.3.).
3. Atomic charges on the nitrogen, oxygen, sulphur and hydrogen atoms are the most 
significant in the molecule as they would be the mostly likely sites of interaction and 
bonding with other cellular molecules such as DNA. The larger the charge on these 
atoms the more likely they are to interact with DNA and form non-covalent bonds.
4. Dipole moment (p). The dipole moment of a polyatomic molecule is the vector sum of 
all the charges acquired on its atoms due to the differences in their respective 
electronegativities24. Compounds with high dipole moment moments are often referred 
to as “polar” and are generally soluble in polar solvents such as water and hence the 
aqueous cell environment. Less polar compounds are generally more stable in 
lipophilic solvents. The measurements were recorded in Debyes.
5. Hetero atom bond lengths. These are important as the hetero atoms are the likely 
binding sites and distortion in the bond lengths will affect how the molecule would 
bind to other cellular molecules. Hydrogen bond length may also play a part in 
binding.
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5.6.1 Active vs. inactive derivatives of anthracene-9,10-dione
Looking at the calculated properties of all the synthesised molecules it is clear that there is a 
wide distribution of charge across the anthracene-9,10-dione molecule (Table 5-17). In order 
to assess the likely binding properties of these derivatives, it is necessary to compare these 
results with those obtained for the highly active derivatives such as Mitoxantrone (24b) and 
Amentantrone (24a) on the one hand, with those for the inactive anthracene-9,10-dione (1) 
and l,4-dihydroxyanthracene-9,10-dione (111) on the other. Accordingly the molecules were 
constructed using Sybyl and optimised using the AMI method with the appropriate 
constraints as before (Table 5-17).
An analysis of the calculated results show that in Mitoxantrone (24b), the oxygen atoms 015 
and 016 carry negative charges of -0.39, the nitrogen atoms N17 and N19 also carry a 
negative charges of -0.34, while the hydrogen atoms HI 8 and H20 carry a positive charge of 
0.26.
Comparison of the active compounds Amentantrone (24a) and Mitoxantrone (24b). 
Bond lengths and charge:
The bond length is slightly longer in the case of Mitoxantrone (24b) with a value of 1.3 75A 
compared to 1.397 A for Amentantrone (24a), the 015-C13 bond length is also longer with 
values of 1.252 A  for Mitoxantrone (24b) and 1.240 A  for Amentantrone (24a) (Table 5-17). 
The atomic charges on the nitrogen atoms N17 and N19 are more negative for Mitoxantrone 
(24b) with average value of -0.34 compared to -0.30 for Amentantrone (24a). A similar 
effect is found for the charge on the oxygen atoms 015 and 016 with values of -0.38 for 
Mitoxantrone (24b) compared to -0.31 for Amentantrone (24a). The hydrogen atoms H23 
and H24 are more positive with values of 0.26 for Mitoxantrone (24b) compared to 0.23 for 
Amentantrone (24a). The significance of the dipole moment is unclear as it will be highly 
affected by the orientation of any side chain present and therefore cannot be considered, 
except to note perhaps that the higher the value the more polar the molecule.
2 1 0
Energies:
The HOMO or ionisation potential for Mitoxantrone (24b) is much lower than Amentantrone 
(24a) with values of 7.71 eV and 7.95 eV respectively. This equates to an energy difference of
5.5 kcal mol'1 (1 eV is equal to 23.06 kcal mol*1) it is therefore more difficult, for 
Amentantrone (24a) to lose an electron than Mitoxantrone (24b). This means Mitoxantrone 
(24b) will be more likely to transfer an electron to DNA and form a stable polar complex.
The parameterisation of the AMI method produces negative values for the LUMO energies. 
The LUMO of Mitoxantrone (24b) is -1.29 eV and -1.04 eV for Amentantrone (24a). This is 
clearly incorrect and is an artefact of the original parameterisation of the AMI method 
developed by Dewar. More accurate calculations at the ab initio level have been carried out 
on sulfur containing species (see latter), which confirm that the LUMO energy is positive and 
overestimated by the AMI method by at least 2 eV. Accordingly it was decide to adjust the 
LUMO energies calculated by the AMI method by 2 eV, to give positive numbers for 
comparative purposes
The adjusted values of Mitoxantrone (24b) and Amentantrone (24a) are 0.71 eV and 0.96 eV 
This means that Mitoxantrone (24b) will except an electron more easily and is therefore more 
likely to undergo a one electron reduction.
Comparison of the inactive compounds anthracene-9,10-dione and 1,4-dihydroxyanthracene-
9.10-dione (Table 5-17).
Bond lengths and charge.
The bond lengths are similar for anthracene-9,10-dione (1) and 1,4-dihydroxyanthracene-
9.10-dione (111) for example the 015-C13 bond is 1.240 A for anthracene-9,10-dione (1) and 
1.246 A for l,4-dihydroxyanthracene-9,10-dione (111). The atomic charge on the oxygen
2 1 1
atoms 015 and 016 is more negative for l,4-dihydroxyanthracene-9,10-dione (111) than 
anthracene-9,10-dione (1) with values of -0.33 and -0.31 respectively.
Energies:
The ionisation potential for anthracene-9,10-dione (1) is higher than 1,4-
dihydroxy anthracene-9,10-dione (111) with values of 10.12 eV and 9.07 eV respectively.
The LUMO for l,4-dihydroxyanthracene-9,10-dione (111) has an adjusted value of 0.38 eV 
compared to an adjusted value of 0.61 eV for anthracene-9,10-dione (1).
Comparison of active vs. inactive anthracene-9,10-diones
The bond lengths of the carbon-hetero atoms are not significant, as both Mitoxantrone (24b) 
and Amentantrone have very similar bond lengths to l,4-dihydroxyanthracene-9,10-dione and 
anthracene-9,10-dione (1). The presence of negative oxygen atoms 021 or 022 in 1,4- 
dihydroxyanthracene-9,10-dione (111) and Mitoxantrone (24b) does not confer activity nor 
do the acidic hydrogen atoms H23 and H24. The presence of the basic nitrogen atoms N17 
and N19 in Mitoxantrone (24b) and Amentantrone (24a) however may be significant. 
Although both the oxygen atoms 021 and 022 of 1,4-dihydroxyanthracene-9,10-dione (111) 
and the nitrogen atoms N17 and N19 of Mitoxantrone (24b) have lone pair of electrons, this 
doesn’t confer activity, it appears that the atoms need to carry a larger negative atomic charge. 
The nitrogen atoms N17 and N19 of Amentantrone (24a) are significantly more negative than 
the oxygen atoms 022 and 021 of 1,4-dihydroxyanthracene-9,10-dione with values of -0.30 
and -0.26 respectively.
The ionisation potential does produce a significant pattern which correlates to the activity of
the molecules in Table 5-17. Mitoxantrone (24b) has the highest activity followed by
Amentantrone (24a) with l,4-dihydroxyanthracene-9,10-dione (111) and anthracene-9,10-
dione (1) being inactive. This activity is reflected in the ionisation potentials of 7.71 eV, 7.95
eV, 9.07 eV and 10.1 eV for the four molecules. There is a difference of at least 1 eV
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between the active and inactive derivatives, which in terms of energy is 23.1 kcal mol'1. This 
is a significant energy difference and suggest that oxidation of the molecules may be related 
to activity. In support of this, it has been reported that Mitoxantrone (24b) is oxidised in situ 
by cytochrome P-450 and the inhibition of this reaction leads to a complete loss in the 
cytotoxicity of Mitoxantrone (24b), in HepG2 cells25.
The LUMO does not appear to correlate with activity, Amentantrone (24a) has the largest 
adjusted energy of 0.96 eV followed by Mitoxantrone (24b) with an adjusted value of 0.71 
eV, then anthracene-9,10-dione (1) with an adjusted value of 0.61 eV and finally 1,4- 
dihydroxyanthracene-9,10-dione (111) which has an adjusted value of 0.38 eV.
It may be significant in the cardiotoxicity of the molecules as a high LUMO could indicate a 
reduced ability to form free radicals.
The presence of a nitrogen or oxygen atom in the side chain of Mitoxantrone (24b) and
Amentantrone (24b) is also important, as both would improve solubility in the cellular
environment. The basic nitrogen atom would stabilise interaction with DNA and promote 
26binding . These studies however were not designed to test this hypothesis and are more 
concerned with the effect of sulphur on the anthracene-9,10-dione molecule.
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5.6.2 l,4-Bis-(am m o)-5,8-dichloroanthraceiie-9,10-dioiies
The atomic charge on the nitrogen atoms N17 and N19 for all the chloro derivatives (123,
124, 125, 127,128,157) is in the region of -0.34 which is comparable to Mitoxantrone (24b) 
which has a value of -0.34 but greater than Amentantrone (24b) which has a value of -0.30 
(Table 5-18).
The ionisation potential for the all the chloro derivatives is lower by comparison with 
Amentantrone (24a). The highest ionisation potential being 7.83 eV for l,4-bis-[2- 
(hydroxyethyl)amino]-5,8-dichloroanthracene-9,l 0-dione (125). Some of the derivatives such 
as l,4-bis(propyIamino)-5,8-dichloroanthracene-9,l 0-dione (123) have even lower values 
than Mitoxantrone (24b), with values of 7.59 eV and 7.71 eV respectively (Table 5-18). The 
ionisation potentials for the chloro derivatives are closer to the active molecules Mitoxantrone 
(24b) and Amentantrone (24a) rather than the inactive l,4-dihydroxyanthracene-9,10-dione 
(111) and anthracene-9,10-dione (1), which have ionisation potentials of 10.12 eV and 9.07 
eV respectively.
The effect on the LUMO is a reduction to 0.76 eV for l,4-bis{[2- 
(hydroxyethyl)amino)ethyl]amino}-5,8-dichloroanthracene-9,10-dione (157), from a 
corrected value of 0.96 eV for Amentantrone (24a) but this value is higher than Mitoxantrone 
(24b) which has a corrected value of 0.71 eV (Table 5-18).
The presence of chlorine in the anthracene-9,10-dione ring results in a decrease in the 
ionisation potential suggesting that the chlorine containing molecule are more likely to 
transfer an electron to DNA and form a stable polar complex than Mitoxantrone (24b). The 
potential negative effect of chlorination is a decrease in the energy of the LUMO which 
suggests that this molecule could more easily form free radical species, however the values 
are comparable to Mitoxantrone (Table 5-18).
215
c
2o
ro
I t
3o3
<o
3
I-A
oo
- j
CO
CO
CJ1ocn
poo
co
o
b)oco
-0
oco
-oro
-N
CD
CO
CO
o
■o
CO
CD
~vl
CO
-o
b>
CO
->l
o
roCO
CO
CO
COro
roco
o O O00 CO co
CO
CD CO CD
p O p
CO CO CO
CO —k ro
CD 00 CO
p p
o> coto
CO o
O O CJ
7J
O
X
ro■tiro
roco
ro
to
ococn
O
XNo
ro
ro
•tk
ro
O
X
o
XN
b
X
ZJ
\
/
z-
co
Iro
o
O
X
CD
CD K>-0
O'.
o>
O -
w -
/
V
<
's i -
<
\J
V
o
/
Iro
\
/
H
»
O '» )fb
in■
h*
00
•
n
EL
o '
ST
Q.
•O
no•a
CO
3
nce
00
SL
?Top+fD
Ou
■a*
i O
cn
-o
/
\  sV  »
® 5* o
o
X
I
cn
Fa
«*
o '
*no03
s
cr
»
0<T>s
fft1
VO
IO-Ck-Ck
IO
00
ro■(k
IO
O
Xro
IOz
o
X
IO
-tk
IO
ro
o-t.
ro
ro
0)
5.6.3 l,4-bis(am ino)-5,8-(sulfanyl)anthracene-9,10-diones
As the presence of hydroxyl groups attached to the 5- and 8- positions of the anthracene-9,10- 
dione moiety has such a significant effect on the physical and biological properties, it was 
desirable to model the equivalent sulfur derivatives of Mitoxantrone, l,4-bis{[2- 
(hydroxyethyl)amino)ethyl]amino}-5,8-bis(thiol)anthracene-9,10-dione (158). The 
introduction o f a sulfur atom in place of an oxygen atom in l,4-bis{[2- 
(hydroxyethyl)amino)ethyl]amino}-5,8-bis(thiol)anthracene-9,10-dione (158) does not effect 
the charge on the nitrogen atoms N17 and N19, with values of -0.34, which is the same value 
calculated for Mitoxantrone (24b) (Table 5-19).
The LUMO is unaffected by the introduction of sulfur, as l,4-bis{[2- 
(hydroxyethyl)amino)ethyl]amino}-5,8-bis(thiol)anthracene-9,10-dione (158) has a adjusted 
value of 0.70 eV compared to a adjusted value of 0.71 eV for Mitoxantrone (24b). The 
ionisation potential is lowered very slightly to 7.69 eV for l,4-bis{[2- 
(hydroxyethyl)amino)ethyl]amino}-5,8-bis(thiol)anthracene-9,10-dione (158) from 7.71 eV 
for Mitoxantrone (24b) (Table 5-19).
Introduction of other sulfur substituents has a similar effect, examination of the data for 1,4- 
bis{[2-(hydroxyethyl)amino)ethyl]amino}-5,8-bis(ethylsulfanyl)anthracene-9,10-dione (161) 
and 1,4-bis {[2-(hydroxyethyl)amino)ethyl]amino} -5,8-bis(phenylsulfanyl)anthracene-9,10- 
dione (162) shows the LUMO is increased in comparison to Mitoxantrone with adjusted 
values of 0.91 eV for l,4-bis{[2-(hydroxyethyl)amino)ethyl]amino}-5,8- 
bis(ethylsulfanyl)anthracene-9,10-dione (161) and 0.90 eV for l,4-bis{[2- 
(hydroxyethyl)amino)ethyl]amino}-5,8-bis(phenylsulfanyl)anthracene-9,10-dione (162) 
compared to 0.71 eV for Mitoxantrone (24b) (Table 5-19). The ionisation potential of 7.71 
eV for Mitoxantrone (24b) is also reduced in the sulfur derivatives l,4-bis{[2- 
(hydroxyethyl)amino)ethyl]amino}-5,8-bis(ethylsulfanyl)anthracene-9,10-dione (161) and
l,4-bis{[2-(hydroxyethyl)amino)ethyl]amino}-5,8-bis(phenylsulfanyl)anthracene-9,10-dione 
(162) with values of 7.31 eV and 7.34 eV respectively (Table 5-19). Again the values
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obtained for the sulfur containing systems are closer to the active compounds Mitoxantrone 
(24b) and Amentantrone (24a) than the inactive compounds l,4-dihydroxyanthracene-9,10- 
dione (111) and anthracene-9,10-dione (1).
The data shows the modification of the groups at the 5- and 8- positions can have a marked 
effect. Introduction of SH in place of OH has no real effect however the introduction of 
sulfur substituents such as SEt and SPh leads to a decreased ionisation potential which could 
indicate improved activity.
This general pattern of reduced ionisation potential and increased LUMO energy is also seen 
in the other derivatives. The synthesised derivatives have similar physical properties to the 
active derivatives such as Amentantrone (24b) as opposed to the inactive derivatives such as 
anthracene-9,10-dione (1). For example l,4-bis[(2-(hydroxyethyl)amino]-5,8- 
bis(ethylsulfanyl)anthracene-9,10-dione (142) has an atomic charge of -0.35 for the nitrogen 
atoms and an ionisation potential of 7.44 eV which compares to -0.34 and 7.71 eV for 
Mitoxantrone. l,4-Bis[(2-(hydroxyethyl)amino]-5,8-bis(ethylsulfanyl)anthracene-9,10-dione 
(142) has a LUMO value of 0.93 eV and compares to 0.79 eV for Mitoxantrone(24b). The 
sulfur containing molecules synthesised in this work (148,133 & 134) were also calculated at 
the ab initio 6-31G** level. The results are consistent with the AMI values shown in Table 5- 
21, taking l,4-bis(propylamino)-5,8-bis(ethylsulfanyl)anthracene-9,10-dione (133) as the 
example it can be seen that the charge distributions are magnified and the HOMO energies are 
around 1 eV smaller. The calculated charge on the nitrogen atom is -0.34 in the AMI method 
(Table 5-20) which compares to -0.83 using the ab initio method 6-31G** (Table 5-21), and 
the calculated HOMO is -7.35 eV for the AMI method compared to -6.63 eV for the ab initio 
method. Significantly however the LUMO energies are positive in line with the adjusted 
values. l,4-bis(propylamino)-5,8-bis(ethylsulfanyl)anthracene-9,10-dione (133) has an 
adjusted LUMO of 0.96 eV for the AMI method compared to 1.05 eV for the ab initio 
method 6-31G**.
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The hetero-carbon bond lengths calculated by the AMI method compare well to the ab initio 
method 6-31G**. The C1-N17 for l,4-bis(propylamino)-5,8-bis(ethylsulfanyl)anthracene-
9,10-dione (133) is predicted to be 1.363 A  by the 6-31G** ab initio compared to 1.376 A  for 
the AMI method. The S22-C11 bond also compares well with values of 1.788 A  for the 6- 
31G** ab initio method compared to 1.779 A  for the AMI method.
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Table 5-21. l,4-bis(amino)-5,8-bis(sulfanyl)anthracene-9,10-diones using ab initio
methods
r 1
Nl7 Ol5 $21 
4 6 8
I II |
^ N 19 0 16 S22V.
R X20 R'
Number (148) (133) (134)
R H (012)2 c h 3 (CH2)2CH3
R’ CH2CH3 CH2CH3 C^Hs
Basis set 6-31G** 6-31G** 6-31G**
Distance*
C1N17 1.361 1.363 1.362
C4N19 1.361 1.363 1.362
H18N17 0.991 0.991 0.991
H20N19 0.991 0.991 0.990
015H18 1.860 1.880 1.901
O16H20 1.860 1.880 1.901
015C13 1.210 1.207 1.207
OI6C6 1.210 1.207 1.207
S21C11 1.770 1.788 1.799
S22C8 1.770 1.788 1.799
Charge b
015 -0.627 -0.629 -0.629
016 -0.627 -0.629 -0.629
N17 -0.805 -0.828 -0.825
N19 -0.805 -0.828 -0.825
H18 0.362 0.363 0.360
H20 0.362 0.363 0.360
S24 0.314 0.314 0.408
S23 0.314 0.314 0.408
Total energyc -1745.8 -1980.0 2282.0
Dipole momentd 0.2404 0.107 0.996
HOMO* -6.858 -6.634 -6.729
LUMO* 1.040 1.046 0.838
8 Bond lengths in angstroms. b Bond angles in degrees.c In A .U .d Dipole moment in D ebyese In eV
2 2 2
5.6.4 Hetero cyclic anthracene-9,10-diones
The charge on the nitrogen atom N24 in the thiazine ring is reduced, when compared to 
Mitoxantrone (24b) which carries a charge on N24 of -0.34 compared with -0.28 for 7-{[2- 
(dimethylamino)ethyl]amino}14H-naptho[2,3a]phenothiazine-8,13-dione (1511) (Table 5-22), 
however the other nitrogen atom N21 is unaffected with a value of -0.34 which is in line with 
Mitoxantrone (24b).
The ionisation potential for the thiazine derivatives is reduced in comparison to Mitoxantrone 
(24b), for example 7-{[2-(dimethylamino)ethyl]amino}14H-naptho[2,3a]phenothiazine-8,13- 
dione (151f) has a value of 7.43 eV, which compares to 7.71 eV for Mitoxantrone (24b).
The introduction of a thiazine ring into the system leads to no real effect on the energy of the 
adjusted LUMO with values of 0.68 eV for 7-{[2-(dimethylamino)ethyl]amino}14H- 
naptho[2,3a]phenothiazine-8,13-dione (1511), this compares to 0.71 eV for Mitoxantrone 
(24b) (Table 5-22).
The thiazine ring reduces the atomic charge on the nitrogen atom within the ring, to values 
similar for the exocyclic oxygen atom present in both Mitoxantrone (24b) and 1,4- 
dihydroxyanthracene-9,10-dione (111) this may not be desirable. However, the ionisation 
potentials are low, indicating an ease of the molecules to undergo oxidation and form polar 
species. The LUMO is unaffected in comparison to Mitoxantrone (24b).
5.6.5 Conclusion
There are a number of differences between the ionisation potentials of the biologically active 
molecules such as Mitoxantrone (24b) and the inactive molecules such as anthracene-9,10- 
dione. The calculated values suggest that anticancer anthracene-9,10-dione molecule should 
have ionisation potentials in the region 7.78 to 7.95 eV. In addition, it seems that the
223
molecules should also possess basic atoms which can perhaps complex with DNA. Clearly 
the nitrogen atoms in Mitoxantrone (24b) and Amentantrone (24a) carry a much larger charge 
than the oxygen atoms in l,4-dihydroxyanthracene-9,10-dione (111). It is suggested therefore 
that the active anthracene-9,10-dione molecules should not only possess basic centres but also 
have the appropriate ionisation potentials.
Many of the molecules synthesised in this work meet both these criteria and may possess 
anticancer activity, however this aspect of the work was beyond the scope of the current 
studies.
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CHAPTER  
Six
C o n c l u s i o n s
2 2 8
6 Summary of the work and conclusion
The main aims of this research which are discussed in detail in chapter 2, were to 
synthesis some novel sulfur containing anthraquinone derivatives. Two classes of 
derivatives were successfully synthesised, i.e. l,4-bis(amino)-5,8-(sulfanyl)anthracene-
9.10-dione and 7-(alkylamino)-l4H-naptho[2,3a]phenothiazine-8,13-dione.
Synthesis of l,4-bis(amino)-5,8-(sulfanyl)anthracene-9,10-dione was achieved from 1,4- 
dihydroxy-5,8-dichloroanthracene-9,10-dione. 1,4-dihydroxy-5,8-dichloroanthracene-
9.10-dione was synthesised from the chlorination of l,4-dihydroxyanthracene-9,10-dione 
using a mixture of boric acid and 65% oleum with a catalyst of iodine. The thiolation of
1.4-dihydroxy-5,8-dichloroanthracene-9,10-dione with thiophenolate, 2-methyl-2- 
propylthiolate and potassium thiocyanate under basic conditions did not result in the 
desired products i.e. the l,4-dihydroxy-5,8-(sulfanyl)anthracene-9,10-diones. It was 
concluded that the lack of reaction was due to the deactivating effect of the hydroxyl 
groups, a similar effect was found in l,4-dimethoxy-5,8-dichloroanthracene-9,10-dione.
Animation of l,4-dihydroxy-5,8-dichloroanthracene-9,10-dione was achieved using the 
reduced form, 2,3-dihydro-9,10-dihydroxyanthracene-l,4-dione (121) with several alkyl 
amines. However, the reaction of 2,3-dihydro-9,10-dihydroxy-5,8-dichloroanthracene-
1.4-dione (121) with aniline to yield l,4-bis(phenylamino)-5,8-dichloroanthracene-9,10- 
dione (131) required the addition of boric acid to facilitate the reaction.
Once synthesized, the l,4-bis(amino)-5,8-dichloroanthracene-9,10-diones were then 
thiolated with thiophenol and 2-ethanethiol in DMF with an appropriate base to yield the
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1,4-bis(amino)-5,8-(sulfanyl)anthracene-9,10-dione. The thiolation of 1,4-bis(amino)- 
5,8-dichloroanthracene-9,l 0-diones either with potassium thiocyanate or with 2-methyl- 
2-propyl thiolate was unsuccessful. The thiolation of 1,4-bis {[2- 
(dimethylamino)ethyl]amino}-5,8-dichloroanthracene-9,10-dione (127) and 1,4-bis{[2- 
(diethylamino)ethyl]amino}-5,8-dichloroanthracene-9,10-dione (128) was also 
unsuccessful with thiophenolate and 2-ethanethiolate.
Prolonged reaction times for the thiolation of l,4-bis(amino)-5,8-dichloroanthracene-
9,10-diones in DMF led to dealkylation products. Dealkylation has been attributed to a 
free radical reaction involving oxygen, which attacks the hydrogen atom a  to the amino 
group and results in the formation of peroxide that decomposes to yield the amine, water 
and a carbonyl compound. Dealkylation also occurred in the simpler 1,4- 
bis(alky lamino)anthracene-9,10-diones.
Synthesis of 7-(alkylamino)-14H-naptho[2,3a]phenothiazine-8,13-dione was obtained 
from the reaction of l-(alkylamino)-4-hydroxyanthracene-9,l 0-diones with 2- 
aminothiophenol in the presence of boric acid. The direct animation of 7-hydroxy-14H- 
naptho[2,3a]phenothiazine-8,13-dione with alkylamines was unsuccessful, as was the 
alkylation of 7-amino-14H-naptho[2,3a]phenothiazine-8,13-dione with 2-chloroethanoL
Molecular modeling studies were carried out using the MNDO, AMI and PM3 methods 
to assess the accuracy of these methods, they were used to calculate the geometries of 6 
known anthracene-9,10-dione derivatives with known structures present in the 
Cambridge crystallographic database. The results showed that:
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• Non-planar structures were predicted for l,4-bis(alkylamino)- and 1,4- 
bis(phenylamino)-anthracene-9,l 0-diones which are contrary to the X-ray 
crystallographic data. This non planar geometry has been attributed in each 
method to the amino group preferring a lower energy sp3 tetrahedral 
conformation rather than a planar sp2 trigonal conformation. This results in 
the carbonyl oxygen atom being pushed out of plane of the molecule to 
maintain the hydrogen carbonyl oxygen bond distance.
• Planar geometries are produced for each molecule however, when the heavy 
atoms are constrained to lie in one plane, though this leads to a small energy 
penalty.
• The PM3 method is more accurate at predicting the hydrogen oxygen bond 
distance but the AMI method is more accurate at predicting the heteroatom 
carbon atom bond lengths. The MNDO method is the least accurate
• The AMI method is better than the PM3 and MNDO methods for modeling of 
l-[6-(sulfanylhexyl)thio]anthracene-9,10-dione as it gives a planar geometry 
in line with the x-ray crystallographic data.
The AMI method was selected to model the synthesized compounds as it gives the best
overall.
As a comparison, some higher level ab initio calculations were also carried out on 
selected models. Although time consuming these calculations did maintain the planar 
geometry in line with crystallographic data.
The computational data highlighted two factors that may be significant in the biological 
activity of anthracene-9,10-diones. These factors are the HOMO or ionization potential 
of the molecules and the atomic charge of exocyclic atoms. It was concluded that 
molecules which are biologically active possess basic nitrogen atoms and ionization 
potentials calculated by the AMI method in the range of 7.7-7.9 eV. The computational 
data of the derivatives synthesized in this work shows many of them meet this criteria
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and therefore may possess anti-cancer activity, though this aspect of the work was 
beyond the scope of the current studies.
Overall a set of twenty four anthracene-9,10-dione derivatives were synthesized, of these 
19 were novel and twelve of them contained sulfur. The computational results indicate 
that the molecules synthesized have properties similar to biologically active derivatives 
such as Mitoxantrone (24b) as opposed to the inactive derivatives such as anthracene-
9,10-dione (1) and l,4-dihydroxyanthracene-9,10-dione (111).
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APPENDIX
The following table defines the keywords commonly used in the semi-empirical calculations 
performed for this research.
Keyword Definition1
AM I Use the Austin Model 1 Hamiltonian
DDMIN = n.nn The minimum size of the trust radius in EF calculations is set to 0.001 if 
this keyword is not used. Various sizes of the trust radius can be defined 
by setting DDMIN = n.nn
EF The eigenvector following routine is used in the search for an energy 
minimum.
GEO-OK Overrides the interatomic distance check.
LET Override certain safety function (used in conjunction with DDMIN).
NOEVTER Do not print interatomic distances.
NOLOG Suppress the generation of a log file.
NOMM Do not use molecular mechanics correction to C(0)NH bonds.
PM3 Use the MNDO-PM3 Hamiltonian.
PRECISE Criteria to be increased by 100 times.
VECTORS The eigenvectors are to be printed.
XYZ Do all geometric operations in Cartesian coordinates.
1 Adapted from \heMOPAC 93 manual, Fujitsu Ltd., Tokyo, Japan, 1993.
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